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Abstract 
Tagetitoxin was first isolated over thirty five years ago and a total synthesis has not been 
achieved to date. A vast amount of research has been carried out on the biological activity of 
tagetitoxin with hundreds of literature reports. However, very few papers have been published 
regarding the synthesis and within this thesis we will explore a number of synthetic pathways 
some towards tagetitoxin. 
The first chapter reviews previous developments regarding the total synthesis of tagetitoxin. It 
also covers the discovery and biological work that has being carried out in identifying the 
structure and the biological activity of tagetitoxin.  
The second part reports my studies towards a total synthesis of tagetitoxin. It details all the 
routes explored showing the key intermediates and novel compounds we obtained. 
The third and final part contains the experimental data for all compounds discussed in part two 
of this thesis.  
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Abbreviations 
Å-Ångström 
Ac-Acetyl aq. -aqueous (solution)  
Ar-aromatic (proton)  
[α]D-specific optical rotation at the sodium D line  
cat.-catalytic  
cm-1-wave number  
°C-degrees Celsius  
c-concentration  
δ-chemical shift  
DAM-Diacetone mannose  
DBDMH-1,3-dibromo-5,5dimethylhydantoin  
DCM-dichloromethane  
DIPA-diisopropylamine  
DMAP-4-(dimethylamino)pyridine  
DMF-N,N-dimethylformamide  
DM-Dess-Martin Periodinane  
DMSO-dimethylsulfoxide  
DMDO-dimethyldioxirane 
eq-equivalent  
FAB-fast atom bombardment  
h-hour(s)  
Hz-Hertz  
IR-Infrared  
Kdo-3-deoxy-D-manno-2-octulosonic acid  
LiAlH4-lithium aluminium hydride  
LDA-lithium diisopropylamine  
M-molarity  
m-CPBA-meta-chloroperbenzoic acid  
min-minute(s)  
mp-melting point  
m/z-mass to charge ratio  
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Ms-mesyl  
MS-mass spectrometry  
NBS-N-bromo succinimide  
NMR-nuclear magnetic resonance  
NTP-nucleotidyl triphosphate  
PCC-pyridinium chlorochromate  
PDC-pyridinium dichromate  
ppm-parts per million  
pTSA-para-toluenesulfonyl acid  
pyr-pyridine  
RNA-ribonucleic acid  
r.t.-room temperature  
sat.-saturated  
SM-starting material(s)  
TBAF-tetrabutylammonium fluoride  
TBDMS-tert-butyldimethylsilyl  
TBDPS-tert-butyldiphenylsilyl  
TEA-triethylamine  
Tgt-tagetitoxin  
THF tetrahydrofuran  
TIP- triisopropylsilyl  
TLC-thin layer chromatography  
Ts-tosyl  
TMS-trimethylsilyl 
Tr-trityl 
 
 
All other abbreviations are used according to the IUPAC nomenclature or SI units. 
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Introduction: 
Background: 
Tagetitoxin is a relatively new toxin which was first isolated and purified in 1981, and since 
then has attracted a lot of attention in chemical research.1 There has been much debate 
surrounding the structure of tagetitoxin, and to this date a crystal structure has not been 
obtained of tagetitoxin in its pure form. There has been a good deal of literature published in 
relation to its biological activity, but there are little papers in relation to the synthesis and 
biosyntheisis of tagetitoxin. Efforts are still ongoing to demonstrate the first total synthesis of 
tagetitoxin, and this has led our group to carry out its investigations towards the total 
synthesis. 
Isolation 
The isolation and purification of a chemical component from Pseudomonas syringae pv. Tagetis 
which was named tagetitoxin, was first published in 1981 by Mitchell and Durbin.1 They began 
by obtaining a culture of Pseudomonas syringae pv. Tagetis, which had been obtained from 
Fahy.2  
After extracting and carrying out purification of the toxin containing fractions and analyzing 
these toxin fractions, Mitchell and Durbin had observed that tagetitoxin was known to contain 
a sulfur atom, an amino group and a phosphate moiety.1  
Mitchell and Durbin were the first group to have isolated and purified tagetitoxin successfully, 
and now more work was needed to characterize the structure of tagetitoxin.2  
Structure 
In 1983 Mitchell and Hart published a paper with the first proposed structure of tagetitoxin 
(Figure 1).3 They believed the structure to contain an eight membered ring. They were unable 
to get an X-ray crystal structure of tagetitoxin due to the isolation of their sample of the toxin 
as a non-crystalline glassy residue. An IR spectrum of tagetitoxin only provided limited 
information indicating the presence of hydroxyl, carbonyl and phosphate group. Field 
desorption mass spectrometry determined that tagetitoxin gave  M/Z of 435 for M+ which 
indicated that tagetitoxin has a molecular weight of 435 corresponding to  a molecular formula 
of C11H18O13SNP. In addition, the hetroatomic components of tagetitoxin were identified as 
nitrogen in an amine from treatment with Ninhydrin which produed a purple colour (a key 
characteristic of nitrogen in an amine), and phosphorus in a phosphate ester from treatment 
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with a molybdate reagent producing a characteristic blue colour. In addition to these tests 
Mitchell carried out 31P NMR and 35S NMR spectroscopy. The sulfur was deduced to be present 
as either a thiol or a thioether and not in a sulfate ester as treatment of tagetitoxin with a 
strong acid did not liberate sulfate but instead a mixture of unknown products. However, 
treatment of tagetitoxin with sodium nitroprusside gave a positive colour, indicating the 
presence of a thiol. In the 31P NMR spectrum it showed a doublet (J=11.5Hz) at δ 1.0 downfield 
from the phosphate, which was consistent with the presence of a phosphate ester or a 
secondary alcohol. The 13C NMR spectrum had signals from 11 carbons in total, three present 
as carbonyl groups and five monosubstituted with oxygen. The functionalities contained in 
these five carbon substituents were deduced from 1H and 13C NMR chemical shifts to be one 
acetyl, one phosphate, and either three hydroxyl functions or one hydroxyl and one ether 
function. 
Using both the NMR and mass spectral data, Mitchell and Hart suggested the molecular 
formula of tagetitoxin to be C11H18O13SNP, and, furthermore, supported the presence of three 
hydroxyl functional groups rather than the alternative combination of one hydroxyl and one 
ether function. In accordance with the molecular formula and functional groups outlined, a 
fully saturated acyclic compound would have 20 hydrogens. Therefore, tagetitoxin has one unit 
of hydrogen unsaturation, and because the 13C NMR showed there were no carbon-carbon 
double bonds present, tagetitoxin must be a single ring structure. These arguments are based 
on the sulfur of tagetitoxin having an oxidation state of -1, such as a thiol or thioether, and thus 
carrying no oxygenation. These observations supported the hypothesis that sulfur was not in a 
sulfate ester. Further tests were conducted on tagetitoxin by reacting it with sodium 
nitroprusside which showed no colour change, but when the toxin was pretreated with dilute 
hydrochloric acid a positive colour change was observed, indicating a thiol. A double labeling 
experiment was performed by growing P.s. Tagetis in the presence of 32PO4
3- and 35SO4
2-, 
yielding a radiochemicallypure tagetitoxin which demonstrated a phosphorus-sulfur ratio of 
1:1, showing the presence of one sulfur atom present in the tagetitoxin molecule. The 1H NMR 
spectrum of tagetitoxin displayed a single methyl group (methyl in the acetyl) and well 
resolved multiplets and, therefore, gave useful structural information about the carbon 
skeleton of tagetitoxin. From both the NMR and mass spectrometry data and functional group 
knowledge from the group this led Mitchell and Hart to propose the first structure of 
tagetitoxin shown below (Figure 1).3 
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Mitchell et al. revised the structure of tagetitoxin in 1989 based on new mass spectrometry 
and NMR analysis they had carried out.4 Higher resolution FAB Mass spectrometry gave a 
(M+H)+ = 417.0316, indicating that tagetitoxin has a molecular formula of C11H17N2O11PS, not 
C11H18O13SNP which had been reported six years earlier by  Mitchell. The functional group 
containing the additional nitrogen was deduced from NMR data to be an amide, since the 13C 
NMR clearly indicated the presence of only one C-N bond, and since there was no 
phosphoramide nitrogen as evidenced by the 31P chemical shift. The oxygen containing 
functional groups of tagetitoxin come from one acetyl, one phosphate, one carboxylic acid, one 
carboxamide and two oxygens, either as hydroxyl or ether groups. A fully saturated non-cyclic 
compound with these substituents would contain 21 hydrogens, and since the mass spectrum 
of tagetitoxin indicated the presence of only 17 hydrogens coupled with the lack of any carbon-
carbon double bonds in the 13C NMR data, tagetitoxin must contain two rings. Using the data 
obtained, in conjunction with chemical shifts, allowed Mitchell et al. to suggest only two 
possible bicyclic ring structures 2 and 3, shown below (Figure 2).  
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Both these bicyclic ring structures and substitution patterns were supported by nOe 
experiments. The coupling constants between the protons of the four-carbon series C5-C6 
(J=3.6 Hz), C6-C7 (J=12.4 Hz), C7-C8 (J=6.0 Hz) allowed the dihedral angles to be deduced as 
follows for C5-C6 approximately 50°, C-6-C7 approximately 180° and finally C7-C8 
aprroximately 35°. Using these angles, they are best accommodated by structure 2, where the 
protons on C-6 and C-7 are in a true diaxial interrelationship. In contrast, the 5-membered ring 
structure 3 places a constraint on the 7-membered ring that does not allow a true diaxial 
relationship between C-6 and C-7 protons, whereas a diaxial interrelationship is fully supported 
by the structure proposed in structure 2. On this basis, Mitchell et al. favoured structure 2, 
although the data they obtained does not entirely eliminate the other proposed structure 3.4 
 
In 2005, Gronwald and colleagues reported that the structure of tagetitoxin which was 
proposed by Mitchell and his co-workers was incorrect due to an incorrect mass spectrum 
analysis.5 Electrospray ionization (ESI) mass spectrometry gave (M+H+) m/z = 679.5216 which 
indicated that the molecular weight of the tagetitoxin is 678, considerably greater than that 
previously reported of 416 by Mitchell et al. The NMR spectra reported by Mitchell et al. did 
however resemble the same NMR spectra obtained by Gronwald. Gronwald assumed that the 
additional mass units were accounted for due to the presence of oxygen, nitrogen, sulfur and 
exchangeable protons, which are not detected by 1D NMR. Their results indicated that the 
molecule contains a phosphate ester but does not contain a primary amine, and tagetitoxin 
cannot absorb UV or visible light. Having shown that the proposed structures by Mitchell et al. 
were incorrect, Gronwald however, failed to propose a molecular formula, let alone a structure 
of tagetitoxin and therefore structure 2 seems still the most plausible structure.5 
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Crystal Structure 
In 2005 Vassylyev and co-workers published the first X-ray structure of tagetitoxin, which was 
obtained as a ttRNA-tagetitoxin complex, with tagetitoxin bound to the active sites of the RNA 
polymerase (Figure 3).6  This structure confirmed that the structure proposed by Mitchell and 
his co-workers was the most probable and removed the uncertainty about the position of the 
carboxamide and the carboxylic acid functional groups within tagetitoxin This bicyclic structure 
is the target described within this thesis. 
 
Figure 3: Left: Structure of Tagetitoxin-RNAP complex; Right: tagetitoxin binding site.6  
Source of Figure 3: Vassylyev, D. G.; Svetlov, V.; Vassylyeva, M. N.; Perederina, A.; Igarashi, N.; 
Matsugaki, N.; Wakatsuki, S.; Artsimovitch, I. Nat. Struct. Mol. Biol. 2005, 12 (12), 1086–1093. 
Biological Activity 
Tagetitoxin is a bacterial non-host specific phytotoxin, produced by Pseudomonas syringae pv 
tagetis, which causes apical chlorosis and leaf spot in host species of the Asteraceae family 
(e.g. zinnia (Zinnia elgans Jacq.) and sunflower (Helianthus annuus)].6 The toxin which is 
produced in planta, is translocated to apical regions, where it inhibits chloroplast RNA 
polymerase III, which in turn blocks chloroplast biogensis. Tagetitoxin was shown also to inhibit 
RNAPs of bacteria, insects and vertebrates at micromolar levels of tagetitoxin in vitro, whereas 
in eukaryotic cells, RNA polymerase III was inhibited while RNA polymerases I and II were 
resistant.6 
 
In 1990 Durbin and Matthews published a paper on the inhibition of eukaryotic transcription 
by RNA polymerase III caused by tagetitoxin.7 Their work focused on the inhibition of RNA 
polymerase from chloroplasts and Escherichia coli. In isolated chloroplasts, tagetitoxin quickly 
and specifically reduced the incorporation of [3H] uridine into RNA. When added to 
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transcriptionally active chloroplast protein extracts, the toxin directly inhibited incorporation of 
[32P] UTP into RNA. In addition, tagetitoxin inhibited in vitro RNA synthesis directed by the RNA 
polymerase from Escherichia Coli. In vitro transcription reactions directed by chloroplast RNA 
polymerase or E. coli RNA polymerase are inhibited at tagetitoxin concentrations less than 1 
μM. Nuclear RNA polymerase II purified from wheat grain was only affected at tagetitoxin 
concentrations greater than 100 μM during in vitro transcription. Tagetitoxin concentrations as 
high as 1 mM did not affect in vitro transcription reactions directed by RNA polymerase from 
bacteriophage T7 or SP6.  
 
In 1992 Steinberg and Burgess published another paper which focused on testing the potential 
inhibition of eukaryotic RNAPs.8 The toxin was shown to inhibit selectively RNAP III in vitro and 
in xenopus oocytes, showing effects on RNAP III from a wide range of organisms. They 
suggested that tagetitoxin acted directly against the RNAP III and not by binding transcription 
factors. This mode of action showed that in RNAP III there was a conserved structure to which 
the toxin could bind. Response differences could also be explained  by the fact that the enzyme 
conformations could be different according to the template or protein cofactors in the 
transcription complexes. Mathews and Durbin carried out further work that indicated that 
tagetitoxin inhibition resulted in the small molecule reversibly binding to the discrete site of 
RNAP-template transcription complexes, creating an enhanced pausing in the transcription 
process, and this was template-dependent.9 
Mechanism action of tagetitoxin 
Vassylyev and his co-workers in 2005, having obtained the crystal structure of the tagetitoxin-
RNAP complex of the bacterium T. thermophilis argued, against the already published simple 
mechanism of tagetitoxin, that tagetitoxin action would be in direct competition with the NTP 
substrate.6,10,11  Vassylyev and his co-workers postulated that the mechanism by which 
tagetitoxin worked was by stabilizing some inactive intermediate during the substrate loading 
in the active site.  
 
Structural analysis carried out by the authors suggests that an intermediate may be formed at 
either the pre-insertion or insertion step. The authors favored a concerted two-step model, in 
which the intermediate is preformed in the pre-insertion site and then is finally stabilized in the 
insertion complex. 
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The authors postulated that while binding to the pre-insertion site in the presence of 
tagetitoxin, the substrate phosphate that coordinates the cMG2 ion would, however, switch 
interactions to a well fixed tMG. This would in turn give a subsequent loss of cMG2. This 
proposal by the group would suggest that the substrate loading in the insertion was probably 
achieved by a simple rotation without repositioning of the phosphates in the NTP, and the 
interactions of NTP with tMG would not be disturbed during the isomerization. The more 
compact conformation of the active site in the insertion stage would result in a tighter binding 
of the tMG-bound substrate to prevent the dissociation of the substrate and the catalytic 
reaction, thereby irreversibly locking RNAP in a nonproductive state (Figure 4).6 
 
Figure 4: Proposed Mechanism of Tagetitoxin.6 
Tagetitoxin inhibited all catalytic activities of RNAP and apparently competed with ppGpp for 
the effect on (and probably binding to) RNAP. The binding of tagetitoxin to RNA polymerase is 
exclusively by polar interactions, 9 of the 11 tagetitoxin oxygen atoms form 18 hydrogen bonds 
with the adjacent protein chains (Figure 3). 
  
A basic and acidic set of side chains that constitute the tagetitoxin-binding site formed an 
extensive network not only with the inhibitor but also formed with each other. This concerted 
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mode of recognition could be essential for the binding of tagetitoxin, which could be highly 
sensitive to subtle altercations either in conformation or position even for a single residue.  
 
Tagetitoxin specifically interacts with three highly conserved basic residues (β Arg678, β 
Arg1106 and β’ Arg731). The basic sidechain β’ Asn458 is probably involved in substrate 
recognition, however, the tagetitoxin-binding and nucleotide triphosphate-binding sites do not 
overlap directly, suggesting that the competition with the substrate is not a major component 
of the tagetitoxin action.12 
Vassylyev and his co-workers also postulated that an important structural feature of the RNAP-
tagetitoxin complex was a well-fixed Mg2+ ion (tMG) that mediates RNAP interactions with 
tagetitoxin. It was shown that this Mg2+ ion was coordinated by the phosphate in tagetitoxin 
and by two other active site residues, β’ Asp460 and β Glu813. The authors also compared this 
with the apo-holoenzyme, the side chain of the β’ Asp460 which was better fixed in the 
complex by the bridging the two Mg2+ ions (cMG1 and tMG); this may favour coordination and 
strengthen binding of the catalytic cMG1. Tagetitoxin was shown to increase RNAP affinity for 
the major catalytic Mg2+ ion, cMG1.  
Previous studies towards the synthesis of tagetitoxin 
Sammakia et al. 
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In 1996 Sammakia et al. published a paper on the synthesis of tagetitoxin.13 From the 
retrosynthetic analysis carried out, Sammakia, envisaged that an enzymatic coupling of 
dihyroxyacetone phosphate 4c with aldehyde 4d would form the fully functionalized 
tagetitoxin precursor 4b. The next step would involve the cyclization of 4b to give the proposed 
structure of tagetitoxin. Sammakia et al. proposed that aldehyde 4d could be prepared from an 
oxazolidine olefin 4e by a dihydroxylation followed by hydrolysis of the oxazolidine complete 
with an oxidation of the primary alcohol to give the desired aldehyde precursor 4d (Scheme 1).  
 
Sammakia therefore examined the preparation of alkenes 5a-e and studied the effect of the 
protecting group on the ratio of dihydroxylation to sulfur oxidation (Scheme 2 and table 1). 
These alkenes were readily available in a one-pot synthesis with the generation of the 
phosphonate in situ followed by a condensation with the oxazolidine aldehyde. Using the 
above methodology Sammakia could vary the thiolate anion to produce a series of oxazolidine 
alkenes bearing protected thiols 5-Z and 5-E of different steric and electronic properties giving 
a mixture of products (Table 1). From the results it is clear that α, β-unsaturated esters were 
much more unreactive than the other systems explored by the group.  
 
R Ethyl 
5a 
i-Propyl 
5b 
t-butyl 
Sc 
Phenyl 
5d 
Benzyl 
5e 
Z:E 60:40 70:30 100:0 20:80 30:70 
Table 1: Ratio of E: Z products of olefin 5 
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The group then attempted the dihydroxlation of 5. The use of stoichiometric amounts of OsO4 
only produced sulfur oxidized products 7 and 8, and therefore led the group to explore other 
ferricyanide oxidants. The use of AD-mix-β gave the poorest results and the group postulated 
that the bulky osmium-ligand complex was sterically demanding and reacted slower with the 
electron deficient and sterically hindered alkene substrates prepared (Scheme 3 and table 2). 
Changing the oxidant to K3Fe(CN)6 gave little of the desired product when used with substrates 
5a, 5b and 5e, with over-oxidation being observed and the major product being the sulfoxide 
instead of the desired sulfone product. Dihydroxylation of the phenyl sulfide 5d followed the 
expected trend and gave less of the sulfur oxidized products, which were isolated with less 
bulky substrates. The t-butyl thiol substrate 5c, was the only substrate to give the desired 
dihydroxylation product using osmium with K2Fe(CN)6 as the co-oxidant in good yield. This 
reaction gave isolated yields in the 50-63% range, and the osmylation gave a diastereoisomeric 
ratio of 25:1, the major product being the desired substrate for the synthesis of tagetitoxin. 
Sammakia reasoned that the major isomer was consistent with the osmium approaching the 
less hindered side opposite the BOC group in the minimum energy conformation.  
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R Oxidant Recovered 
Starting 
Material 
6 7 8 
5-a AD-mix-β 54 - 46 - 
K3Fe(CN)6 30 - 70 - 
5-b AD-mix-β 56 6 28 - 
K3Fe(CN)6 39 15 44 - 
5-c AD-mix-β 86 14 - - 
K3Fe(CN)6 32 55 11 - 
5-d AD-mix-β 99 - <1 - 
K3Fe(CN)6 34 27 - 39 
5e AD-mix-β 88 - 10 - 
K3Fe(CN)6 22 6 72 - 
Table 2: Results of dihydroxlations of olefin 5 using varying oxidants  
In conclusion, Sammakia developed a methodology to synthesize the required aldehyde 4d as 
the major intermediate in their methodology in the total synthesis of tagetitoxin, however no 
more work on this approach has since been reported, and the quest continues to  achieve a 
total synthesis of tagetitoxin. 
Dent et al. 
 
In 1999 Dent explored making different analogues of tagetitoxin due to its unique biological 
activity.14 They based their studies on structure 9; the authors hypothesized that the acetate, 
amine and phosphate groups are important for the activity while the C-S-C link was present to 
impose the required geometry. Dent believed that structure 9 matched tagetitoxin the best 
and studies began on analogues derived from D-sugars because they are readily available. 
These staring materials are structurally related to 9, and have shown biological activity.  In the 
paper, Dent described several approaches to these analogues based on structures 11 and 12.14 
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The overall aim of the authors was to provide an insight into the structure-activity relationships 
of tagetitoxin, and also incidentally the construction of carbohydrate-based vicinal cis-amino 
phosphates. While compounds of 11 where synthesised, making bicyclic compounds like 
compund 12 where X=S,O had unexpected problems. 
 
Dent began with a cyclization of the dialdehyde 13 with nitromethane and sodium methoxide 
to give the 1,6-anhydro-3-deoxy-3-nitro-D-gulose adduct 14. The dialdehyde 13 was easily 
obtained by the periodate oxidation of levoglucosan. The nitro 14 product was subsequently 
reduced by a catalytic hydrogention to give the amine 15. The configuration obtained was the 
D-gulo-configuration, which was supported by the large 1H nmr coupling constant of J3,4=9.9 
Hz, and  was also confirmed from the X-ray analysis of the hydrochloride salt of compound 15. 
Dent decided it was desirable then to exploit the syn-disposition of the C-2 and C-3 subsituents 
in the anhydride 15 which permitted selective esterifcation on the C-2 and C-4 hydroxyl groups. 
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Amine 15 was then N-Boc protected to form compound 16, which was then treated with 
bis(tributyltin) oxide, followed by tetrabutylammonium bromide and benzyl bromide in toluene 
under reflux giving the desired N-benzyl-protected cyclic carbamate 17. Protection of the free 
hydroxyl on C-4 with THP under acidic conditions leading to the protected compound 18, 
followed by alkaline cleavage of the carbamate group led to compound 19, and selective N-
benzylation with dibuytltin oxide followed by tetrabuytlammonium bromide and benzyl 
bromide to give the tertiary amine 20. Phosphitylation with o-xylylene N,N-
diethylphosphoramidite and 1H-tetrazole, followed by peracid oxidation, gave compound 21. 
Removal of the THP protecting group on O-4 in acidic conditions gave the alcohol 22, which 
was then acetylated with acetic anhydride in pyridine to afford 20. Hydrogenolysis of 
compound 23 afforded the tagetitoxin analogue 11 (X=O) as a salt in quantitative yield 
(Scheme 4).  
Dent subjected 11 to biological testing, and from the results the analogue was not active 
against the following pre- or post-emergent agriculturally important weeds: Avena Fatua (wild 
oat), Setaria viridis (green foxtail), Amaranthus retroflexus (redroot pigweed) or Chenopodium 
album (fat hen). 
Dent also carried out a second approach based on compound 11 on the theory that it was 
necessary to functionalize O-2 and O-4 of 1,6-anhydro-D-galactose 24 and develop a good 
leaving group at C-3 to introduce the amino function with a configurational inversion. 
Phosphate 26, which was prepared from 24→26→29→31 as shown in scheme 5, was treated 
with acetic anhydride in pyridine to give  the diacetate 34 in 18% yield, and an inseparable 
mixture of the monoacetates 35 and 36 in 64% yield. The mixture contained over 90% of the 4-
ester 35, which was derived by selective reaction of the more accessible equatorial hydroxyl 
group. With selective acetylation established from compound 31, the group decided to carry 
out selective acetylation on other closely related anhydrides 32 and 33 (Scheme 5). Work on 
these closely related anhydrides was unsuccessful due the sensitivity of compound 30 to acid 
and the failure to yield the diol 33. This sensitivity they presumed was due to the participation 
of the sulfur atom in reactions of the carbocations generated under these conditions. 
Acetylation of 32 with acetic acid and pyridine, or followed by the reaction with dibutyltin 
oxide or bis(tributyltin) oxide, gave inseparable 1:1 mixtures of the monoacetates 37 and 38 
contrasting with the selectivity seen in the model study of 31. Treatment with bulkier pivaloyl 
chloride and dibuytltin oxide also gave a mixture of unsuitable monoesters. Dent postulated 
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that these reactions might be victims of subsequent ester migration which would reduce the 
initial selectively. A selective acetylation was achieved when diol 32 was first converted into 
the cyclic orthoacetate 39 and then subjected to a mild hydrolysis. While this gave the desired 
acetate 38 with the new ester group axial at the O-3 position all attempts to turn this to an 
advantage were unsuccessful. The brominated orthoesters 40, which were expected to give an 
O-3 ester that could be removed in the presence of an acetate at C-4, did not hydrolyse 
selectively but produced an inseparable mixture of bromoacetates 41 and 42.  
 
Dent worked on an alternative method of selectively functionalizing anhydrides 24 and 25, 
based on the regioselective reductive cleavage of the O-benzyl and O-allyl derivatives of the 
endo-isomer of methoxybenzylidene acetal 43, which was previously reported in the 
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literature.15 Reduction of the 2-O-silyl derivatives 44 and 46, derived from 43 and 45, with 
LiAlH4 and AlCl3 gave the PMB protected O-3 ethers 47 and 50. Acetylation gave esters 48 and 
51, followed by the removal of the PMB ethers to give the hydroxyl acetates 49 and 52, 
followed by sulfonylation to give the derived 3-triflates, mesylates and tosylates, 49a, 49b, 49c 
and 52a, 52b, 52c. Attempts by Dent to obtain the desired azides 53 and 54, from 49a, 49b, 49c 
and 52a, 52b, 52c all failed with sodium azide in DMF, HMPA or DMSO (Scheme 6). Dent 
presumed that this failure may have been due to the incoming nucleophile being impeded by 
the bulky substituent on O-2, and the desired product was not obtained, with just 
decomposition being observed. 
 
Having developed a route towards the synthesis of tagetitoxin analogue 11 (X=O), Dent  then 
focused on the more closely related compound 9 (X=O,S), and envisaged making 12 from D-
galactopyranose by a chain extension, by one carbon at C-1, followed by a ring closure via a 
linkage of the new atom and C-7 through sulfur. D-galactose pentacetate 55 was therefore 
brominated with HBr, and acetic acid to give the α-glycosyl bromide, which was then treated 
with mercury (II) cyanide in nitromethane to give the β-nitrile 56. Reductive hydrolysis with 
Raney nickel, produced the unstable aldehyde, which was trapped with 1,2-dianilinoethane to 
give the imidazolidine 57. Regeneration of the aldehyde followed by a reduction, and then 
acetylation, gave the known pentacetate 58 (Scheme 7).  
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Deacetylation of 58 with sodium methoxide in methanol gave the pentaol 59, followed by a 
selective tosylation at the primary centre, gave the ditosylate 60 in 33 % yield. Conversion of 
the ditosylate 60 into the acetonide was achieved easily to give 62. Attempts to displace both 
tosylates with a divalent sulfur nucelophile failed to give the desired product 64, and the only 
product isolated was 63 (Scheme 8).  
 
Other attempts were carried out by Dent involing the removal of the steric constraints from 
the isopropylidene protecting groups, which was carried out by making a modified substrate. 
Thus deacetylation of 57, followed by tritylation of the primary alcohol gave 65, followed by 
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perbenzylation to give 66. Aldehyde unmasking followed by a reduction and detritylation gave 
the diol 67. Ditosylate formation was achieved similar to the previous substrate to give 70. 
Treatment of the ditosylate with sodium hydride gave a complex mixture, with no trace of the 
desired cyclic compound 71 being isolated (Scheme 9).  
 
Dent also explored the possibility of having an α-nitrogen bonded substituent at C-4 position, 
prior to ring closure, therefore eliminating any steric hindrance associated with at β-
substituent at this position. Dent developed a suitable substrate with a good leaving group at 
C-4. Pentaol 59 was treated with benzaldehyde dimethyl acetal to give the diacetal 72, which 
was then converted to make the already known acetate 73. Several sulfonate esters were 
prepared from the diacetal 73, triflate 74, mesylate 75, tosylate 76, and the p-
fluorobenzenesulfonate 77. Dent carried out a range of nucleophilic displacements with 
sodium azide or tetrabutylammonium nitrite in DMF or DMSO. There was no reaction or 
decomposition was observed except with the tosylate 76 which provided a little of the azide 
product 78 in 10% yield. Dent could not improve on this result to gain a higher yielding reaction 
(Scheme 10). 
25 
 
 
Dent in conclusion only made the tagetitoxin analogue 11 (Scheme 1), but all other routes 
towards the more closely related structure 12 were unsuccessful as well as all biological testing 
carried out on analogue 11, and Dent finished his studies towards the total synthesis of 
tagetitoxin having obtained very little success with the synthesis. 
Porter et al.  
In 2006 Porter and Plet published a paper on the synthesis of the bicyclic core of tagetitoxin.16 
Porter’s strategy focused on a carbene-mediated ring expansion of 1,3-oxathiolanes, on which 
his group had previously published.17,18 Porter started his studies from D-glucose, which was 
converted into the bicyclic monothioacetal 79 through a displacement of an anomeric bromide, 
followed by a 6-tosylate displacement with potassium O-ethylxanthate. Ring expansion was 
then attempted using ethyl diazo(triethylsilyl)acetate, in the presence of catalytic rhodium(II) 
acetate, which the group had developed previously, but this did not lead to the anticipated 
bridged bicycle, but had led to the undesired glycal 81.17,18 Porter postulated that this product 
may have arisen through sulfur ylid formation and hetrocyclic C-S bond cleavage to give the 
zwitterion intermediate 80, rather than the desired C-C bond formation. Porter presumed that 
this intermediate 80 underwent ring-flip to the more stable conformer followed by a proton 
transfer to afford the observed undesired product 81. 
In order to prevent this from happening, Porter designed a conformationally constrained 
substrate, where the zwitterionic intermediate would be incapable of ring flipping. Porter 
started from the readily available 3-methyl-D-glucose starting material, which was converted 
into bicyclic 82 using the same conditions as the previous substrate (Scheme 1). The acetate 
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groups were deprotected on bicycle 82, and then treated with a di-tert-butylsilylene protecting 
group, to bridge the hydroxyl groups and give the tricycle 83. Treatment of the tricycle 83 with 
ethyl diazo(triethylsilyl)acetate in the presence of rhodium(II) heptaflourobutyrate yielded the 
primary alcohol 85 as the only isolable product. Porter presumed that in this case, the sulfur 
ylid 84 intermediate formed as required, however rather than undergoing the required C-S 
bond heterolysis and ring expansion as expected; it was trapped by adventitious water to give 
the bicyclic alcohol 85 (Scheme 11). 
 
Porter changed his strategy, since the initial approach had failed to achieve the tagetitoxin 
skeleton. The new strategy involved the synthesis of a 1,4-oxathiane ring, which would be 
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formed by the cyclization of a thiol onto an electron deficient ketone, rather than carrying out 
a carbene-mediated ring expansion, which had failed the earlier approaches. 
Porter began with phenyl 1-thio-β-D-glucopyranoside 86; selective primary alcohol protection 
was achieved with TBDPS, followed by a benzyl protection of the other hydroxyl groups to give 
the fully protected analogue 87 in very good yield. NBS-promoted hydrolysis of the 
thioglycoside linkage was carried out, followed by oxidation of the lactol using Dess-Martin 
periodinane to give δ-lactone 88 in a reasonable yield. Treatment of 88 with cerium mediated 
addition of trimethylsilylacetylene, followed by deoxygenation and desilylation gave the 
terminal alkyne 90. Bromination was then carried out with NBS to give 91, followed by 
oxidation of 91 with KMNO4 to give the desired α-ketoester 92 in high yield (Scheme 12). 
Deprotection of the primary alcohol of 92 was needed in order to replace the primary alcohol 
with a good leaving group (eg MsCl), and carry out a displacement with potassium thioacetate, 
to introduce the sulfur atom at C-6 followed by a deprotection of the thioacetate and an in situ 
cyclization to give the bicyclic core. When Porter carried out this deprotection of the primary 
alcohol with TBAF, he ended up with an elimination of the 2-benzyloxy group, to form an enol 
ether, which is not what was expected. He then decided to carry out the deprotection using 
HF-pyridine on the silyl ether, and the sole product  observed was the tricyclic acetal 93, which 
he had not been expecting, and in which not only the silyl ether was cleaved but also the 3-
benzyl and 4-benzyl ethers. Formation of an acetal between the ketone and the 3-OH and 6-OH 
groups had occurred (Scheme 12). 
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Porter decided since this method had failed to introduce the necessary sulfur atom on the C-6 
position by carrying out an alternation of order of the the steps allowed completion of the 
synthesis of the tagetitoxin skeleton; thus double desilylation of substrate 89 was achieved 
with TBAF, to give the deprotected compound 94 (Scheme 13). Primary alcohol activation as 
the mesylate was achieved followed by subsequent displacement with potassium thioacetate 
to yield the desired sulfur atom at C-6 position. Bromination of the alkyne was achieved; 
similarly to the previous work with NBS to give compound 95, followed by oxidation with 
KMNO4 to give the desired α-ketoester 96. Deprotection of the S-acetyl was then achieved 
using hydrazine hydrate in methanol, giving the free thiolate, which underwent an in situ 
cyclization onto the carbonyl group of the α-ketoester to yield the desired bicyclic 
hemithioacetal compound 97 of tagetitoxin (Scheme 13). 
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In conclusion, Porter had achieved the synthesis of the bicyclic core of tagetitoxin through an in 
situ cyclization of the thiolate onto the carbonyl of the α-ketoester. This paper showed the 
importance of selecting the correct protecting groups as shown, and how to overcome 
obstacles in the synthesis of the core structure. Porter has been successful in achieving a 
skeleton closely related to tagetitoxin; however he is still missing a key carbonyl moiety on the 
anomeric carbon. 
Porter et al. 2008  
In 2008 Porter, published another paper on the synthesis of the bicyclic structure of tagetitoxin 
using a photo-Stevens rearrangement.19 Porter had published a paper in 2006, on the 
metallocarbenoid-mediated ring expansion of 1,3-oxathiolanes, but had been unsuccessful in 
obtaining the desired compounds, and they postulated that this failure was likely due to the 
conformational flexibility of a monocyclic intermediate 80, and that carrying out the ylide 
formation in an intramolecular fashion, this should give a more constrained intermediate, 
where the desired C-C bond formation would be favoured.16,20 
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Glucose-derived C(3)-diazo esters such as 98 were chosen for test reactions. D-glucose was 
converted into the 1,6-thioanhydroglucose 99 in four steps from a literature preparation.20 The 
C-2 and C-4 hydroxyl groups were selectively protected with a di-tert-butylsilylene bridge to 
give 100. Acetoacetylation and diazo transfer using the Clemmens method proceeded smoothly 
to give the model substrate 98. Treatment of 98 with 1 mol % of rhodium (II) acetate dimer 
gave the tetracyclic ylide 101. Porter was fortunate to grow a crystal of 101, and to obtain an 
X-ray crystal structure to prove the stereochemistry (Scheme 14).21 
 
Porter suggested two mechanisms for the thermal rearrangement of ylide 101, to give the 
desired tetracycle 102 (Scheme 15). The two mechanisms that Porter proposed were pathway 
A, the homolysis pathway, which is normally the more favoured mechanism for the Stevens 
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rearrangement as reported in previous examples, and pathway B, the heterolytic mechanism, 
which he believed was the most favoured in this case.22–24 To understand the mechanism more 
closely, Porter tried to promote heterolysis by addition of protic (TFA, TfOH) or Lewis 
(Cu(acac)2) acids to ylide 101, with the expectation that this would increase the polarization of 
the C-S bond, but all these attempts were unsuccessful.  
 
After the failure of the attempted induced rearrangement of the ylide thermally, Porter 
changed his strategy, to a photochemical Stevens rearrangement, which had been reported 
previously in the  literature, but  limited studies had been carried out on this topic (Scheme 
16).25–32   
Ylide 101 was subjected to photolysis in acetonitrile, to give the desired rearranged tetracycle 
102 within two hours.   
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Having achieved the target molecule by the Photo-Stevens rearrangement, Porter decided to 
investigate, which structural elements were essential for ylide formation and for this reaction. 
Acetoacetate 103 was deportected with TBAF, and the resulting diol was reprotected with 
TESCl to give 104 in good yield (Scheme 17). Diazo-transfer with p-carboxy-benzenesulfonyl 
chloride, and rhodium catalysed diazodecomposition gave 105. Photolysis furnished the 
tricyclic ring-expanded product 106 with exactly the same results as 102. 
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The authors also synthesized diazoacetate 108 from alcohol 100 from a previous reported 
synthesis (Scheme 18); acetylation of alcohol 100 gave ester 107, which was converted into the 
diazoacete by Danheiser’s detrifluoroacetylating diazo transfer method.33 Rhodium (II) acetate 
treatment of 108 in benzene led to the unexpected cycloheptatriene 109 as the major 
product.34 A simple change of the solvent to DCM, with the same reaction conditions, yielded 
the anticipated ylide intermediate 110. Purification of this ylide intermediate was not possible 
due to the instability of the product, and therefore the crude reaction mixture was subjected 
to photolysis to afford the desired tetracycle 111 in a good yield over the two steps.  
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In conclusion Porter has synthesized the bicyclic core of tagetitoxin in two different ways: the 
first from an in situ cyclization of the free thiolate onto the carbonyl group of the electrophilic 
α-ketone to give the hemithioacetal, and the second from the photo-Stevens rearrangement. 
Similarly to the first publication on the previous studies, the bicyclic core synthesized by Porter 
in this case lack the key carbonyl moiety on the anomeric carbon, and the quest for the total 
synthesis of tagetitoxin continues.16  
Porter et al. 2009  
In 2009 Porter published a paper in Synlett on his continued studies towards the synthesis of 
tagetitoxin.35 In this paper he describes efforts in applying the thiol cyclization route towards 
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the synthesis of tagetitoxin.16,19 The α-allyl glucsoide 112 was prepared using a  literature 
procedure.36 This was followed by a tosylation of the 2-hydroxyl group which was achieved 
with good selectivity and this was then accompanied by a ring closure to yield the desired β-
epoxide, followed directly by treatment with sodium azide under acidic conditions to afford the 
altro-configured azidosugar 113 (Scheme 19).37–40 Protection of the free hydroxyl was then 
achieved with TBSCl, followed by the deprotection of the allyl protecting group. The resulting 
lactol was then oxidized to give the desired lactone 114. All attempts by the group to 
synthesize 115 through the addition of TMS-acetylide to the carbonyl group of 114 were 
unsuccessful. When the group used known conditions for a similar substrate reported in the 
literature, they were only able to isolate the undesirable compound 116.16 Porter postulated 
that the initial addition to give the lithium salt of 115 was followed by the ring opening to form 
a ketone, and a second organometallic addition must have taken place in order to produce 
116. Migration of the silyl group of the tertiary alkoxide, which was relatively unhindered due 
to the presence of two sp-hybridized substituent’s, must have then occurred to give the 
undesired product 116. 
Porter then investigated the use of ytterbium triflate in place of cerium chloride as the additive 
in the lithium acetylide addition, as this had been used on other substrates.41 To his surprise, 
by changing reagent he was able to achieve the desired bicycle 117, which was obtained in 
around 48% yield.  
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Porter proposed a mechanism for the formation of 117 (Scheme 20), suggesting that it was 
obtained following the addition of the acetylide to give 118 and ring opening to afford a ketone 
119, by a transannular hydride shift to yield a secondary alkoxide 120. Upon work-up, 
cyclization to the cis-fused bicyclic lactol 117 took place. Despite the earlier successes, 
attempts to furnish the key intermediate117 were unsuccessful and only the starting lactone 
was recovered. 
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Having faced such difficulties in the synthesis of the key intermediate the group decided to 
change methodology, and instead introduce the alkyne moiety to a glucose derivative prior to 
inversion of the C-2 and C-3 sterogenic centres. 1,6-Anhydroglucose 121 was prepared 
according to previously literature procedures and this was converted to its 2,4-di-O-trietylsilyl 
derivative (Scheme 21).42 Porter then used Vasella’s method to steroselectively introduce a β-
configured alkynyl substituent at C-1.43 Using this procedure, lithium trimethylsilyl acetylide 
was reacted with aluminium trichloride prior to addition to the substrate. Having used these 
optimized conditions, an 81% yield of the diol 122 was obtained. 
Removal of the triethylsilyl ethers of 122 was achieved, and the introduction of a p-
methoxybenzylidene acetal gave the bicycle 123, followed by treatment with numerous 
sulfonylation conditions (TsCl, Ts-imidazole, Ts2O, or MsCl as reagent; NaH or pyridine as base). 
Porter found that no selectivity was obtained for one alcohol over another, and an inseparable 
mixture of 1:1 sulfonates was obtained.  
Porter, having been faced with this problem, came up with a solution by using different 
protecting groups on the O-2 and O-3 hydroxyl groups of 122. Selective primary alcohol 
protection was carried out with a silyl ether, followed by acetylation of the secondary alcohol. 
This reaction required numerous attempts as it proved to be much more difficult than 
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anticipated. The acetylation only occurred in the presence of acetic anhydride, triethylamine 
and in the presence of 4-(1-pyrrolidino)pyridine.44–46 Acid hydrolysis then cleaved the three silyl 
ethers and induced acetal formation to give the desired monoacetate 124.  This was followed 
by sulfonylation of the free hydroxyl group of 124, using tosyl chloride in pyridine under reflux 
to give the desired unstable sulfonate intermediate, which was immediately subjected to 
treatment with sodium methoxide in methanol-dichloromethane to remove the acetate and 
TMS protecting group and initiate the cyclization to give the epoxide 125.  
The next problem Porter encountered was in the diaxial ring opening of the epoxide using 
acidic conditions, as this was unsuccessful due to the hydrolysis of the acetal protecting group 
in such conditions, whilst heating with sodium azide in DMF gave an elimination product 126. 
However with the use of Yamamoto’s conditions, Porter was able to achieve the ring opening 
of the epoxide, in which the epoxide was treated with a combination of ytterbium 
triisopropoxide and TMS-azide.47 Acetylation of the 2-O hydroxyl group, followed by hydrolysis 
of the p-methoxybenzylidene acetal, was achieved. This was followed by a selective tosylation 
of the primary alcohol; followed by a tosylate displacement with potassium thioacetate, which 
gave the desired thioester 127.  
The secondary alcohol of 127 was then protected with TESCl, and the alkyne was brominated 
with a mixture of NBS / silver nitrate affording 128.48,49 However, all attempts to achieve the 
oxidation to the α-ketoester 129 were unsuccessful, only complete decomposition being 
observed.50   
In order for Porter to complete the synthesis, he needed to form the α-ketoester followed by 
the introduction of a phosphate group, and the reduction of the azide, followed by the 
cleavage of the thioester to the thiol, which would undergo an in situ cyclization to give the 
desired natural product. However despite numerous attempts the group were unable to obtain 
the desired α-ketoester 129 and the completion of the synthesis of tagetitoxin could not be 
achieved (Scheme 21). 
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Since his initial synthetic approach to tagetitoxin had not included the important carboxylic 
acid moiety on C-5, Porter decided to try to install this extra carbon substituent. Porter used a 
previously reported method in the literature from Rao in which a Grignard reagent was added 
steroselectively to a 5-keto glucose derivative (Scheme 22).51 
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The free hydroxyl group of diacetone-D-glucose 130 was protected with a PMB group, followed 
by a selective hydrolysis of the 5,6-acetonide, which was achieved using aqueous acetic acid. 
Silylation of the 6-hydroxyl group was achieved with TBSCl. Oxidation of the remaining 
secondary alcohol with a Swern oxidation proceeded smoothly to give the keto product. 
Steroselective Grignard addition was achieved using the Rao method, which gave the tertiary 
alcohol 131 (Scheme 22).51 Porter then heated 131 for an extended period of 72 hours in a 
mixture of aqueous acetic acid and TFA, in the presence of thioanisole, and was able to achieve 
a global deprotection and a cyclization to give the desired 1,6-anhydro-5-C-vinylglucose 132. 
Extensive Fischer esterification also took place under these conditions, and the crude material 
was treated subsequently with sodium methoxide to methanolyse the mixture of acetates to 
give the desired triol 132 in 70% yield. (Scheme 22) 
 
Selective desilylation was then carried out on triol 132, which underwent aluminum-mediated 
alkynylation to give the β-C-glycoside 133 (Scheme 22).43 However, carrying on from this work, 
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Porter was never able to achieve the desired natural product tagetitoxin using this 
methodology. 
In conclusion Porter has developed a new methodology, but like previous reported papers he 
has been so far unsuccessful in achieving the total synthesis of tagetitoxin. 
Porter et al. 2012  
In 2012 Porter published another paper on the inter and intramolecular reactions of 1-deoxy-1-
thio-1,6-anhydrosugars with α-diazoesters, as a continuation of his previous  papers.16,19,35,52 
Following on from the previous work on synthesizing the tricylic ring-expanded product 106, 
Porter carried out an oxidation of tricycle 103 with m-CPBA, which was followed by 
diazotransfer, and the sulfoxide product 134 was isolated as a single diastereoisomer (Scheme 
23). Porter assumed that the sulfoxide stereochemistry was to be as depicted, since 
diazodecomposition with rhodium acetate led to the tetracyclic sulfoxonium ylide 135. 
Compound 135 was subjected to Irradiation with UV light, and only decomposition was 
observed rather than the rearrangement that he had been hoping to observe based on 
previous studies. 
 
Porter then decided to see if he would be able to form the sulfur ylide 101, by a photochemical 
generation of a free carbene from the diazo compound 98 (Scheme 24).53 He had hoped that if 
this methodology worked, he could carry out the ylide formation, followed by the 1,3-
rearrangement in a single photochemical operation and this would improve the synthesis of 
the bicyclic core. However, this methodology did not work as had been anticipated, due to the 
photolysis of the diazo compound 98 forming an inseparable mixture of compounds which 
42 
 
could not be characterized, but was tentatively assigned as a methylmalonate monoester 136 
and an oxazole 137. Porter had postulated that 136 had been formed through a Wolff 
rearrangement of the carbene intermediate, followed by hydrolysis of the resulting acylketene, 
and that 137 had been formed through the reaction of the carbene intermediate with solvent,  
acetonitrile in this case (Scheme 24). To prove this, Porter carried out the photolysis again in 
different solvent, using both dichloromethane and chloroform, and the only major product 
observed from the reaction was the malonate 136 with none of the desired compound 
tetracycle 102.  
 
Porter had one further synthetic goal to achieve, involving the reactivity of substrates in which 
the diazo compound was tethered through equatorial oxygen functionality on the C-2, rather 
than axial on the C-3. Porter decided to introduce nitrogen functionality at the C-3 position, 
since this was present within the natural product, and to synthesize the decarboxy analogue of 
tagetitoxin. He started the synthesis from the readily available 4,6-O-benzylidene-α-D-
glucopyranoside 138 (Scheme 25), which was converted into the 2,3-β-epoxy derivative, which 
was then ring opened with sodium azide under acidic conditions to give 139 following 
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literature procedures.54,55 A Hanessian-Hullar oxidative ring opening of 139 using NBS and 
Barium carbonate, led to the 6-bromo-4-benzoyl derivative from which the bromide was 
displaced with potassium thioacetate to give the thioester 140.56–5843 Treatment of the 
thioester 140 with acidic acetylating conditions for seven days not only acetylated the free 
hydroxyl group but caused cleavage of the thioacetate and an in situ cyclization to the desired 
bicyclic structure 141. Conversion of the acetate 141 to the diazoacetate was the next step; 
however deprotonation of the acetate with LDA followed by triflouroacetylation gave none of 
the desired trifloroacetate, but instead gave a mixture of the acetoacetate 147 and alcohol 
142. Unfortunately, after many different attempts this pathway could not be suppressed by 
variations of base or temperature. Porter postulated that following initial deprotonation of 
141, either an intermolecular Clasien condensation takes place, or elimination occurs to give 
142 and ketene, which further reacted with an ester enolate species to give 147.  
Having obtained this undesired reaction, the authors decided to selectively cleave the acetate 
of 141 with guanidine to give the alcohol 142, which was then treated with a 2-triflouroacetyl 
derivative of Meldrum’s acid, to give the trifluoroacetoacetate as previously reported.59,60 
Detrifluroacetylating diazo transfer then gave the desired diazoacetate 143 using known 
conditions.33 
Treatment of 143 to give the desired ylide 144, with the optimized conditions from the group, 
proved more difficult than with the C-3 diazo compound previously obtained by the group. 
Variation of catalysts for the diazo decomposition failed to yield the desired ylide 144.  
Porter then attempted to generate the desired ylide 144 using a sequence of intramolecular 
alkylation followed by deprotonation. Bromroacetate 145 was prepared by the reaction of the 
alcohol 142 with bromoacetylbromide in the presence of DMAP, but was unsuccessful in their 
attempts to cyclize 145 with or without silver salts to give the desired cyclic compound 146.  
Since Porter had earlier in previous reported synthesis observed the stability of acetyl 
substituted ylides 101, 105 and 135, he decided to prepare diazoacetoacetate 148 from the 
alcohol 142, which was acetoacetylated to give 147. Diazotransfer of 147 gave the desired 
diazoactoacetate 148.16,19,35 The final step was diazodecomposition of 148; however the 
reaction worked in a very low yield, to give an impure mixture containing the desired ylide 149, 
but did not produce the yields that Porter was expecting (Scheme 25). 
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In conclusion Porter had hoped to be able to apply his methodology of a one carbon ring 
expansion of monocyclic 1,3-oxathiolanes using diazoesters to thioanydrosugars, however the 
reactions with these thioanydrosugars did not give the desired ylides but other ylide-derived 
products.17,18 He also noted that tethering the diazo compound through an equatorial linkage 
at C-2 of the sugar was much less successful than the previous studies carried out, and he 
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postulated that these undesired reactions may be caused with an increase in strain in the ylide 
product. Porter also carried out DFT calculations on the photo-Stevens rearrangement, which 
strongly suggested that the process involved an initial homolysis of the carbon-sulfur bond 
followed by radical recombination to form a new carbon-carbon bond.52 
Nishikawa et al.   
Nishikawa et al. have just published a paper on the synthesis of the core structure of 
tagetitoxin in 2013.61 Nishikawa began his sterocontrolled synthesis of the core structure of 
tagetitoxin with the readily available tri-O-acetyl-D-galactal 150 by a Ferrier type α-selective 
glycosylation, with an acetylene derivative using previously reported work from the group.62–64 
Compound 150 was treated with bis(trimethylsilyl)acetylene in the presence of the Lewis acid 
SnCl4 to give the desired compound 151 in a poor yield of 35%.  The use of different Lewis acids 
and solvent systems, did not improve on the previous yield. However, when Nishikawa 
changed from the silyl acetylene to tin acetylene, in the presence of TMSOTf he achieved the 
desired product 151 in a high yield with high stereoselectivity (α/β > 20:1).65,66 Cleavage of the 
two acetates and the TMS group was achieved with sodium methoxide in methanol, to give the 
diol 152 in 95% in two steps from 150. Selective protection of the primary alcohol was achieved 
with TBSCl, to give 153, and the remaining alcohols of 153 were carbamolyated to give 154 in 
two steps, firstly trichloroacetyl carbamoylation with and then a hydrolysis to give the desired 
compound 154 in good yield. Compound 154 was subjected to standard aziridination 
conditions of Rh(OAc)2 and PhI(OAc)2 in the presence of MgO, and the desired aziridine 157 
was obtained, but in a very low yield.67 Simple adjustment of the conditions reported in the 
literature, by adding MS-4Å in DCM to Rh2(OAc)4 and PhIO, improved the yield of the desired 
aziridine 155 to 70%.68 
Regioselective opening of aziridine 155 at the C-6 position was achieved using acetic acid, and 
heating gave the desired acetate 156. Benzylation of the carbamate 156 using standard 
conditions proceeded smoothly, followed by deprotection of the primary alcohol TBS group 
with TBAF to give alcohol 157 (Scheme 26).  
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The next part of the synthesis was to carry out a cyanation at the C-1 position from the 
preparation of a spiro-epoxyacetal. Attempts to form the spiro-epoxyacetal from the 
epoxidation of an exo-glycal, which Nishikawa had hoped to obtain by the elimination of a 
halide or sulfonate on the primary alcohol in 157, had failed. Nishikawa postulated that the 
failure of the reaction was due to the steric hindrance around the C-1 position. He then 
decided to carry out an intramolecular elimination of a selenoxide. The selenide 158 was 
prepared from 157 in two steps by the triflation of the primary alcohol in 157 followed by a 
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nucleophilic substitution with lithium phenylselenide.69 Oxidation of 158 with m-CPBA followed 
by heating of the selenoxide in the presence of a base gave the desired exo-glycal 159 in good 
yield. The next step was the formation of the desired spiro-epoxyacetal 160, which was 
achieved by treatment of 159 with m-CPBA in the presence of a base to in a very good yield. 
Compound 160 proved to be surprisingly stable and purification on neutral silica gel gave a 3:2 
diastereisomeric mixture. Treatment of the epoxide 160 with TMSCN in the presence of many 
different Lewis acids did not yield the desired cyano group on the C-1 position. After many trial 
runs a solution was found that had been reported previously, with the use of TMSCN in the 
presence of I2 in a mixture of toluene and hexane at 0 °C.
70,71 These optimised conditions gave 
the desired nitrile 161 as a single diastereoisomer in 44% yield, after acid hydrolysis of the 
TMS-ether. The group obtained a crystal structure of 161 and so proved the configuration of 
the asymmetric centre at the C-1 position (Scheme 27). 
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Nishikawa having successfully synthesized the pyranose core structure of tagetitoxin, started to 
carry out the synthesis of the cyclic sulfide (Scheme 28). Triflation of the hydroxyl group of 161 
followed by a displacement reaction with potassium thioacetate introduced the thioacetate 
group to give compound 162. Treatment of 162 with LiSMe, to remove the acetyl group, gave 
an undesired product which was unexpected forming a 7-memebered sulfide product.72 It was 
postulated that the generated thiolate underwent the undesired 7-endo-dig cyclization. The 
group decided to prevent this undesired cyclization from happening by utilizing an 
intramolecular conjugate addition of a thiolate to a vinyl sulfoxide from 162. Vinyl sulfoxide 
163 was synthesized by a radical addition of thiophenol to the acetylene, followed directly by 
an oxidation with m-CPBA to give a 4:1 E:Z mixture of 163. Treatment of the sulfoxide 163 with 
lithium hydride allowed the desired intramolecular conjugate addition of the thiolate. The 
acetate had been removed and the nirtile group was transformed into the imidate, giving the 
desired product 164, which was then hydrolysed with HCl to give the desired methyl ester 165 
in good yield. Acetylation of 165 gave 166 in 71% yield for the two steps from 163. Pummerer 
rearrangement transformed the phenyl sulfoxide of 166 into the desired aldehyde, but 
unfortunately this was not achieved with standard conditions for a Pummerer 
rearrangement.73–76 It was observed that when 166 was treated with triflouroacetic anhydride, 
only starting material was observed, but interestingly the diasteromeric ratio of sulfoxide, had 
changed, implying that activation of the sulfoxide had in fact occurred. Further work on 
conditions to achieve the desired aldehyde was carried out, finding that the combination of 
TMSOTf and TEA gave the desired rearrangement to give the desired aldehyde 166 in 63% yield 
(Scheme 28).77 
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The final transformations required were amide formation from the aldehyde 167 and 
hydroxylation at the C-4 position. Aldehyde 167 underwent oxidative amidation conditions 
using benzylamine, having been previously treated with iodine in methanol using previously 
reported conditions, did not obtain the expected product 168, but instead the thioacetal 169 
was obtained as a single diastereoisomer, confirmed by extensive NMR analysis using HMBC 
correlations, and isolated as the acetate 170.78 This reaction thus provided a fully 
functionalized core structure of tagetitoxin in 30% yield (Scheme 29). 
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In conclusion, Nishikawa has achieved the synthesis of the tagetitoxin core using several very 
interesting methodologies such as C-glycosylation of the galcatal 150 with tin acetylene in the 
presence of TMSOTf, stereoselective introduction of a cyano group through the opening of a 
spiro-epoxyacetal 160 with TMSCN, and the construction of the 6-membered sulfide through 
an intramolecular conjugate addition of thiol to vinyl sulfoxide. To date, this is the first 
synthesis of a functionalized core structure of tagetitoxin.  
Previous Work within the Page Group 
The Page group has previously attempted a number of synthetic routes to prepare the bicyclic 
core of tagetitoxin. First of all, Claud-Eric Roy’s work had used different sugars as starting 
materials in order to generate the target bicyclic structure of tagetitoxin.79 
D-galactose Route 
The first route by the group focused on the functionilization of a pyranose ring where O-2, O-3 
and O-4 configurations would be preserved until their conversion into the desired moieties 
(Scheme 30). 
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Starting from the readily available D-galactose and following a short sequence reported in the 
literature, the aldehyde intermediate 174 was synthesized.80 The alkyne 173 would be 
prepared from the aldehyde 174 using a known methodology previously reported in the 
literature.  The cyano moiety would be inserted by a glycosidation reaction.81,82 The next step 
would be the introduction of the thioacetate functionality, which would be derived from the 
condensation with formaldehyde on the anomeric carbon following a previously reported 
literature procedure, after a displacement of the protected hydroxyl with a thioacetate anion.83 
The final step of the synthesis would be the conversion of the cyano group into an ester, using 
well documented transformation procedures (Scheme 30).84 
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The penta-silylation of D-galactose proceeded smoothly in quantitative yield, using pyridine 
and TMSCl to give 176. The next step involved the oxidation of the alcohol of 176, via a Swern 
oxidation, which led to the desired aldehyde 177 been obtained in very good yields of between 
80-98%. The next step was for conversion of the aldehyde into the desired alkyne using a 
Corey-Fuchs procedure previously reported in the literature, but unfortunately this reaction 
did not yield the desired alkyne (Scheme 31).85 An explanation was postulated for the failure of 
this reaction, due to the hindrance generated by the –OTMS group on the C-4 position 
(Scheme 32). 
 
Several other methods were carried out by the group to overcome this problem including using 
other known alkyne synthesis methodologies such as the Seyferth-Gilbert reaction, using the 
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Ohira-Bestmann protocol, however all attempts proved to be unsuccessful.86–89 The group 
attempted other reactions to obtain the desired alkyne 178, but with the problems 
encountered, the group decided to change their focus and develop a new strategy from a 
different starting material. 
D-galactaric acid 
The next strategy carried out by the group involved starting from a non-cyclic readily available 
starting material D-galactaric acid 184 (Scheme 33). 
 
In this strategy, the formation of the pyranose ring would proceed from an ether synthesis 
through a ring closure by attack of a nucleophilic oxygen onto an epoxide to yield an advanced 
synthetic intermediate 181. The targeted precursor 180 would be derived from a displacement 
of an activated hydroxyl group by a thioacetate. Intermediate 181, which is fully functionalized, 
could be derived from a terminal epoxide 182. This intermediate could be formed from a di-
ketoester 183 through a previously reported Tebbe olefination-epoxidation sequence, or a 
Corey-Chaykovsky reaction on one of the two ketone carbonyls, as reported in the literature.90–
92 This intermediate 183 could be synthesized from the readily available starting material D-
galactaric acid 184 in a few simple steps (Scheme 33). 
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The first part of the synthesis was to obtain the di-ketoester 187, which was prepared 
following a literature procedure reported by Hirsch.93 The initial step was the synthesis of the 
bis-methyl-ester 186 using a mixture of methanol and conc sulfuric acid which was obtained in 
90-99% yield. The next step was the formation of the bis-ketal 187 using acetone and a Lewis 
acid, but the product was obtained in very low yields (17-25%) despite numerous attempts and 
changing of the acid catalyst for Brønsted acids (H2SO4, pTSA, HCl), however this generally 
tended to reduce yields or lead to decomposition. Spectral and single crystal X-ray data for bis-
ketal 187 product were analysed and they were found to match the previously reported 
structure (Scheme 34).79,93 
 
The second part of this strategy was to obtain the diketoester intermediates, with the simplest 
route appearing to be the use of enolate chemistry, with the formation of the enolates of the 
ester functions on 187, allowing the enolate anion to attack a derivative of oxalic acid, diethyl 
oxalate. After addition to diethyl oxalate, the intermediate 188 was decarboxylated under 
acidic conditions and subsequent esterification to give the desired diketoester 189 (Scheme 
35).94 
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However when the group carried out this reaction using Kagan’s conditions, using sodium 
ethoxide as a base, unfortunately the desired di-ketoester 189 was not obtained and only 
starting material was recovered.94 The group also carried out the reaction with the more basic 
sodium hydride or the commonly used LDA however the desired product was not obtained. 
The group carried out further attempts to alkylate the intermediate 187, in order to assess the 
reactivity and the accessibility of the carbon to be deprotonated. The group used ethyl iodide 
as a reactant, in order to ascertain the feasibility of the addition onto a small alkyl group, using 
both the same bases, as in the previous reaction with LDA and sodium hydride. Unfortunately 
all these reactions failed to yield the product and only starting material was obtained again.  
The group decided to abandon this route due to the low yields for the bis-ketal they obtained 
and also the lack of success obtaining the desired bis-ketoester 189 and decided to focus on 
other potentially more successful strategies. 
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D-mannose route 
 
The next strategy (Scheme 36) carried out by the group involved the development of the ester 
intermediate 191 which could be prepared from 192. Intermediate 192 could be prepared from 
an open carbohydrate 193 by a cyclization process. Alcohol 193 could be easily prepared from 
diacetone mannose 194. Diacetone mannose 194 was easily obtained following a literature 
procedure, from the readily available cheap starting material D-mannose 195.95 This strategy 
provides many advantages, especially the fewer steps from diacetone mannose. The insertion 
of a hydroxymethyl group has been reported in the literature previously on a similar 
intermediate to that of 192, using enolate chemistry.83 
The first step in the synthesis was the protection of D-mannose to form diacetone mannose 
190, using a classic reaction in carbohydrate chemistry developed by Schmidt in 1963 (Scheme 
36).95 
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The next step in the synthesis was the addition of a masked α-ketoester onto an aldehyde 
moiety of diacetone mannose 191. Diacetone mannose exists as an equilibrium between the 
lactol form which exists as a mixture of α and β anomers and the open hydroxyl aldehyde form 
(Scheme 38), and therefore a nucelophilic species was chosen to add to the aldehyde function. 
Numerous methods were used by the group to condense ethyl diazoacetate under various 
conditions from the literature, however all attempts proved to be unsuccessful and the group 
had to move on to another method to produce the desired ketoester 196 intermediate.96  
 
With the lack of success from this route, another pathway was investigated by the group. 
Whilst still using diacetone mannose the group again focused on the aldehyde moiety and the 
hydroxyl group in the open form would be protected before any reaction would be carried out 
on the aldehyde. Initially the group tried to carry out the protection of the open form hydroxyl 
group directly from diacetone mannose. Despite several procedures to protect the 4-OH 
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hydroxyl of diacetone mannose using a variety of silyl ethers, the group obtained either a 
protection of the 1-OH hydroxyl or starting material, and no desired compound was observed.  
 A new route again was envisaged by the group to synthesize the targeted aldehyde. It involved 
the protection of the aldehyde function, masked in the lactol form, as a thioacetal, thus, 
several protections of the various hydroxyls and hydrolysis of the sulfur would give the desired 
intermediate (Scheme 39).97,98 
 
The initial thioacetal formation was performed in a good yield of 89% using ethanethiol as 
solvent and HCl as the acid catalyst to give the desired product 197. The second step involved 
the selective 2,3-5,6-diisopropylidene formation to produce compound 198. The use of 
acetone with sulfuric acid under similar conditions as for the formation of diacetone mannose 
191 led to an inseparable mixture of multiple acetonides or degradation of the starting 
material. 
Having had little success with the thioacetal route the group decided to try a sequential 
silylation protection method on diacetone mannose. The synthesis began with the reduction of 
diacetone mannose 191 using lithium hydride, which was previously reported in the literature 
to give the diol 200 in very high yields.99–101 Several silylation procedures were carried out using 
TMSCl and TESCl, leading to the diprotected species of both silyl ethers 201 in good yields 
(Scheme 40). 
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The next step of the synthesis was the selective oxidation of the primary silyl ether. Following 
previously reported literature procedures for the precedent on silyl ether oxidation.100,101 
Swern oxidation reactions were preformed on the desilylated species, however no desired 
aldehdye 198 was obtained. 
 
Several attempts were made in order to form the desired aldehyde intermediate 202, however 
none of the reactions yielded the desired intermediate, and the group decided to abandon this 
pathway (Scheme 41). 
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Carrying on from the failure of the strategy above the group decided to revise the synthesis for 
the desired silylated aldehyde and complete a five step synthesis to obtain the desired 
aldehyde following a previously reported literature by Hashimoto (Scheme 42).99 It firstly 
consisted of a protection of the primary alcohol of diol 200 with a benzoyl. The secondary 
alcohol of the diol was then protected with TBSCl to obtain the TBS protected compound 204, 
however no desired reaction was obtained so they decided to change the conditions an use 
TBSOTf in TBME and were able to obtain the desired TBS intermediate 204 in 37% yield. The 
next step was the saponification of the ester to give the hydroxyl function which proceeded in 
quantitative yield,  With the free hydroxyl the next step was to oxidize to give the desired 
aldehyde 205, but they were unable to produce the desired aldehyde 205 using Parikh-
Doering, IBX-mediated, Swern or Moffat oxidation conditions.102–105  
The group decided to abandon this route since they could not obtain the desired aldehyde and 
moved on to alternative routes.  
Dithioacetal Route 
The final strategy investigated by Claude-Eric Roy within the group was a nucleophilic addition 
of a synthetic equivalent of an α-ketoester onto diacetone mannose (Scheme 43). 
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This route was largely inspired from a reported synthesis by Schmidt of KDO (3-deoxy-D-
manno-2-octulusonic acid), which at the time was highly topical, involving the use of a 
dithiomercaptal and dithiane species to afford the required intermediate 209.106 The first step 
in the synthesis was the making of the diethymercaptal species 211 following a literature 
procedure, formed from the reaction of methyl dichloroacetate and ethane thiol (Scheme 
44).107 
 
Having synthesized this intermediate, the next step along with the other two mercaptals which 
were commercially available was the nucleophilic addition onto diacetone mannose following a 
literature procedure.106 
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Entry Thioacetal Conditions Yield 
1 Diethyl mercaptal  DIPA, BuLi then mercaptal, then 
MgBr2, then 191. 
SM 
2 Ethyl dithiane carboxylate  DIPA, BuLi then dithiolane, then 
MgBr2, then 191. 
SM 
3 Ethyl dithiane carboxylate DIPA, BuLi then dithiane, then 
MgBr2, then 191. 
SM 
4 Ethyl dithiane carboxylate DIPA, BuLi then dithiane, then 
MgBr2, then 191. 
65% 212 
Table 3: Reagents and conditions for the nucleophilic addition reaction. 
Despite many attempts, the reported nucelophilic attack using entry 1 and 2 were unsuccessful 
and only starting material was observed. The addition of the dithiane ester (entry 4) led to the 
desired product 212 in good yield and as a single diasterisomer. It was also shown that the 
same reaction without the intermediate formation of the organomagnesium bromide 
derivative of the dithiane species prevented the addition and only starting material was 
observed (Scheme 45 and Table 3). 
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Further work was carried out by the group on the selective protection of the C-3 hydroxyl 
group on intermediate 212 and dethioketalization to trigger cyclization to form the desired six 
membered intermediate 213 (Scheme 46). Several protecting groups were used such as TBS, 
benzyl and benzoyl but only starting material, decomposition or diacetone mannose was 
observed and the group were unable to selectively protect at this position (Scheme 46). 
Having obtained such poor results with the selective protection of the C-3 hydroxyl the group 
decided to alter the sequence of the steps so that the cyclization step would be performed 
first. Thus the dethioketalization was attempted using conditions reported in the literature 
(Scheme 47).106 
 
Initial attempts using the previous reported conditions from the literature did not reproduce 
the same results, and gave a dramatically low yield of 18% for intermediate 212 compared to 
the 76% yield reported in the literature (Scheme 47).106 When a scale up was performed on this 
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reaction even poorer results were obtained, and even controlling the purity of the reagents 
and solvents (recrystalization of NBS, HPLC grade acetone and distilled water) led to no change 
in the poor yields obtained. The group carried out many deprotection procedures of dithiane 
using reagents such as NIS, I2 and different halogen sources, but this led to no greater increase 
in yield.  
Only a small amount of the desired 6-membered pyranose 214 was obtained from the 
described procedures above, and purification of this led to decomposition or loss of the 
desired pyranose. 
This initial work carried out by the Page group on the synthesis of tagetitoxin led to a number 
of interesting intermediates, and some routes which would not be investigated further due to 
the problems encountered. 
Pearce 
Following on from the work carried out within the group by Claude-Eric Roy, Chris Pearce  
carried on using the dithioacetal route as this had given the most promising results towards a 
synthesis of the bicyclic core of tagetitoxin, and optimizing some of these results could provide 
the shortest and most efficient route towards the synthesis of the bicyclic core. Pearce 
continued the work on the addition of a dithioacetal-protected ketoester onto diacetone 
mannose 191 (Scheme 48).108 
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The first step in the synthesis was the conversion of D-mannose into diacetone mannose 191 
using the same procedure reported above.72 The next step in the synthesis was the nucleophilic 
addition of the dithiane protected ketoester onto diacetone mannose to give compound 212. 
The group used the same procedure carried out previously and optimized the reaction 
conditions to obtain 212 in very high yield of 98%.77 The next step in the synthesis was the 
removal of dithiane group in 212, and the cyclization to form the six membered pyranose ring 
214. The group carried out the deprotection and cyclization using previously reported 
conditions by Schmidt, using NBS in acetone and water, however despite numerous attempts 
the group was never able to obtain the reported yields and the highest they obtained of 
pyranose 214 was 40%.106 Pearce obtained an X-ray crystal structure for compound 214 which 
confirmed its stereochemistry (Scheme 48).108 
Having obtained such poor results for the deprotection of the dithiane and the cyclization to 
give 214, Pearce carried out numerous literature dithiane deprotection reactions, including 
mercury reagents, halogen donors and several oxidants.109–114 Unfortunately, none of these 
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procedures gave higher yields than the use of NBS, and sometimes the only isolated product 
was diacetone mannose. 
Despite the very low yields obtained for 214 the group decided to continue with this route. The 
group carried out investigations on the removal of the anomeric hydroxyl group of 214 and 
came across a report of a samarium diiodide-promoted coupling of anomeric acetate with 
carbonyl compounds.115 The group believed they could apply this methodology to compound 
214 to remove the anomeric hydroxyl group and introduce the methylene alcohol group in one 
step (Scheme 49).  
The group used a modified version of the samarium diiodide procedure for the conversion of 
the diacetate 218 to the alcohol 215 using formaldehyde as the carbon source, hoping that this 
would give the desired alcohol. Diacetate 218 was easily prepared using standard acetate 
conditions from pyranose 214 (Scheme 49) in very high yield. The next step was the samarium 
diiodide-mediated coupling reaction. However after numerous attempts the group was unable 
to obtain the desired alcohol 215.116 
 
Unfortunately, having tried numerous attempts and procedures the group were forced to 
abandon this route. 
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Wittig Route 
 
Pearce then decided to move on and envisaged a new route involving a Wittig reaction to 
introduce the ester moiety (Scheme 50). The group decided to start again from diacetone 
mannose 191, carry out a Wittig reaction on the aldehyde function of the open furanose to 
produce the alkene 219, after a simple protection of the secondary alcohol. The alkene then 
would be subjected to either a bromination, iodination or a dihydroxylation to give the desired 
product 220-222.  The group then postulated that removal of the protecting group on the 
secondary hydroxyl group and a displacement of either the halogen or a manipulated hydroxyl 
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group alpha to the ester function would lead to the cyclized pyranose 223-225. The next step 
would be the introduction of the thiol function, which the group postulated could be 
introduced using enolate chemistry to obtain the desired primary alcohol on the anomeric 
position, and then a displacement with a thioacetate anion to give the desired intermediate 
215. The final steps would involve the selective removal of the acetal and then oxidation and a 
protection to give the compound 216. The final step of the postulated synthesis was the 
removal of the acetate on the thioacetate to give the free thiol, which would undergo an in situ 
cyclization to give the desired bicyclic structure 217 (Scheme 50).   
The group began with the first step of the synthesis of the target bicyclic structure 217 by 
carrying out a Wittig reaction on diacetone mannose 191 using literature conditions, where 
diacetone mannose was heated at reflux with the corresponding ester ylid to produce a range 
of alkenes.117 Under these conditions the E-alkene was the major product and easily separated 
from the Z-alkene. The next step was the protection of the hydroxyl moiety, which was carried 
out easily using standard acetate protection conditions, which gave the product in good yield, 
and also a TMS protection which gave very low yields. The group carried out a dihydroxylation 
on the TMS-protected alkene, which was then followed by a selective tosylation of the 
hydroxyl α to the ester moiety, but the tosylation gave very low yields due to the mild 
conditions. The next step was the removal of the TMS protecting group and a cyclization to 
give the 6-memebered pyranose intermediate, however only decomposition was observed, 
and this led the group to explore other methods to reach this intermediate. 
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The group then decided to functionalize the alkene. The group postulated that a direct 
bromination of the alkene 219 could lead to a cyclization to form the desired intermediate 224 
in one step (Scheme 51). However following bromination conditions the group was unable to 
obtain the desired cyclized product, and decomposition of the starting material was observed. 
Other methods to brominate the alkene and reach the desired cyclized product 224 were 
unsuccessful and forced the group to abandon this route and look for an alternative method 
(Scheme 51). 
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Reduction Route 
 
Following on from the lack of success in achieving the desired bicyclic structure, Pearce, 
decided to go back to the dethioketalization, strategy but this time to remove the ester moiety 
completely (Scheme 52).108 The first step was the nucleophilic attack of ethyl ester dithiane on 
diacetone mannose 191, which had been carried previously and optimized by the group. The 
next step was the reduction of the ethyl ester 212 using lithium aluminium hydride in THF to 
give the triol 226, in which the primary alcohol was selectively acetate protected to give 227 
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(R=Ac) in very high yields without using DMAP as this had produced the triacetate product. The 
group had also protected the primary group with a tertiarybutyldiphenylsilyl ether to give 228 
(R=TBDPS), however the reaction was very low yielding (18%). The group believed that the 
removal of the ester moiety would give a reduction in the likelihood of the reversion back to 
diacetone mannose 191; following reaction with NBS, without the ester moiety present the 
dithiane anion, generated during the production of diacetone mannose when reacting 227 and 
228 with NBS, would be far less stable.  
 
When compounds 227 and 228 were subjected to the dethioketalization reaction using NBS no 
desired product was obtained. When compounds 227 and 228 were treated with 1,3-dibromo-
5,5-dimethylhydantoin (DBDMH), however, the group obtained the desired protected 
pyranoses 229 and 230 in good yields (Scheme 53).   
The next step in this route was the removal of the anomeric hydroxyl on 229 and 230. 
Following the removal of the hydroxyl group to give 229 and 230, the ester moiety would need 
to be restored giving compound 232. The group had then postulated that having obtained the 
ester moiety to give compound 232; this would enable the enolate addition of formaldehyde 
and a subsequent displacement of the primary alcohol with a thioacetate anion to give 
compound 215. The group then postulated that the rest of the synthesis would be the same as 
the previous dithiane route, with the generation of the keto-ester 216, followed by the 
deprotection and in situ cyclization to give the desired bicyclic structure 233 (Scheme 52).  
The group began the first part of the synthesis with the removal of the anomeric hydroxyl 
group from compound 229 using a previously reported procedure from the literature, to give 
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231 (Scheme 54), unfortunately this procedure was unsuccessful, and despite numerous 
attempts led only to complete decomposition of the starting material.118 
 
The group decided that despite these disappointing results with the removal of the anomeric 
hydroxyl on 229, instead to firstly convert the free hydroxyl groups on compounds 229 and 230 
(R=Ac or TBDPS) to a methoxy group in the hope it would aid the removal of the group on the 
anomeric position. However the group were unsuccessful in carrying out the conversion with 
methyl iodide in the presence  of sodium hydride and the group observed complete 
decomposition to the starting material. When the reaction was carried out on the acetate 
protected compound 229 no desired product 234 was observed. When they applied the same 
conditions to the TBDPS protected compound 230, they also observed decomposition of the 
starting material and none of the desired product 235 but they also identified one of the 
decomposition compounds as the methoxy diacetone mannose compound 236 (Scheme 55). 
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Following further disappointing results the group decided to abandon this route and carried 
out other routes towards obtaining a synthesis of the bicyclic structure of tagetitoxin, however 
all these routes did not lead to any success, and with time constraints no further work was 
carried out on these strategies by Pearce.108  
The previous work carried out within the Page group had led to a number of interesting 
intermediates and some of these were investigated and are described within this thesis. 
Project 
Following on from previous work within the group, my aim was to continue on from previous 
intermediates especially, the dethioketalization strategy, but involving the reduction of the 
ester moiety completely to the alcohol, as this had produced some of the most successful 
intermediates in our aim to complete a total synthesis of the bicyclic core of tagetitoxin.79,108 
74 
 
 
Our initial goal was to produce the bicyclic structure of tagetitoxin, but without the acid 
functional group on the anomeric position. We would develop later a suitable synthesis to 
complete this later once this methodology had been carried out (Scheme 56). Starting from 
diacetone mannose 191, made from readily available D-mannose, the next step was the 
nucleophilic addition of the dithiane protected ketoester to give compound 212. Reduction of 
the ethyl ester to the alcohol could be achieved using lithium aluminium hydride in THF to give 
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the triol 226, followed by a selective protection of the primary alcohol to produce acetate 227 
or tert-butyl silyl 237. The next step was to carry out the dethioketalization and the in situ 
cyclization to give pyranose 238 (R=Ac) or 239 (R=TBS). Deprotection of the acetate to the free 
primary alcohol could be carried out using conventional acetate deprotection methods to give 
pyranose 240 (X=OH). Triflation of the primary alcohol could be carried out easily using 
previously reported conditions to give 241,  followed subsequently by a thioacetate anion 
displacement of the triflate using sodium thioacetate to give 242.119 The next step involved the 
selective acetal deprotection using a procedure previously reported in the literature to give the 
diol 243.120 Selective primary alcohol protection using a silyl ether TBS 244, TBDPS 245 or a 
trityl 246 protecting group and an oxidation of the secondary alcohol to produce ketone 247, 
248 and 249. The final step involved the deprotection of the thioacetate to the thiols 250, 251 
and 252, and in situ cyclization to produce the bicyclic structure 253 (Scheme 56). From this 
structure, theoretically all functional groups could be introduced using known carbohydrate 
chemistry, and the readjustment of the synthesis to introduce the carboxylic acid moiety on 
the anomeric to give the natural product. 
It is also noteworthy that the synthetic pathways within the group are designed in order for the 
synthesis to start from the D-series and to obtain a pyranose core 229, as opposed to the 
strategy developed by Porter previously to afford 249 (Scheme 56). Our aim was to synthesize 
the bicyclic core structure 248, and with a simple modification of this methodology to obtain 
the bicyclic structure 229.  
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Since the production of this thesis a new paper has been published by Aliev, Karu, Mitchell and 
Porter in October 2016.121 Aliev et al. report new NMR and MS data for tagetitoxin which 
contradicts previous published structures of tagetitoxin and reported a new proposed 
structure of tagetitoxin 255 (Figure 5).3–6 A sample was obtained which had been previously 
isolated and purified by Mitchell and this was analysed.1,3,4 Most of the spectral features in the 
1H NMR were the same as those observed by Gronwald et al. two peaks were not observed at 
1.75 and 2.53 ppm.5 In the 13C NMR no peak was observed at 181.45 ppm. Based on the NMR 
analysis obtained Aliev et al. postulated that the material studied by Gronwald et al. was not as 
pure as that which was extracted by Mitchell et al.3–5 The mass spectrum data obtained also 
during this work contained no species with a molecular weight of 678 which Gronwald et al. 
had reported as the revised molecular weight for tagetitoxin.5     
 
 
Micthell in 1989 revised the structure of tagetitoxin in which his revised structure had been 
proposed based on the analysis of 1H and 13C NMR  spectra in particular the 1H NOES and the 
COLOC spectrum for 1H-13C long range correlations.4 In this paper Aliev et al. based on HMBC 
spectra as well as values of long range nJCH couplings revealed several correlations which they 
used to rule out the previously reported published structures of tagetitoxin structures 1 and 
2.121 In particular the authors discussed the following points in which they were in 
disagreement with the previously reported structures and helped them rule out structures 1 
and 2: 
1. A cross-peak was observed for the C11-H8 pair which is in disagreement with structure 
2a with six bonds between C11 and H8. 
2. A strong cross peak C10-H2’ observed in disagreement with structure 2b with four 
bonds between C10 and H2’. They noted that 4JCH correlations were observed in the 
78 
 
HMBC spectra, but a value for the JC10H2 coupling which was derived from the HMBC-JC 
spectrum had a value equal to 5.0 Hz in which could not be attributed to a 4JCH 
coupling.  
3. Cross peaks observed for C7-H2 (JCH=5 Hz) and C7-H2 (JCH=3 Hz), was in total 
disagreement to the structures 1, 2a and 2b, with four bonds separation between C7 
and H2. 
4. Lastly for structure 2a the dihedral angle between C4 and C6 is approximately 180° and 
they only observed a weak HMBC cross peak in the HMBC. The HMBC-JC value of JC4H6 
was 1.4 Hz.121 
In particular the authors discussed the following points in which they were in disagreement 
with the previously reported structures: 
1. A Cross-peak was observed for C11-H8 pair which was due to the 3JCH coupling in 255. 
2. A Cross-peak was observed for C10-H2 which was due to the 3JCH coupling in 255. 
3. Cross-peaks were observed for C7-H2 (JCH=5Hz) and C7-H2 (JCH =5Hz) which was due to 
the 3JCH coupling in 255 
4. They assumed a chair conformation of the six membered ring, where the dihedral 
angle between C4 and H6 would be approximately 60°, which is in agreement with the 
coupling they observed for 3JC4H6=1.4 Hz which is based on the Karplus type 
relationships for 3JCH couplings.
121 
Aliev et al. also analysed all the 3JCH couplings in which they believed them to be in good 
agreement with their new proposed structure 255.121 They also analysed the few JHH couplings 
in tagetitoxin. They observed a large value for 3JH6H7=12.2 Hz which they suggest is in favour for 
the trans fusion of the two cycles with both protons occupying axial orientations.  
Further data was collected to support their claim for the new predicted structure of tagetitoxin 
which can be found in the latest paper attached in Appendix A of the thesis. However, a total 
synthesis has still to be completed for tagetitoxin to prove which structure is in fact correct. 
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Results and Discussion: 
Route 1 Dithiane Route: 
Several retrosynthetic pathways were envisaged. A continuation of the work already carried 
out within the Page group on the dithiane route is where this research began. The first two 
steps had previously been worked on within the group and this project began with the 
optimization of these steps and to continue further to complete the synthetic route towards 
the bicyclic structure of tagetitoxin 260 (Scheme 58).  
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The first step in the synthesis involved the conversion of D-mannose into diacetone mannose 
DAM 191 using a literature procedure in 70-90% yield after crystallization to give the product 
as a mixture of anomers which was used in the next step (Scheme 37).1 
 
The reaction occurs through a displacement of the lactol equilibrium from the 6-membered 
ring to the 5-membered ring (Scheme 59). 
 
The next step involved the nucleophilic addition of a masked α-ketoester to diacetone 
mannose 191 using Schmidt’s previously reported procedure (Scheme 60).2 
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The addition of ethyl 1,3-dithiane-2-carboxylate 261 to diacetone mannose 191 proceeded 
smoothly in very high yields of up to 98% to give 212 after optimization. We found working 
with less than 10 g of diacetone mannose reduced the yield and more than three equivalents 
of dithiane were needed to achieve a high yield (Scheme 60).  
 
Attempts to add ethyl 1,3-dithiane-2-carboxylate 261 onto diacetone mannose 191 in the 
absence of MgBr2 led only to starting material 191 being obtained because lithiated dithiane 
263 works as a base, which leads to the ring closing of the hydroxy-aldehyde 262 (Scheme 61). 
The addition of ethyl 1,3-dithiane-2-carboxylate 261 onto diacetone mannose in the presence 
of MgBr2 led to the formation of an organomagnesium bromide intermediate which led to 
nucleophilic attack to give compound 212 (Scheme 60). 
The next step involved the removal of the dithiane moiety on 212 and the in situ cyclization to 
form the six membered pyranose 214 (Scheme 47).2  
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Our initial work involved the use of Schmidt’s conditions for the hydrolysis of the dithiane with 
the use of NBS in 95% acetone. This reaction proved to be highly troublesome and failed to 
reproduce the yields reported by Schmidt.2 The highest yielding method that we were able to 
devise involved the reaction being completed in 12 tubes in a carousel, with 0.1g of 212 in each 
tube using acetone and NBS at 0 °C, with a yield of between 30-40% being obtained. We 
decided to investigate what was happening in this reaction, and we isolated and characterized 
the byproduct in high yields which proved to be the starting material DAM 191.  
We postulated a reaction mechanism for its formation, shown below, and since the reaction is 
in equilibrium we see that the five membered ring is more favoured than the six membered 
ring under these conditions. We postulated that this may be due to mechanism of the NBS 
mediated cleavage of the ditihiane group: an intramolecular reaction is taking place which led 
to the removal of the entire ethyl 1,3 dithiane-2-caboxylate group. Removing this group led to 
the formation of the hydroxy aldehyde 262 which in turn led back to DAM 191 (Scheme 62).  
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Having had limited success we decided to carry out a variety of deprotections of dithiane on 
substrate 212, using known reactions from the literature in collaboration with Pearce using 
NIS, NCS, DBDMH, mercury chloride and mercury oxide but no improvement was obtained.3  
We postulated that the yield of the reaction could be improved by the protection of the free 
hydroxyl groups of 200 before the dethioketalization with NBS, as we believed that the 
protection of the free hydroxyl group on the α-position of the dithiane would prevent the 
intramolecular reaction during the NBS-mediated cleavage of the dithiane and improve the 
yield of the reaction. 
This synthetic pathway started with the reduction of the diacetone mannose 191 with LiAlH4 in 
THF to provide 2,3-5,6-di-O-isopropyliden-D-mannitol 200 according to the literature in a high 
yield of up to 98% yield (Scheme 63).4 
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The next step carried out was the selective protection of the primary hydroxyl group of 200, 
with TBSCl to give the silyl derivative 264 in a high yield of 99% (Scheme 64).4 
 
After protecting the primary hydroxyl group successfully with TBSCl, the secondary hydroxyl 
group of 264 was protected with an acetate group using acetic anhydride, DMAP and TEA to 
give compound 265 in a high yield of over 95% (Scheme 65).  
 
The next step was the selective deprotection of silyl group on the primary hydroxyl of 265. The 
selective deprotection of the TBS group of compound 265 was carried out using TBAF which 
gave the corresponding alcohol 266 in a very good yield of over 90% (Scheme 66). 
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After the selective deprotection of the primary hydroxyl, the next step we wanted to carry out 
was to oxidize this primary hydroxyl 266 to the aldehyde 267 (Scheme 67).6 
 
We completed this by carrying out a Swern oxidation on the corresponding alcohol 266 to 
provide the aldehyde 267 in a high yield of up to 91% (Scheme 67). The obtained aldehyde 267 
was unstable because it could easily be converted back to the starting material diacetone 
mannose 191. For that reason the aldehyde 267 was used directly for the next step without 
further purification. 
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The addition of a masked α-ketoester onto the aldehyde 267 was attempted. This next step 
involved the addition of ethyl 1,3-dithiane-2-carboxylate or methyl 1,3-dithiane-2-carboxylate 
onto the aldehyde 267 to provide compound 268 (Scheme 68), using Schmidt’s conditions.2 
However after reaction work up and purification, analysis of the NMR spectrum showed that 
only diacetone mannose 191 was obtained. 
The only rationale for the formation of DAM 191 was that the organomagnesium bromide 
intermediate 269 attacked the carbonyl group of the acetate instead of the carbonyl group of 
the aldehyde, which led to the formation an anionic oxygen 270. The anionic oxygen attacked 
the aldehyde which led to the formation of diacetone mannose 191 (Scheme 69). 
 
In order to overcome this problem we decided to change the protecting group from an acetate 
to another protecting group to prevent this side reaction from occurring. The free hydroxyl 
group of compound 264 was protected with MOMCl to provide compound 271 (Scheme 70) as 
described in the literature.4 
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After protecting the free hydroxyl group of compound 264 successfully, the silyl group of 
compound 271 was deprotected using TBAF in THF to provide alcohol 272 (Scheme 71).4 
 
We again attempted the oxidation of the alcohol to the aldehyde and the nucleophilic addition 
of the dithiane as described in the previous step, however we again only isolated diacetone 
mannose 191 and we therefore decided to look at alternative ways to reach the bicyclic core 
260. 
Having had limited success with improving the yield of the dethioketalization of compound 212 
we decided to try an alternative strategy in order to improve the reaction yield. This time we 
decided to incorporate a nitrile functionality on the dithiane instead of the ester. We could 
eventually carry out the hydrolysis of the nitrile to give the carboxylic acid. 
We first had to synthesize the 2-cyano-1,3-dithiane substrate 275, which we were able to 
obtain using previous reported literature by the Page group on dithiane work.7,8 1,3-dithiane 
273 was treated with triphenylcarbenium tetrafluoroborate in DCM to give the 
tetrafluoroborate salt 274 after work up. The next step to form the desired nitrile-derived 
dithiane, was the addition of TMSCN to 274 in DCM at -20 °C to give nitrile 275 in up to 60% 
yield for the two steps (Scheme 72). 
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The next task was the nucleophilic attack of the anion of the nitrile-dithiane onto DAM 191. We 
used the same conditions as Schmidt, however we were unable to obtain the desired product 
276 (Scheme 73) with only starting material being observed.2 Having being unsuccessful in 
obtaining the desired product 276, we believed that the lithiation of the cyano dithiane was 
not being achieved. Work in conjunction with Pearce was attempted to see if we were able to 
displace the proton on the C-2 position with a deuterium atom and by comparison of NMR to 
show the displacement was carried out however this proved to be unsuccessful and this route 
was dropped.3  
 
We also obtained the methyl ester-derived dithiane to see if an alternative ester on the C-2 
position of the dithiane would have an influence on the dethioketalization reaction and help 
improve the yield. From Schmidt’s reported work, higher yields were obtained using a methyl 
ester rather than an ethyl ester when carrying out the dethioketalization reaction.2 
We synthesized the methyl ester derived dithiane 278 from 1,3-dithiane 273, following a 
literature procedure, with the lithiation using n-BuLi, followed by the addition of solid carbon 
dioxide and an acidic work up to give the carboxylic acid derivatized dithiane 277. HCl gas was 
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then bubbled through a solution of the carboxylic acid derivatized dithiane 277 in MeOH to 
give the desired methyl ester derivatized dithiane 278 (Scheme 74).9 
 
Having obtained the 2-methyl ester dithiane 278, we used the same conditions as Schmidt for 
the coupling of the 2-methyl ester dithiane derivative 278 with diacetone mannose 191 
however we were unable to obtain the desired compound 279 after numerous attempts using 
the same conditions as above (Scheme 75).2 
 
 Despite the poor yield obtained in the synthesis of ethyl ester 214 (30-40% after optimization) 
and the unsuccessful synthesis of methyl ester 279, we decided to carry on to the next step: 
the selective protection of the secondary hydroxyl at the C-3 position, followed by the 
activation and removal of the tertiary hydroxyl at the C-2 position, to see if our methodology 
would work.   
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Converting the free hydroxyl groups to the corresponding acetate groups was highly successful, 
often taking place in 99% yield with Ac2O, Et3N and DMAP (Scheme 76). The diacetylated 
compound 218 was also a crystalline material, enabling an X-ray crystal structure 
determination to be made, proving the stereochemistry. This was carried out previously within 
the group.3 
We were then tasked with the removal of the anomeric hydroxyl group on pyranose 218. A 
paper in the literature described a samarium diiodide-promoted coupling of anomeric acetates 
with carbonyl compounds.11 Malapelle described how to convert the anomeric acetate of their 
substrate N-acetylneuraminic acid derivative to the corresponding alcohols using samarium 
diiodie and a series of different aldehydes and ketones (Scheme 77).10  
 
Malapelle also proposed a mechanism for the formation of the samarium enolate 282 that 
reacted with the carbonyl substrates performed by the group (Scheme 78). 
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We decided to apply this methodology to compound 218 to see if we could remove the 
anomeric hydroxyl group and introduce a methylene alcohol group, all in one step. Modifying 
the conversion of the diacetate 218 to the alcohol could be done using samarium diioide, and 
formaldehyde could be used as the carbonyl source. 
 
However after numerous attempts we were unable to achieve the removal of the anomeric 
hydroxyl moiety or introduce the methylene alcohol group to give 215 using samarium diioide 
in the presence of paraformaldehyde (Scheme 49). We initially thought the issue might have 
been with the commercially available samarium iodide solution in THF we were using since we 
noticed it degraded rapidly and tried to make our own using literature procedures, however we 
were unable to obtain any Samarium Iodide solution which was noted by the absence of a dark 
blue solution. Since working with samarium iodide was extremely difficult we decided to move 
onto other routes to try and synthesize the desired bicyclic core 260. 
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Route 2 KDO Route: 
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Following on from the poor yields obtained in route 1 the next route attempted in our strategy 
(Scheme 79) involved again D-mannose and its conversion into diacetone mannose 191.1 
Alkene 283 was targeted, a product of the Wittig condensation between 
(methoxymethyl)triphenylphosphonium chloride and diacetone mannose. We synthesized the 
required Wittig salt on a 300 g scale using literature procedures by reacting triphenylphosphine 
with MOMCl in toluene under reflux for 24 hours.12 
Alkene 283, was prepared using the Wittig reaction with the Wittig salt derived from 
(methoxymethyl)triphenylphosphonium chloride, potassium tert-butoxide and diacetone 
mannose 191 to give alkene 283 in over 93% yield as a mixture of 70:30 E/Z isomers.13  
 
Pyrolysis of 283, using a bulb-to-bulb distillation apparatus under reduced pressure in the 
presence of a catalytic mercury acetate led to the six membered alkene ring 284 through an 
intramolecular vinyl esterification reaction in up to 67% yield (Scheme 81).14  After 
optimization, a yield of over 70% was obtained when the reaction was carried out on a one 
gram scale. 
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After forming the six membered alkene ring 284, the next step in the synthesis was the acid 
catalysed addition of the methallyl alcohol in the presence of TPHB, to give the α-glycoside 285 
with complete diastereoselectivity, however we were unable to obtain the desired product 285 
despite replicating the literature conditions numerous times (Scheme 82).15 . 
 
After being unable to obtain 285 we decided to abandon this route to obtain KDO and move on 
to alternative routes to obtain the desired bicyclic compound 292. 
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Route 3 Alternative route towards KDO 
 
  
102 
 
While trying to improve the synthesis and form the bicyclic structure 292 we came across a 
paper in the literature on an alternative route towards the synthesis of KDO by Ohrui and co-
workers.5 They had proposed the construction of the tetrahydropyran ring of 2-deoxy-β-KDO 
by an intramolecular C-C bond formation.5 They had selected a 2,3-O-isopropylidene-4-O-
alkoxycarbonylmethyl-D-mannitol derivative having a leaving group on the C-1 position as the 
key intermediate. They had tried placing a tosyl group on this position; however the authors 
describe the problems encountered with the tosyl, with the major product being starting 
material. After a slight modification with Iodine and triphenylphosphine in DCM they were able 
to obtain the 1-iodide product in up to 77% yield with only a slight amount of the starting 
material recovered. The last part in obtaining the desired KDO involved the intramolecular C-C 
bond formation using lithium diisopropylamide (LDA) in THF at -75 °C to give the 2-deoxy-β-
Kdo derivative stereospecifically in 84% Yield.5 We decided to apply this methodology to our 
substrate in the hope of achieving 292. 
The first step was the reduction of diacetone mannose 191 to the diol 200 using lithium 
aluminium hydride in THF in 98% yield  as seen above (Scheme 63).  
We then introduced a base stable protecting group on the O-1 position using a benzyl group in 
order to introduce an ethoxycarbonylmethyl group on the O-4 position. The authors had tried a 
TBDMS group previously; however extensive O-desilylation was observed when this substrate 
was treated with sodium hydride and ethyl bromoacetate.5 
In order to achieve the benzylation of 200, we used benzyl bromide in the presence of sodium 
hydride in THF to give the benzyl protected 293 in a high yield of 98% (Scheme 84).5 
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We hoped treatment of 293 with ethyl bromoacetate in the presence of sodium hydride in THF 
would give 294 in a good yield like Ohrui and co-workers achieved. However, after numerous 
attempts using their conditions and varying the amount of sodium hydride or ethyl 
bromoacetate we were unable to synthesise the desired compound and the route had to be 
abandoned (Scheme 85).  
 
We also were able to introduce allyl group on the O-4 position of 293 using sodium hydride and 
allyl bromide in DMF and were able to obtain the desired substrate 298 in 96% yield (Scheme 
86). Having obtained 298 we had hoped to carry out modifications to the allyl group, however 
we decided to continue with other routes and this route could be further explored in the 
future.  
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Route 4 Epoxidation Route 
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As described previously (Scheme 80-81) the key intermediate 284 was prepared on a 50g scale 
in up to 70% yield. 
We then wanted to carry out the epoxidation of the alkene, which was tried on the protected 
alkene 284 but could not be achieved either with m-CPBA or other oxidants with only starting 
material being observed (Scheme 88). After numerous attempts and conditions and varying the 
equivalents of the oxidant, we were unable to form the epoxide 308 from the alkene 284 
(Table 4). 
 
Reagents Product 
m-CPBA (1 equiv.), DCM, 0 °C SM 
m-CPBA  (1.5 equiv.), DCM, 0 °C SM 
m-CPBA  (2 equiv.), DCM, 0 °C SM 
DMDO (0.03 M) (1.2 equiv.), DCM, 0 °C  SM 
DMDO (0.03 M) (2.4 equiv.), DCM, 0 °C SM 
Table 4: Expoxidation conditions attempted on alkene 284 
We then decided to make some freshly prepared DMDO 310 which we were able to make from 
acetone, NaHCO3, and oxone (Scheme 89).
16 However, again even after numerous attempts, 
with different amounts of DMDO, we were again unable to synthesize the epoxide 308 from 
the alkene 284 (Table 4). 
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After the unsuccessful epoxidation of the alkene 284 we decided to remove the isopropylidene 
groups and use other protecting groups as we believed that the isopropylidene groups could be 
causing some steric hindrance and prevent the epoxidation from happening. In order to be 
able to deprotect the isopropylidene groups and not affect the alkene we first had to carry out 
a bromination with NBS and MeOH of the alkene 284 to give the methoxy bromo derivative 
311 in up to 96% yield (Scheme 90).17 We noticed that anhydrous methanol was needed in 
order for the reaction to take place.  
 
We also synthesised the ethoxy-bromo derivative 312, using ethanol instead of methanol and 
we obtained the ethoxy-bromo derivative 312 in 91% yield (Scheme 91).  
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Having obtained substrate 311 we were then tasked with the deprotection of the 
isopropylidene groups on pyranose 311. We came across a paper in the literature where both 
isopropylidene groups had been removed using TFA in DCM on a different compound and 
decided to try these conditions on our substrate 311. We were able to obtain the deprotected 
pyranose compound 313 in quantitative yields (Scheme 92).2  
 
Having successfully deprotected both isopropylidene groups and having obtained a pure 
sample of compound 313, we then wanted to look at introducing different protecting groups 
on the hydroxyl groups and to reform the alkene to carry out the epoxidation of the alkene or 
to introduce a cyano functionality on the anomeric carbon which we could hydrolyse to the 
carboxylic acid. 
We decided to look at acetate protecting groups on the deprotected compound 313 to see the 
effect on forming the epoxide after the alkene was reformed. We took substrate 313 and 
carried out standard acetate protection conditions using 4 equivalents of acetic anhydride with 
DMAP in anhydrous DCM to give tetra-acetate pyranose 314 in over 90-94% yield (Scheme 93). 
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We were then tasked with reformation of the alkene to carry out the epoxidation. Consulting 
the literature, we came across a paper where the author had been able to carry out the 
reformation of the alkene on a substrate similar to 314, except with an acetate on the 
anomeric position and a bromine at the C-2 position. They used zinc dust in the presence of 
sodium acetate acetic acid water mixture and due to the affinity of zinc to bromine they 
reformed the alkene. In order to carry out the reaction using our substrate we had a problem 
since we had a methoxy group on the anomeric position. We decided to carry out the reaction 
on the methoxy substrate 314, however we were unable to reform the alkene with only 
starting material observed.17 
In order to reform the alkene, we first needed to convert the methoxy group on the anomeric 
position to acetate and form 315. This was obtained using a trace amount of sulfuric acid in 
acetic anhydride. After dilution with chloroform and washing with an ice water mixture, base 
and water, we dried the organic layer and after chromatography we were able to obtain the 
desired penta acetate 315 in quantitative yield (Scheme 94).18  
 
After the formation of the acetate on the anomeric carbon 315 we then attempted to reform 
the alkene. The usage of zinc dust in the presence of sodium acetate and acetic acid led to the 
formation of the tetra-acetate alkene 299 (Scheme 95). 
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Having formed the tetra-acetate alkene 299 we then wanted to see if we would be able to 
afford the epoxide 316, which we were hoping to ring open with TMSCN in the presence of a 
Lewis acid to introduce a cyano group on the anomeric group, which we hoped to hydrolyse to 
the carboxylic acid (Scheme 96). 
 
The first reaction we tried involved the epoxidation of the tetra acetate alkene 299 using m-
CPBA. Again, after many attempts we were unable to form the desired expoxide 316. We again 
tried DMDO on this substrate but unfortunately after numerous attempts we were unable to 
achieve the desired epoxide 316 (Table 5). 
Reagents Product 
m-CPBA (1 equiv.), DCM, 0 °C SM 
m-CPBA  (1.5 equiv.,) DCM, 0 °C SM 
DMDO (0.03 M) (1.2 equiv.) , DCM, 0 °C  SM 
DMDO (0.03 M) (2.4 equiv.) , DCM, 0 °C SM 
Table 5: Epoxidation conditions attempted on alkene 299 
We then decided to try silyl groups to see the effect they might have on forming the epoxide. 
We started this time with the tetra acetate alkene 299. A simple deprotection was carried out 
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using an excess of sodium methoxide in anhydrous methanol to achieve the free hydroxyl 
groups on compound 300 and after flash chromatography we obtained the product 300 in 95% 
yield (Scheme 97). 
  
The next step involved the protection of the free hydroxyl groups of alkene 300 using over 4 
equivalents of TBSCl and imidazole in DCM to achieve the tetra tert-butyl silyl alkene 301 in up 
to 60% yield (Scheme 98).19 We again decided to carry out the epoxidation of alkene 301, 
firstly with m-CPBA, but again we were unsuccessful. 
 
After the disappointment of being unable to get the epoxidation reaction to work with m-
CPBA, we came across some papers in the literature where Danishefsky had carried out 
epoxidation of glucals with similar protecting groups with DMDO, and had been very 
successful.20–22 We carried out the epoxidation of the alkene 301 with DMDO and to our 
pleasure we obtained the desired epoxide 303 in quantitative yield after around 2 hours at 0 °C 
whilst monitoring the reaction completion by tlc (Scheme 99).  
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We were able to complete the assignment of the stereochemistry using NMR analysis and 
comparing it to previous work in the literature on similar susbtrates.21 Based on the 1H NMR 
spectrum assignment we obtained a doublet for the proton in the H-1 position with a coupling 
constant of 2.2 Hz at 4.90 ppm and a triplet for the proton on the H-2 position with a coupling 
of 2.1 Hz at 2.79 ppm. Comparing this to Danishefsky α-epoxide substrate 317 in which he 
obtained a doublet for the proton on the H-1 position with a coupling constant of 2.20 Hz at 
4.90 ppm, and he also obtained a doublet for the H-2 position with a coupling constant of 2.45 
Hz at 2.92 ppm (Figure 6).21 Danishefsky had run his 1H NMR on a 250 MHz NMR compared to 
ours which was run at 500 MHz. Danishefsky had also predicted his compound to be the α-
epoxide. Within the paper Danishefsky stated that while the NMR spectra of the crude product 
did not rigorously define the stereochemical sense of epoxidation, this point was established 
by a sequence of methanolysis followed by acetylation to prove it with the α-epoxide subjected 
to methanolysis and acetylation to give the β-product. When their β-epoxide was subjected to 
methanolysis and acetylation the α-product was obtained. When the coupling constants we 
obtained were compared to the literature values, we could show that the α-epoxide 303 is the 
only product obtained (Scheme 99). For the β-epoxide on our substrate, we should observe 
larger coupling constants for the H-1 and H-2 protons of between 7-10 Hz, which we did not 
observe. Danishefsky  also observed similar coupling constants for his β-epoxide derivatives of 
7-10 Hz compared to his α-epoxides with coupling constants of 2-3 Hz.21 
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Having being successful we also introduced the TIPS protecting groups on the free hydroxyl 
groups of alkene 300 using over 4 equivalents of TIPSCl in the presence of imidazole to obtain 
the tetra-TIPS alkene product 302 in around 50% yield (Scheme 100).19 
 
Having obtained another substrate, we carried out the epoxidation of the alkene 302 with 
DMDO and to our pleasure we obtained the desired epoxide 304 in quantitative yield after 2 
hours at 0 °C whilst monitoring the reaction completion by tlc (Scheme 101). Simple 
evaporation under reduced pressure removed the acetone byproduct and after drying under 
high vacuum we were able to obtain pure 304 without further flash chromatography. 
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We were able to complete the assignment of the stereochemistry using NMR analysis and 
comparing it to previous work in the literature on similar substrates and the work carried out 
above on 303.21 Based on the 1H NMR spectrum assignment we obtained a doublet for the 
proton in the H-1 position with a coupling constant of 2.4 Hz at 4.91 ppm and a doublet for the 
proton on the H-2 position with a coupling of 2.4 Hz at 2.86 ppm. Comparing this again to 
Danishefsky α-epoxide substrate in which he obtained a doublet for the proton on the H-1 
position with a coupling constant of 2.20 Hz at 4.90 ppm, and he also obtained a doublet for 
the H-2 position with a coupling constant of 2.45 Hz at 2.92 ppm we can show that we have 
obtained the α-epoxide as a single product 304 (Scheme 101).  
 
Having obtained both epoxides 303 and 304 from DMDO we then wanted to introduce a cyano 
group on the anomeric position and then hydrolyse this cyano group to an acid or ester 
functionality. 
We began trying to ring open the epoxides 303 and 304 using TMSCN in the presence of a 
Lewis acid, however after numerous attempts shown (Table 6) below and trying many different 
conditions and Lewis acid combinations or using TMSCN on its own we were unable to obtain 
the desired compound 318 and only decomposition was observed (Scheme 102).23–25 
 
Reagents Product 
TMSCN, Al(OiPr)3, Hexane Decomposition 
Me2PhSiCH2MgCl, CuI, THF Decomposition 
TMSCN Decomposition 
Vinylmagnesium Bromide, DCM -60 °C,  Decomposition 
Table 6: Attempted ring opening of epoxides conditions on 303 and 304 
114 
 
Having been unable to ring open epoxides 303 and 304 using conditions described above we 
decided to change strategy and introduce a functional group on alkenes 301 and 302. In order 
to check if this strategy could be carried out deprotonation was attempted on the anomeric 
position using t-BuLi. We quenched the reaction with D2O and we were able to see the 
disappearance of the anomeric proton in the NMR spectrum. We were able to obtain the 
deuterated compounds 319 and 320 (Scheme 103).  
 
Having discovered that it was possible to deprotonate at the anomeric position, we examined a 
range of reactions using a range of bases from t-BuLi to Schlosser’s base, a mixture of n-BuLi 
and t-BuOK, to carry out the deprotonation on alkenes 301 and 302 (Scheme 104). Quenching 
the reactions with reagents such as ethyl or methyl chloroformate should allow us to introduce 
ester moieties. 
 
Unfortunately, we were unable to introduce an ester moiety, with only starting material 
observed. We also tried another procedure from the literature with the use of 
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paraformaldehye with an excess of t-BuLi, but again we were unable to obtain the desired 
functionalization of the anomeric position of the alkene. After several attempts listed (Table 7) 
below we were unable to introduce a functional group on the anomeric position even after 
showing that the deprotonation can occur using D2O.
26–30  
Reagents Product 
t-BuLi, Ethyl chloroformate, THF SM 
t-BuLi, Methyl chloroformate, THF SM 
t-BuLi, Methyl chloroformate, t-BuOK, THF    SM31 
t-BuLi, Paraformaldehyde, THF     SM 27 
t-BuLi, CO2, THF     SM 
28 
n-BuLi, t-BuOk, Bu3SnCl, THF     SM 29 
t-BuLi,  THF, Bu3SnCl     SM 
30 
Table 7: Conditions carried out for the attempted synthesis of 321 and 322. 
Since writing my thesis a paper has been published by Nishikawa in which they have 
successfully ring opened an epoxide by using TMSCN in the presence of Iodine in toluene to 
introduce a cyano functional group on the anomeric group. This methodology could be tried 
within our group on substrates 303 and 304 in the future (Scheme 105).31 
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Route 5 Reduction route: 
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The next route attempted in our strategy (Scheme 56) involved steps described previously 
(Schemes 37 and 47), with the key intermediate 212 being prepared from D-mannose on a 50g 
scale in 98% yield.2 
However, this time, instead of carrying out the deprotection and the in situ cyclization, we 
reduced the ethyl ester of the dithiane 212 to the alcohol 226 using LiAlH4 to give 226 in yields 
above 98% (Scheme 106). The next step was to carry out the deprotection of the dithiane on 
226 using NBS and acetone and the in situ cyclization; however the desired product was not 
obtained, with just starting material 226 being observed.  
 
Having had no success in obtaining the desired compound, we decided to selectively protect 
the primary alcohol of 226 with an acetate to give 227 and then carry out the deprotection and 
the cyclization again using the same conditions (Scheme 107). Again only diacetone mannose 
191 was obtained.  
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We decided then to look at DBDMH 324 to carry out the deprotection of the dithiane and in 
situ cyclization. We synthesized it freshly within the lab, prior to use, using previously reported 
conditions, starting with 5,5-dimethylhydantoin 323, which was dissolved in a 5% NaOH 
solution and added to neat bromine and stirred until a colourless precipitate was formed, 
which was filtered and dried (Scheme 108).45  
 
Instead of carrying out the usual NBS deprotection reaction and in situ cyclization we used 
DBDMH 324 on the acetate protected compound 227. We found using DBDMH instead of NBS 
gave to our surprise a very high yield of the desired triacetonide pyranose 238, and after the 
optimization of the conditions, we were able to improve the yield to 70-90% (Scheme 109). 
 
We finally obtained the reaction in a good yield. The next step was the deprotection of the 
acetate on pyranose 238 to give the primary alcohol 240. Using sodium methoxide, freshly 
prepared prior to usage, we were able to obtain the desired compound 240 in a quantitative 
yield (Scheme 110). 
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We decided also to protect the primary alcohol with a silyl group using TBSCl to see if this could 
increase the yield further on the deprotection and cyclization step compared to the acetate 
protected substrate 227. We were able to obtain the TBS protected substrate 237 in up to 76% 
yield (Scheme 111)  compared with the acetate protected substrate 227 obtained in over 90% 
yield. 
 
Having obtained the TBS protected substrate 237, we carried out the deprotection and in situ 
cyclization using DBDMH and we were able to obtain the desired triacetonide pyranose 239 in 
up to 70% yield (Scheme 112). Since the yield of the protection step with TBS to give 237 was 
lower than the acetate 227 we decided to continue using the acetate substrate 227 for the 
remainder of this route.  
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The next step was the conversion of the primary hydroxyl group into a leaving group on 
substrate 240 in order to carry out a displacement with a thiol. The first reaction we tried 
involved the introduction of a mesylate group. Using standard conditions, 
methanesulfonylchloride in pyridine was added to the primary alcohol 240 and stirred for one 
hour.32 After work up and purification by column chromatography mesylate 325 was obtained 
in 89% yield (Scheme 113).  
 
Having obtained such success forming the mesylated compound 325, we then moved onto the 
displacement of the mesylate with potassium thioacetate to introduce the thiol functionality at 
this position. We found that this reaction proved very difficult and only starting material was 
recovered. We tried many different conditions with some shown in (Table 8) in order to obtain 
the thioaceteate product 242, but we were unable to obtain it. We postulated that the 
mesylate might be sterically hindered due to the presence of the tri-acetonides on compound 
325, and this might explain why we were unsuccessful in obtaining our desired compound 242 
(Scheme 114).33,34 
121 
 
 
Reagents Products 
KSAc (2 equiv.), Butanone, Reflux SM 
KSAc (4 equiv.), Butanone, Reflux SM 
KSAc (2 equiv.), DMF, Reflux SM 
KSAc (4 equiv.), DMF, Reflux SM 
Table 8: Conditions tried in order to displace the mesylate to form thioacetate 242. 
Having been unsuccessful in obtaining pyranose 242 we looked at other leaving groups. The 
next step we tried involved using iodine in the presence of triphenylphosphine and imidazole in 
toluene to introduce the iodide on substrate 240. We obtained pyranose 326 in a very good 
yield (Scheme 115). We then carried out the displacement reaction using potassium 
thioacetate in DMF, but again to our surprise we were unable to obtain pyranose 242.11  
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We had experienced limited success so we then decided to try to introduce a triflate on the 
primary alcohol of 240 as triflates are known to be very good leaving groups. Using triflic 
anhydride in DCM at -78 °C and stirring for 1 hour with an aqueous work up we were able to 
obtain the triflated pyranose 241 in very high yields of up to 90-96% without purification 
(Scheme 116).35  
 
We were successful in obtaining the triflated pyranose 241 and the next step was to attempt 
the displacement with potassium thioaceteate in DMF. Monitoring the reaction closely by tlc 
we were able to see total consumption of our starting material 241 and a new product being 
formed. After a work up and purification we were able to obtain the thioacetate pyranose 242. 
After optimization of the reaction, using 4 equivalents of potassium thioacetate in dry DMF, we 
were able to obtain pyranose 242 in yields greater than 90% (Scheme 117). 
 
The next step involved the selective deprotection of one of the acetonides so we could oxidize 
the secondary alcohol to the ketone and then carry out the in situ cyclization to prove our 
methodology could be achieved to form the bicyclic structure. We came across a paper in the 
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literature where they had carried out a selective deprotection of an acetonide on a different 
substrate using 80% aqueous acetic acid.36 We decided to carry this out on our triacetonide 
substrate pyranose 242, and after monitoring by tlc we saw that the reaction had reached 
completion after around 2 hours. After aqueous work up and purification using flash 
chromatography we were able to obtain our selectively deprotected acetonide 243 in 80-94% 
yield (Scheme 118). We noticed that if the reaction was left for more than 3 hours, the 
deprotection of the other acetonides occurred. 
 
The next step involved the selective protection of the primary alcohol over the secondary on 
243. We decided to use TBSCl as the protecting group and using standard TBSCl protection 
conditions in the presence of imidazole in DMF, using only one equivalent of TBSCl in order to 
avoid the protection of both alcohol moieties. We were able to obtain the selectively protected 
pyranose 244 in very good yields of up to 70% (Scheme 119).37,38  
 
After obtaining the selectively protected primary alcohol 244 we then wanted to oxidize the 
secondary alcohol to the ketone, and after deprotecting the thioacetete to attempt an in situ 
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cyclization to obtain the bicyclized product 253. We initially carried out a Dess-Martin oxidation 
to obtain the ketone 247, but we were unable to repeat this reaction using the literature 
conditions.39 We then carried out a Swern and we were able to obtain the desired ketone 
pyranose 247 in quantitative yields (Scheme 120).40  
 
The next step we were tasked with was the deprotection of the thioacetate of 247 to give the 
thiol intermediate 250 and the in situ cyclization to form the bicyclic product 253 (Scheme 
121). We tried the thioacetate deprotection on the TBS silyl protected ketone 247 with 
multiple methods used for different substrates from the literature shown below (Table 9), from 
the most common deprotection conditions such as sodium methoxide in methanol, right 
through to other methods for thioacetate deprotections with only decomposition being 
observed (Table 9). This was very disappointing as we were very close to obtaining the desired 
bicyclic structure 253 to prove our methodology. We thought that perhaps there was some 
steric hindrance between the bulky TBS silyl group and the acetonide groups. We thought 
about the deprotection of the acetonides before carrying out the reaction, or in earlier steps, 
to see if this steric hindrance was preventing the cyclization from happening. We also studied 
the reaction by monitoring it by NMR spectroscopy, but were unable to see what was 
happening and we could only observe decomposition.  
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Reagents Product 
NaOMe, MeOH  Decomposition 
TBAF (1.0 M), THF  Decomposition 
Hydrazine Acetate, THF  Decomposition 
Hydrazine mono-hydrate, AcOH, DMF  Decomposition 
2-methoxy ethanol, H2O, NaHCO3   Decomposition 
K2CO3, MeOH  Decomposition 
KOH, MeOH, H20  Decomposition 
LiOH, THF, H2O  Decomposition 
Table 9: Thioacetate deprotection conditions carried out on thioacetate 247 and 248.33,35–38,41–43 
As we were unable to obtain bicyclic compound 253 or the deprotected thiol 250, we decided 
to look at other silyl protecting groups with primary alcohol selectivity and decided to use 
TBDPS instead of TBS. Using standard TBDPS protection conditions in the presence of imidazole 
in DMF using only one equivalent of TBDPSCl in order to avoid the protection of both alcohol 
moieties, we were able to obtain the selectively protected pyranose 245 in a yield of up to 74% 
(Scheme 122). 38 
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After achieving the selective protection of the primary alcohol to form 245 we carried out a 
Swern oxidation in order to obtain the ketone pyranose 248 in a quantitative yield (Scheme 
123). 
 
We then attempted the thioacetate deprotection on the TBDPS silyl protected ketone 248 with 
multiple methods as used with the TBS substrate (Table 9). Unfortunately, only decomposition 
was observed and intermediate 251 or bicyclic structure 253 were not obtained (Scheme 124).  
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Further to this we decided to look at other protecting groups besides the silyl groups to see if 
these would influence the reaction. We decided to selectively protect the primary alcohol of 
pyranose 243 with a trityl group.3444 We obtained the trityl protected compound 246 in very 
high yield after purification on deactivated silica gel to obtain the product 246 in yields of up to 
90% (Scheme 125). 
 
We then oxidized the secondary alcohol of 246 to the ketone 249 using the Swern oxidation 
conditions reported above, and obtained the ketone 249 in a yield of up to 51% (Scheme 126).  
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After achieving the desired ketone 249, the next step was the deprotection of the thioacetate 
to give the thiol intermediate 252 and the in situ cyclization to form the bicyclic compound 253 
(Scheme 127). We first tried similar conditions as used with the previous substrate but to our 
disappointment only complete decomposition was observed. After numerous attempts we 
then decided to look at other ways to cleave the thioacetate to the thiol. However, from all 
conditions carried out listed (Table 10) below, only complete decomposition was observed. 
Further work was carried out using bases such as LiOH and NaOH which showed promising 
results, but further work needs to be carried out in order to achieve the bicyclic compound 
253. 
 
Reagents Product 
Hydrazine acetate, DMF Decomposition 
Hydrazine Hydrate, Acetic Acid, DMF Decomposition 
2-methoxy ethanol, H2O, NaHCO3   Decomposition 
K2CO3, MeOH  Decomposition 
KOH, MeOH, H20  Decomposition 
LiOH, THF, H2O  Decomposition 
Table 10: Thioacetate deprotection conditions carried out on thioacetate 249. 33,35–38,41–43 
We also decided to try and introduce a triflate on the secondary alcohol instead of oxidizing to 
the ketone on substrate 246. We believed by having a good leaving group in this position and 
trying to carry out the deprotection of the thioacetate to the thiol should aid an in situ 
cyclization to form a bicyclic structure. We began with the triflation of 246 using triflation 
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conditions we used previously and after two or three attempts we were unable to obtain the 
desired compound 327 with only decomposition observed (Scheme 128). 
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Conclusion and future work: 
By the end of our studies towards the synthesis of tagetitoxin, a range of routes had been 
explored (Routes 1-5), producing the key intermediates shown below (Scheme 129).  
Within our first route the use of dithiane followed by a dethioketalization produced 
intermediate 214 in low yield and the acetate protected derivative 218. We had hoped to 
complete the removal of the anomeric hydroxyl moiety or the introduction of a methylene 
group to give 215, however we were unable to introduce this after numerous attempts. We 
also tried to improve the yield of the key intermediate 214 using different deprotection 
conditions of the ditihiane or by synthesizing other dithiane derivatives, for example, 
protecting the free hydroxyl group on the α-position of intermediate 268 prior to the NBS 
mediated cleavage of the dithiane. However no improvement could be made on the initial 
reaction discussed in route one. 
Route two (Scheme 79) involved a Wittig reaction to produce alkene 283 which, following 
pyrolysis after an intramolecular esterification, led to the key intermediate 284. Intermediate 
284 provided a lot of interesting work following Waldrop’s route, however we were unable to 
replicate the literature route to KDO after obtaining intermediate 284.15 This intermediate led 
us to complete further work on alkene intermediate 284 discussed in route four. 
In route three we tried an alternative route towards KDO (Scheme 83).5 In this route we 
started again from starting material 191. We then carried out a reduction of diacetone 
mannose to give 200 and protected the O-1 hydroxyl with a benzyl group to give intermediate 
293. Intermediate 293 was treated with ethyl bromoacetate in the presence of sodium hydride 
in THF to introduce an ethoxycarbonylmethyl group on the O-4 position to give 294 in the same 
way as Ohrui and co-workers achieved. However, after numerous attempts using their 
conditions and varying the amount of sodium hydride or ethyl bromoacetate we were unable 
to synthesize the desired compound 294.This route would have provided a quick route towards 
achieving a KDO substrate which could be modified so further work could be completed on this 
in the future. 
In route four (Scheme 87) we started with intermediate 284 previously prepared in route two. 
Epoxidation of the alkene moiety followed by epoxide ring opening to introduce functional 
groups on the anomeric position was envisaged. However, this provided difficult as no epoxide 
131 
 
was formed using substrate 284. In order to change the isopropylidene protecting groups and 
to allow the formation of epoxide derivatives, we first had to carry out a bromination of the 
alkene moiety on 284. This produced the methoxy-bromo derivative 311, the isopropylidene 
groups of 311 were removed and acetate protecting groups were introduced to form 
intermediate 314. In order to reform the alkene we first had to convert the methoxy group on 
the anomeric position of 314 to an acetate to produce 315. Having obtained 315 we could then 
reform the alkene using zinc dust in the presence of sodium acetate and acetic acid to form 
tetra-acetate alkene 299. We also tried to form the epoxide from alkene 299 using m-CPBA or 
DMDO; however, we were unsuccessful. We decided to look at alternative protecting group 
and deprotected the acetate groups on alkene 299 using sodium methoxide in methanol to 
give 300. We were then able to protect the hydroxyl groups with TBS and TIPS groups to 
produce alkenes 301 and 302. We then completed the epoxidation of both alkenes using 
DMDO to give solely the α-epoxides 303 and 304. Numerous attempts were carried out to 
successfully ring open epoxides 303 and 304 which proved unsuccessful but more work should 
be carried out especially since this would provide a fast way to introduce functional groups.   
Route five (Scheme 56) provided the closest route we had in obtaining a bicyclic intermediate 
253. Using the same chemistry as in route one with the reduction of the ethyl ester to alcohol 
which was then acetate protected and the use of DBDMH to carry out the dethioketalization 
we were able to increase significantly the yield. Acetate deprotection followed by the 
introduction of a good leaving group produced triflate 241. The triflate group was displaced 
using potassium thioacetate to form the intermediate 242. The selective deprotection of an 
isopropylidene group on 242 to produce 243 was achieved in high yield. Selective protection of 
the primary alcohol with silyl and trityl groups followed by the oxidation of the secondary 
alcohol produced key intermediates 247, 248 and 249. The next step involved the deprotection 
of the thioacetate to produce the thiol which we had hoped would allow an in situ cyclization 
to form the bicyclic structure 253. However after numerous attempts to deprotect the 
thioacetate on substrates 247-249 to the thiol 250-252 we were unable to obtain the desired 
product. Further work should be carried out to try and achieve this with the use of other 
protecting groups which might favor the cyclization.  
A number of key intermediates and novel compounds were synthesized in our aim towards a 
total synthesis of tagetitoxin which are shown (Scheme 129 and 130, respectively). Route four 
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and five produced the best results. Further work should explore the ring opening of epoxides 
303 and 304 using a set of recently reported conditions (Scheme 105). 
Further work should also be carried out on route three as this could lead to a fast route in 
obtaining a KDO derivative which could be modified to form a bicyclic derivative 292 and prove 
our methodology. 
Route five produced the best results with higher yields and less steps and the thioacetate 
deprotections reaction on thioacetate intermediates 247-249 to the corresponding thiols 250-
252 and in situ cyclization to achieve bicyclic structure 253 should be further explored to show 
that the methodology works. Further modifications in the synthesis would be required to 
introduce functional groups to achieve a total synthesis of tagetitoxin.  
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Experimental: 
Experimental Procedures  
Air sensitive reactions were run using flame-dried glassware and under an argon atmosphere. 
Extractions were performed using the reported organic solvent and, if not indicated, were 
equivolumetric. Where petroleum ether fractions 40/60 has been used, it is referred to in the 
term “petrol”.  
 
Chromatography on silica gel was performed using a standard purification procedure using 
Fluka Kieselgel 60, 0.023-0.063 mm particle size with the reported solvent systems. Thin layer 
chromatography was performed using Merck aluminium-backed plates coated with Kieselgel 
60 F254 silica coating. The plates were visualized by U.V. irradiation at a wavelength of 254 nm, 
or by dipping the plate in an ethanolic solution of phosphomolybdic acid, or potassium 
permanganate solution.  
 
Fourier transformation Infrared spectroscopy was recorded using a Perkin Elmer Model 
spectrophotometer in the range of 4000-500 cm–1. Samples were dissolved in the reported 
solvent and applied onto a sodium chloride plate as thin films.  
 
Nuclear magnetic resonance spectroscopy was acquired using a Bruker 400 and 500 MHz 
Spectrometer instrument for 1H NMR analyses and for 13C NMR analyses. The spectra were 
calibrated where possible to the signals of tetramethylsilane, at d=0.00 ppm, or else using the 
residual peak of CHCl3 present in CDCl3, at δ=7.26 ppm. Chemical shifts (δ) are reported in ppm. 
When possible, coupling constants (J) are shown denoting the multiplicity as: singlet (s), 
doublet (d), triplet (t), quarter (q), multiplet (m) or any combination of those. The size of the 
coupling constant is given in Hertz. Carbons are shown as follows: CH3, CH2, CH and Cq 
(quaternary carbons).  
 
Optical rotations values were measured with a Bellingham and Stanley ADP-440 polarimeter, 
operating at λ = 589 nm, corresponding to the sodium line (D), at the temperatures indicated. 
The solvent used for these measurements were of spectrophotometric grade and the solutions 
for these measurements were prepared in volumetric flasks for maximum accuracy.  
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High resolution mass spectroscopy was carried out by the EPSRC national mass spectrometry 
service at the University of Wales, Swansea, utilizing electrospray (ES), nanoelectrospray 
(NESP) and MALDI-TOF ionization techniques.  
 
Melting points were obtained using an Electrothermal-IA 9100 melting point instrument 
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2,3:5,6-di-O-isopropylidene-α-D-mannofuranose (191) 1 
 
α-D-Mannose 190 (20 g) was dissolved in acetone (600 ml). Concentrated sulfuric acid (14 ml) 
was added and the mixture was left to stir for 2 h until all the sugar had dissolved. After 2 h. 
the mixture was neutralized with anhydrous sodium carbonate and was filtered off. The filtrate 
was then heated under reflux for 1 h with activated charcoal and anhydrous sodium carbonate 
(2-3 g). After 1 h the mixture was filtered over celite and the filtrate was evaporated to dryness 
to give a colourless solid. The crude product was subjected to crystallisation by dissolving in 
diethyl ether and the product was precipitated with petroleum ether. This was carried out 2 
times with the precipitate filtered of using a Buchner funnel. 20 g was obtained from the first 
recrystallization and a further 6-7 g was obtained from the mother liquor. White crystalline 
solid obtained 191. Yield of 92%. 
mp 122-123 °C (Lit. 122-123 °C); IR γmax (film)/cm
-1: 3428, 2979, 2948, 2899, 2948, 1457, 1372, 
1350 1318, 1237, 1202, 1087; 1H NMR (400 Hz, CDCl3): δ 1.33 (3H, s, CH3 isopropylidene), 1.38 
(3H, s, CH3 isopropylidene), 1.46 (3H, s, CH3 isopropylidene), 1.47 (3H, s, CH3 isopropylidene), 
3.49 (1H, s, OH), 4.03 (1H, dd, J = 8.7, 4.8 Hz, H-6), 4.09 (1H, dd, J = 8.6, 6.2 Hz, H-6), 4.19 (1H, 
dd, J = 7.1, 3.6 Hz, H-5), 4.43 – 4.38 (1H, m, H-4), 4.63 (1H, d, J = 5.9 Hz, H-2), 4.82 (1H, dd, J = 
5.9, 3.7 Hz, H-3), 5.38 (1H, s, H-1); 13C NMR (100 MHz, in CDCl3): δ 24.42 (1C, CH3 
isopropylidene), 25.12 (1C, CH3 isopropylidene), 25.81 (1C, CH3 isopropylidene), 26.76 (1C, CH3 
isopropylidene), 66.48 (1C, CH2, C-6), 72.28 (1C, C-5), 79.62 (1C, C-4) 80.08 (1C, C-3), 85.49 (1C. 
C-2), 101.16 (1C, C-1), 109.10 (1C, Cq isopropylidene), 112.60 (1C, Cq isopropylidene). 
Data is in agreement with the literature reference. 
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Ethyl-2-deoxy-4,5:7,8-di-O-isopropylidene-D-glycero-D-galacto-0ctulosonate-1,3-propane-
dithio-acetal (212) 2 
 
A solution of diisopropylamine (17.80 mL, 126 mmol) in anhydrous THF (200 mL) was treated 
with n-BuLi (50.26 mL, 2.5 M in hexane, 126 mmol) at −20 °C. After stirring for 15 min ethyl 1,3-
dithiane-2-carboxylate (18.1 mL, 115 mmol) was slowly added. The dark red solution was kept 
for 2 h at −20 °C and then added to a cooled suspension of MgBr2 (−20 °C) in anhydrous THF 
(250 mL) made from magnesium (4.2 g, 173 mmol) and 1,2-dibromoethane (13.25 mL, 153 
mmol). Then 191 (10 g, 38.4 mmol) was added without any solvent. The reaction mixture was 
warmed to room temperature over a period of 3 h, stirred for 3 h at 50 °C, then poured into 
ice-cold, satd. Aqueous NH4Cl (500 mL) and extracted with EtOAc (900 mL). The combined 
extracts were washed with water, dried (MgSO4) and evaporated; the residue was purified by 
flash chromatography (toluene:EtOAc, 5:1)to afford excess ethyl 1,3-dithiane-2-carboxylate 
and 212 (17.24 g, 99%) as a light brownish syrup; TLC (toluene:EtOAc, 5:1): Rf 0.54. 
 
IR γmax (film)/cm-1: 3454, 2983, 2934, 1727, 1370, 1213, 1158, 1063 and 850; 1H NMR (400 Hz, 
CDCl3): δ 1.38 (3H, t, J=7.2 Hz, CH3 ester), 1.45 (9H, s, 3 x CH3 isopropylidene), 1.54 (3H, s, CH3 
isopropylidene), 1.94 (1H, m, CH2 dithiane), 2.11 (1H, m, CH2 dithiane), 2.82 (2H, m, CH2 
dithiane), 3.06 (1H, dd, J= 11.3 Hz, 3.0 Hz, CH2 dithiane), 3.26 (1H, dd, J= 11.5 Hz, 2.8 Hz, CH2 
dithiane), 3.67 (1H, d, J= 7.3 Hz, H-5), 3.77  (1H, s, OH), 3.95 (1H, s, OH), 4.10 - 4.06 (1H, m, H-
2), 4.19 - 4.12 (2H, m, H-6, H-6), 4.36 - 4.27 (3H, m, CH2 ester), 4.46 (1H, dd, J= 7.6, 1.0 Hz, H-4), 
4.61 (1H, d, J=7.6 Hz, H-3); 13C NMR (100 MHz, CDCl3): δ 14.08 (1C, CH3 ester), 24.16 (1C, CH2, 
dithiane), 25.13 (1C, CH3, isopropylidene), 25.34 (1C, CH3, isopropylidene), 26.09 (1C, CH3 
isopropylidene), 26.92 (1C, CH3 isopropylidene), 27.24 (1C, CH2 dithiane), 27.55 (1C, CH2 
dithiane), 58.67 (1C, Cq dithiane), 62.74 (1C, CH2 ester), 67.59 (1C, CH2, C-6), 70.63 (1C, C-4), 
72.50 (1C, C-5), 74.17 (1C, C-1), 75.72 (1C, C-2), 77.22 (1C, C-3), 109.19 (1C, Cq isopropylidene), 
109.35 (1C, Cq isopropylidene), 169.92 (1C, carbonyl of ester). 
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Data is in agreement with the literature reference. 
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Ethyl 4,5:7,8-di-O-isopropylidene-α-D-glycero-D-galacto-2-octulopyranosanate (214) 2 
 
A solution of NBS (1.38 g, 7.73 mmol) in acetone (60 ml) was added slowly to a solution of 212 
(1 g, 2.21 mmol) in acetone (60 ml) at 0 °C and the reaction mixture was stirred for 5 min at 0 
°C. Saturated aqueous solutions of Na2S2O3 and NaHCO3 were added to the reaction mixture 
which was then extracted with EtOAc. The combined organic layers were washed with water, 
dried over MgSO4 and the filtrate was concentrated under reduced pressure. The residue was 
purified by flash chromatography on silica gel (Petrol/ EtOAc, 1:1) to give the pure compound 
214 as a white solid (0.32 g, 40%).  
 
mp 127-128 °C (Lit. 128 °C); IR γmax (film)/cm-1: 3419, 2982, 2950, 2899, 1732, 1458, 1437, 
1374, 1350, 1279, 1253, 1026; 1H NMR (400 MHz in CDCl3): δ 1.27 (3H, t, J=7.1Hz, CH3 ester), 
1.30 (3H, s, CH3 isopropylidene), 1.33 (3H, s, CH3 isopropylidene), 1.34 (3H, s, CH3 
isopropylidene), 1.49 (3H, s, CH3 isopropylidene), 4.01 - 3.88 (3H, m, H-3, H-4, H-6), 4.13 - 4.06 
(2H, m, CH2 ester), 4.32 - 4.22 (4H, m, H-2, H-5, H-7, H-7); 
13C NMR (100 MHz, in CDCl3): δ 13.98 
(1C, CH3, ester), 25.49 (1C, CH3 isopropylidene), 26.37 (1C, CH3 isopropylidene), 26.88 (1C, CH3 
isopropylidene), 28.21 (1C, CH3 isopropylidene), 63.31 (1C, CH2 ester), 66.78 (1C, CH2, C-7), 
69.86 (1C, C-5), 70.87 (1C, C-2), 73.01 (1C, C-3), 74.0 (1C, C-4), 77.26 (1C, C-6), 95.07 (1C, Cq), 
109.39 (1C, Cq isopropylidene), 109.79 (1C, Cq isopropylidene), 169.16 (1C, Cq ester). 
Data is in agreement with the literature reference. 
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(3aS,4R,6S,7R,7aS)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(ethoxycarbonyl)-2,2-
dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6,7-diyl diacetate (218) 
 
Ac2O (0.46 ml, 4.84 mmol), DMAP (92 mg, 0.75 mmol), and Et3N (0.675 ml, 4.84 mmol) were 
added to a solution of 214 (0.5 g, 1.1 mmol) at 0 °C in anhydrous dichloromethane, and the 
reaction mixture was stirred for 3 h at room temperature. Saturated NaHCO3 was added the 
mixture was extracted with dichloromethane. The organic layer was washed with water and 
brine then dried over MgSO4. Purification by column chromatography (Petrol: EtOAc, 1:1) 
furnished the pure compound as a white solid 218 (0.414 g, 84.4%). 
IR γmax (film)/cm-1: 2988, 2933, 2853, 1740, 1691, 1456, 1380, 1370, 1325, 1282, 1258, 1211, 
1178, 1117, 1096, 1042, 1004, 902; 1H NMR (400 MHz in CDCl3): δ 1.25 (3H, t, J = 7.1 Hz, CH3, 
ester), 1.36 (3H, s, CH3 isopropylidene), 1.38 (3H, s, CH3 isopropylidene), 1.42 (3H, s, CH3 
isopropylidene), 1.53 (3H, s, CH3 isopropylidene), 2.11 (3H, s, CH3 acetate), 2.15 (3H, s, CH3 
acetate), 3.70 (1H, dd, J = 8.2, 1.9 Hz, H-5), 3.97 (1H, dd, J = 9.1, 4.1 Hz, H-7), 4.10 (1H, dd, J = 
9.1, 6.2 Hz, H-7), 4.18 (2H, qd, J = 7.1, 2.2 Hz, CH2 ester), 4.39-4.36 (2H, m, H-4, H-3), 4.44 (1H, 
ddd, J = 8.2, 6.2, 4.1 Hz, H-6), 5.23 (1H, d, J = 6.9 Hz, H-2); 13C NMR (100 MHz, CDCl3): δ 14.0 
(1C, CH3 ethyl ester), 20.9 (1C, CH3 acetate), 21.0 (1C, CH3 acetate)  25.4 (1C, CH3, 
isopropylidene), 26.3 (1C, CH3 isopropylidene), 27.1 (1C, CH3 isopropylidene), 27.5 (1C, CH3 
isopropylidene), 62.8 (1C, CH2, ester), 67.1 (1C, CH2, C-7), 69.7 (1C, C-2), 71.7 (1C, C-5), 72.3 
(1C, C-4), 73.6 (1C, C-3), 73.8 (1C, C-6), 95.9 (1C, Cq, C-1), 109.7 (1C, Cq isopropylidene), 110.7 
(1C, Cq isopropylidene), 164.9 (1C, Cq acetate), 168.1 (1C, Cq acetate), 169.8 (1C, Cq ester). 
m/z [M+NH4]
+: 464.2123 ; [C20H30O11+NH4]
+ requires 464.2126. 
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1,3-dithiane-2-carboxylic acid (277)3 
 
 
1,3-Dithiane 273 (5 g, 41.6 mmol) was dissolved in anhydrous THF (150 ml) and the mixture 
was cooled to -20 °C. n-BuLi (18.3 mL, 2.5 M in Hexane , 45.74 mmol) was added and the 
reaction mixture was allowed to stir at -20 °C for 1.5 h, then CO2 (dry ice) was added quickly 
and the reaction mixture was allowed stir for 1 h at -20 °C. The reaction mixture was then 
allowed to reach room temperature and allowed to stir at r.t. for 2 h. After quenching the 
reaction mixture with NH4Cl (sat), the mixture was evaporated to reduce the amount of 
solvent. The aqueous layer was acidified to p=3 with a 1 M HCl solution, extracted with ethyl 
acetate and dried over anhydrous MgSO4, filtered and evaporated to dryness. The crude 
mixture was purified by column chromatography (Petrol: EtOAc, 4:1) to afford the product 277 
as a white solid (4.687 g, 68%). mp 114-116 °C (Lit. 114-116 °C);  
 
IR γmax (film)/cm-1: 2971, 2942, 2927, 2908, 2826, 2681, 2570, 1692, 1422, 1212, 1301, 1242, 
922 cm-1; 1H NMR (300 MHz, CD3OD): δ 1.84–1.98 (2H, m, SCH2), 2.48–2.55 (2H, m, SCH2), 3.15–
3.24 (2H, m, SCH2), 4.14 (1H, s), 4.80 (1H, s); 
13C NMR (75 MHz, CD3OD): δ 25.18 (1C, CH2), 
26.07 (2C, 2 x CH2), 41.08 (1C, CH), 172.17 (1C, C=O). 
Data is in agreement with the literature reference. 
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1,3-dithiane-2-carbonitrile (275)4 
 
 
Triphenylcarbenium tetrafluoroborate (2.26 g, 6.8 mmol) was added to a solution of 1,3-
dithiane 273 (1.5 g, 12.48 mmol) in anhydrous dichloromethane (150 ml). The mixture was 
heated under reflux for 1 h and then allowed to cool to room temperature. The solvents were 
removed under reduced pressure to yield an orange solid. Trituration with cold diethyl ether 
gave 1,3-dithienium tetrafluoroborate (2.33 g) as a yellow solid. TMSCN (1.41 mL, 1.12g, 11.31 
mmol) was added to the 1,3-dithienium tetrafluoroborate (2.33 g, 11.31 mmol) in anhydrous 
dichloromethane under a nitrogen atmosphere at −20 °C. The reaction mixture was stirred at -
20 °C for 1 h then quenched by the acidification of 1 M HCL (ml). The resulting mixture was 
washed with saturated aqueous NH4Cl, the aqueous layer was extracted with dichloromethane 
twice (2x 25 ml). The combined organic layers were dried over MgSO4, filtered and the solvent 
was removed under reduced pressure. The crude product was purified by column 
chromatography (Petrol: EtOAc, 9:1) to give the 2-cyano-1,3-dithane 275 as a pale brown solid 
(0.95 g, 58%). mp 86-87 °C (Lit. 87-88 °C) 
 
IR γmax (film)/cm-1: 2931, 2908, 2843, 2228, 1669, 1438, 1427, 1412, 1286, 1274, 1242, 1212, 
942, 910, 766; 1H NMR (400 MHz, CDCl3): δ 1.95-2.08 (1H, m, CH2), 2.16-2.26 (1H, m, CH2), 2.76-
2.85 (2H, m, SCH2), 3.28-3.38 (2H, m, SCH2), 4.42 (1H, s, SCHCN); 
13C NMR (75 MHz, CDCl3): δ 
25.0 (1C, CH2 dithi), 26.9 (1C, SCH2), 28.6 (1C, SCH), 116.0 (1C, CN).  
Data is in agreement with the literature reference. 
 
 
 
 
 147 
 
Methyl 1,3-dithiane-2-carboxylate (278)4 
 
HCL(gas) was bubbled through a methanolic solution (40 mL) of the carboxylic acid 277 (4.687 g, 
28.4 mmol). The solvent was removed under reduced pressure and the crude product was 
distilled in a kugelrohr apparatus. The desired ester 278 (4.315 g, 85%) crystallized upon 
standing at room temperature. mp 26-28 °C (Lit. 28 °C).4 
 
1H NMR (300 MHz, CDCl3): δ 1.93-2.22 (2H, m, CH2), 2.50-2.66 (2H, m, SCH2), 3.31-3.46 (2H, m, 
SCH2), 3.78 (3H, s, CH3), 4.19 (1H, s, SCH); 
13C NMR δ (75 MHz, CDCl3): 25.0, 26.1, 26.3, 40.0, 
170.6. 
Data is in agreement with the literature reference. 
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(R)-2,2-dimethyl-1,3-dioxolan-4-yl)-(4S,5R)-5-(2-methoxyvinyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)methanol (283)5 
 
Methoxymethyltriphenylphosphonium chloride (9.26 g, 27 mmol) was added in portions over 5 
min to a stirred solution of potassium t-butoxide (3.03 g, 27 mmol) in anhydrous THF (250 ml) 
at 0 °C. After stirring for 30 min at 0 °C a solution of DAM 191 (2.37 g, 9.1 mmol) in anhydrous 
THF (50 ml) was added dropwise. The red suspension was left to stir overnight at room 
temperature and the reaction was quenched by addition of aqueous brine solution (100 ml). 
After equilibration and separation of the layers, the aqueous layer was extracted with diethyl 
ether 3 times. The combined organic layers were dried over Na2SO4, filtered and evaporated. 
The crude product was purified by column chromatography on silica gel (Petrol: EtOAc, 7: 3) to 
give a mixture of pure products of cis and trans isomers of the vinyl ether 283 as a colourless 
syrup (2.43 g, 93%).  
IR γmax (film)/cm-1: 3542, 2988, 2980, 2835, 1650 1455, 1411, 1372, 1321, 1259, 1121, 1070, 
1042, 935, 889, 853; 1H NMR (500 MHz, CDCl3): δ 1.35 (3H, s, CH3 isopropylidene), 1.39 (3H, s, 
CH3 isopropylidene), 1.40 (3H, s, CH3 isopropylidene), 1.40 (3H, s, CH3 isopropylidene), 3.61 (3H, 
s, CH3 methoxy), 4.04 – 3.99 (3H, m, 3 x CH), 4.12 – 4.06 (2H, m, 2 x CH), 4.30 (1H, dd, J = 7.4, 
1.1 Hz, H-6), 4.34 (1H, dd, J = 7.3, 1.4 Hz, H-6), 4.66 (1H, dd, J = 9.6, 7.4 Hz, CH), 4.74 (1H, dd, J = 
8.7, 6.3 Hz, C=C, cis-alkene), 5.05 (1H, dd, J = 12.7, 9.6 Hz, CH=CH, trans-alkene), 5.27 (1H, ddd, 
J = 8.6, 7.4, 1.1 Hz), 6.13 (1H, dd, J = 6.3, 1.2 Hz, CH=CH, cis-alkene), 6.64 (d, J = 12.7 Hz, CH=CH, 
trans-alkene); 13C NMR (125 MHz, CDCl3): δ 24.30, 24.39, 25.29, 25.35, 26.71, 26.82, 26.84 (8 x 
CH3 one overlapping), 56.19, 60.10, 66.88, 67.07, 70.78, 70.85, 71.24, 75.98, 76.14, 76.17, 
76.22, 76.72, 97.96, 101.97, 107.75, 107.92, 109.20, 109.31, 150.17, 153.03; m/z 
[M]+:288.1567; [C14H24O6]
+ requires 288.1573. 
Data is in agreement with the literature reference. 
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(3aR,4R,7aR)-4-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-2,2-dimethyl-4,7a-dihydro-3aH-
[1,3]dioxolo[4,5-c]pyran (284)5 
 
 
 
 
A solution of the hydroxyl-vinyl ether 283 (1.471 g, 4.46 7mmol) and mercury (II) acetate (0.285 
g, 0.893 mmol) in anhydrous dichloromethane (30 ml) was evaporated to give a colourless 
viscous oil, which was heated in a Kugelrohr at 110 °C and 20 mm Hg for 2 h. The product was 
collected in the Kugelrohr flask and gave the pure cyclic compound 284 (0.755 g, 67%) without 
any further purification. 
[α]25D -7.9 (c 0.0107 in CHCl3); IR γmax (film)/cm
-1: 2986, 2934, 2888, 1648, 1456, 1371, 1236, 
1138, 1099, 1061, 1028, 992, 969; 1H NMR (400 MHz, CDCl3): δ 1.40 (6H, s, 2 x CH3 
isopropylidene), 1.45 (3H, s, CH3 isopropylidene), 1.47 (3H, s, CH3 isopropylidene), 3.80 (1H, d, J 
= 7.9, 0.9 Hz, H-5), 4.09 (1H, dd, J = 8.9, 5.0 Hz, H-7), 4.14 (1H, dd, J = 8.9, 6.1 Hz, H-7), 4.41-
4.37 (1H, m, H-6), 4.45 (1H, dt, J = 6.2, 1.0 Hz, H-4), 4.68 (1H, dd, J = 6.2, 2.8 Hz, H-3), 4.81 (1H, 
ddd, J = 6.2, 2.8, 1.5 Hz, H-2), 6.37 (1H, d, J = 6.3, H-1); 13C NMR (125 MHz, in CDCl3): δ 25.31 
(1C, CH3 isopropylidene), 26.88 (1C, CH3 isopropylidene), 27.07 (1C, CH3 isopropylidene), 28.14 
(1C, CH3 isopropylidene), 66.70 (1C, CH2, C-7), 68.46 (1C, C-5), 72.06 (1C, C-6), 74.18 (1C, C-4), 
75.10 (1C, C-3), 103.07 (1C, Cq C-2), 109.44 (1C, Cq isopropylidene), 110.58 (1C, Cq 
isopropylidene), 144.52 (1C, Cq C-1); m/z [M+NH4]
+: 274.1648; [C13H20O5+NH4]
+ requires 
274.1649. 
Data is in agreement with the literature reference. 
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Chloro(methoxy)methane (329)6 
 
A three-neck 250 ml flask fitted with a thermometer, reflux condenser, and addition funnel 
was charged with dimethoxymethane 328 (44.25 ml, 0.5 mol), toluene (133 ml), and Zn(OAc)2 
(9.2 mg, 0.01%). Acetyl chloride (33.5 ml, 0.50 mol) was placed in the addition funnel, and was 
introduced into the reaction mixture at a constant rate over 5 min. Zn(OAc)2 dissolved shortly 
after the addition of AcCl was started. During the next 15 min, the reaction mixture warmed 
slowly to 45 °C, and cooled to ambient temperature over 3 h, at which time analysis of an 
aliquot of the reaction by NMR indicated complete consumption of dimethoxymethane to 329. 
1H NMR (CDCl3): δ 2.03 (3H, s, MeOAc), 3.49 (3H, s, MOMCl), 3.64 (3H, s, MeOAc), 5.44 (2H, s, 
MOMCl). 
Data is in agreement with the literature reference. 
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(Methoxymethyl)triphenylphosphonium chloride (330)7 
 
 
MOMCl 329 (2.1 M in toluene, 25.43 mL, 50.83 mmol) was added to a solution of 
triphenylphosphine (20 g, 76.25 mmol) in toluene. The solution was heated under reflux 
overnight and the white salt that precipitated out was filtered off, washed with toluene, and 
dried under reduced pressure to yield the product compound 330 (16.35 g, 94%).  
mp 187-188 °C (Lit. 185-195 °C); 1H NMR (300 MHz, CDCl3): δ 3.69 (3H, s, methoxy), 5.89 (2H, d 
J = 4.0 Hz, CH2-OMe), 7.87–7.61 (15H, m, CH aryl). 
Data is in agreement with the literature reference. 
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3,3-dimethyldioxirane (310)8 
 
Sodium hydrogenocarbonate (29.0 g) was added in a mixture of water (127 mL) and acetone 
309 (96 mL) through a solid addition funnel. The resulting white suspension was stirred 
vigorously, and the reaction was allowed to cool to 0 °C in an ice bath. Oxone (60.0 g) was 
added to the reaction mixture under vigorous stirring. The solid addition funnel was then 
removed and replaced with a thermometer adapter fitted with the thermometer in order to 
keep the temperature of the exothermic reaction mixture between 0 and 5 °C. After 15 min, a 
conelflexible tubing adapter was connected to a pump and a moderate vacuum (100 mmHg) 
was applied. The reaction mixture was allowed to rise to 30 °C by means of a warm water bath. 
The pale yellow effluent of dimethyldioxirane-acetone solution was collected in the previously 
cooled receiving flask at − 78 °C over 4 h. When the distillation was over, the pump was 
disconnected and a nitrogen flux was connected to the conelflexible tubing adapter. The 
dimethyldioxirane solution obtained was kept on molecular sieves (4 A) in a freezer. Iodometric 
titration allowed us to determine the concentration of dimethyldioxirane 310 in the solution 
(75 mL, 0.05-0.08 M, 5% yield);  
IR γmax (neat)/cm
-1: 2980 (O-C-O), 1210 (C-O); 1H NMR (400 MHz, CDCl3): δ 1.65 (6H, s, 6CH3); 
13C NMR (400 MHz, CDCl3): δ 22.1 (2C, 2 x CH3), 214.0 (1C, C(CH3)2). 
Data is in agreement with the literature reference. 
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(R)-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-(4S,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-
4-yl-methanol (200)9 
 
DAM 191 (10 g, 38.42 mmol) was dissolved in anhydrous THF (200 ml) at 0 °C and LiAlH4 (1.6 g, 
42.26 mmol) was slowly added portion-wise. The mixture was stirred at room temperature for 
2 h. The excess LiAlH4 was carefully destroyed by the addition of 1.5 g of Na2SO4, followed by 
the slow addition of few drops of water. The mixture was filtered through celite and extracted 
with diethyl ether. The combined filtrate was concentrated under reduced pressure, and the 
crude product was purified by column chromatography (Petrol:EtOAc, 1:2) on silica gel to give 
the pure diol 200 as a colourless syrup (8.314 g, 83%). 
IR γmax (film)/cm
-1: 3427, 2987, 1381, 1216, 1068, 850; 1H NMR (400 MHz in CDCl3): δ 1.39 (3H, 
s, CH3 isopropylidene), 1.33 (3H, s, CH3 isopropylidene), 1.43 (3H, s, CH3 isopropylidene), 1.45 
(3H, s, CH3 isopropylidene), 2.79 (s, 1H, 4-OH), 3.52 (1H, dd, J=7.6, 1.5 Hz, H-4), 3.76 (1H, dd, 
J=12.2, 4.4Hz, CH2, H-1), 3.83 (1H, dd, J=12.2, 4.4Hz, CH2, H-1), 4.09-3.93 (3H, m, H-5, H-6), 4.24 
(1H, dt, J=7.3, 4.4Hz, H-2), 4.32 (1H, dd, J=7.3, 1.5Hz, H-3). 13C NMR (100 MHz, in CDCl3): δ 
24.79 (1C, CH3 isopropylidene), 25.25 (1C, CH3 isopropylidene), 26.77 (1C, CH3 isopropylidene), 
26.80 (1C, CH3 isopropylidene), 60.98 (1C, CH2, C-1), 67.33 (1C, CH2, C-6), 70.26 (1C, C-4), 75.71 
(1C, C-3), 76.08 (1C, C-5), 77.23 (1C, C-2), 108.38 (1C, Cq isopropylidene), 109.46 (1C, Cq 
isopropylidene). 
Data is in agreement with the literature reference. 
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(R)-(4S,5R)-5-(tert-butyldimethylsilyl-oxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl-(R)-2,2-
dimethyl-1,3-dioxolan-4-yl-methanol (264)9 
 
Diol 200 (8.314 g, 31.73 mmol) was dissolved in anhydrous DMF (35 ml) at 0 °C and TBSCl (5.74 
g, 38.08 mmol) and imidazole (6.55 g, 96.142 mmol) were added. The mixture was stirred at 
room temperature for 4 h, then poured into water (50 mL) , extracted with Et2O (50 mLx4). The 
combined organic layers were washed with brine, dried over MgSO4, then filtered, 
concentrated under reduced pressure, and the residue was purified by column 
chromatography (Petrol:EtOAc, 4:1) on silica gel to give pure compound 264 as a colourless 
syrup (11.489 g, 96%). 
IR γmax (film)/cm
-1: 3394, 2985, 1370, 1241, 1208, 1059 and 845; 1H NMR (400 MHz in CDCl3): δ -
0.0 (6H, s, (Si(CH3)2), 0.80 (9H, s, SiC(CH3)3), 1.25 (3H, s, CH3 isopropylidene), 1.28 (3H, s, CH3 
isopropylidene), 1.30 (3H, s, CH3 isopropylidene), 1.39 (3H, s, CH3 isopropylidene), 3.06 (1H, d, J 
= 6.0 Hz, OH), 3.56 (1H, dd, J= 7.6 Hz, 5.8 Hz, H-4), 3.72 (1H, dd, J=11.0 Hz, 3.8 HZ, H-1), 3.94-
3.87 (2H, m, H-1, H-5), 4.04-3.96 (2H, m, H-6), 4.13 (1H, dt, J=6.7 Hz, 3.8 Hz, H-2), 4.28 (1H, dd, 
J= 7.1 Hz, 1.0 Hz, H-3). 13C NMR (100 MHz, in CDCl3): δ -5.51 (1C, SiCH3), -5.48 (1C, SiCH3), 18.26 
(1C, Cq SiC), 24.82 (1C, CH3 isopropylidene), 25.31 (1C, CH3 isopropylidene), 25.81 (3C x 
SiC(CH3)3), 26.66 (1C, CH3 isopropylidene), 26.87 (1C, CH3 isopropylidene), 61.56 (1C, CH2, C-1), 
67.50 (1C, CH2, C-6), 70.30 (1C, C-5), 75.72 (1C, C-4), 75.79 (1C, C-3), 77.35 (1C, C-2), 108.19 
(1C, Cq isopropylidene), 109.23 (1C, Cq isopropylidene). 
Data is in agreement with the literature reference. 
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Tert-butyl(4R,5R)-5-(R)-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-methoxymethoxy-methyl-2,2-
dimethyl-1,3-dioxolan-4-yl-methoxy-dimethylsilane (271)9 
 
264 (11.5 g, 36.07 mmol) was dissolved in anhydrous dichloromethane (50 mL) at 0 °C and 
iPr2NEt (18.37 mL, 112.53 mmol) and MOMCl (8.42 mL, 104.6 mmol) were added. The mixture 
was stirred overnight at room temperature, and then diluted with Et2O (100 mL), washed with 
water, saturated aqueous NH4Cl, and brine, and dried over MgSO4. The solution was 
concentrated under reduced pressure, and then the residue was purified by column 
chromatography (Petrol: EtOAc, 5:1) on silica gel to give pure compound 271 as a colourless 
syrup (9.49 g, 63%). 
IR γmax (film)/cm
-1: 2987, 2931, 2858, 1463, 1370, 1252, 1212, 1150, 1092, 1064, 1006, 970, 
894; 1H NMR (400 MHz, in CDCl3): δ 0.1 (6H, s, Si(CH3)2), 0.9 (9H, s, SiC(CH3)3), 1.34 (3H, s, CH3 
isopropylidene), 1.35 (3H, s, CH3 isopropylidene), 1.40 (3H, s, CH3 isopropylidene), 1.45 (3H, s, 
CH3 isopropylidene), 3.42 (3H, s, OCH2OCH3), 3.72 (1H, dd, J=10.5, 4.7 Hz, H-6), 3.85 (1H, dd, 
J=10.5, 7.0 Hz, H-6), 4.1 (4H, m, H-1, H-1, H-2, H-4), 4.12 (1H, m, H-3), 4.12 (1H, m, H-5), 4.83 
(2H, s, OCH2OCH3). 
Data is in agreement with the literature reference. 
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(4R,5R)-5-(R)-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-methoxymethoxy-methyl-2,2-dimethyl-1,3-
dioxolan-4-yl-methanol (272)9  
 
271 (9.451 g, 22.4 mmol) was dissolved in THF (50 mL) at 0 °C and TBAF (1 M solution in THF, 
22.4 mL, 22.4 mmol) was added. After stirring for 2 h at room temperature, the mixture was 
diluted with Et2O, washed with water and brine, dried over MgSO4, and then concentrated 
under reduced pressure, and the residue was purified by column chromatography 
(Petrol:EtOAc, 1:1) on silica gel to give pure compound 272 as a colourless syrup (5.394 g, 79%).  
IR γmax (film)/cm
-1: 3407, 2985, 2931, 2858, 1462, 1371, 1250, 1212, 1156, 1063 and 939, 921, 
834; 1H NMR (400 Hz, CDCl3): δ 1.34 (3H, s, CH3 isopropylidene), 1.41 (3H, s, CH3 
isopropylidene), 1.48 (6H, s, CH3 isopropylidene), 3.40 (3H, s, OCH2OCH3), 3.65 (1H, dd, J=11.1, 
7.0 Hz, CH, H-6), 3.83 (1H, dd, J=11.1, 4.5 Hz, CH, H-6), 3.87 (1H, t, J=6.8 Hz, H-1), 3.94 (1H, t, 
J=7.7 Hz, CH, H-1), 4.08 (1H, dt, J=12.7, 6.3 Hz, CH, H-6), 4.21-4.011 (3H m, CH, H-5, H-3, H-2), 
4.75 (1H, d, J=6.8 Hz, OCH2OCH3), 4.80 (1H, d, J=6.8 Hz, OCH2OCH3). 
Data is in agreement with the literature reference. 
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(R)-(4R,5R)-5-(tert-butyldimethylsilyl-oxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl-(R)-2,2-
dimethyl-1,3-dioxolan-4-yl-methyl acetate (265) 
 
Acetic anhydride (4.5 ml, 47.74 mmol), DMAP (0.9 g, 7.4 mmol) and TEA (6.63 ml, 47.74 mmol) 
were added to a solution of 264 (8.15 g, 21.7 mmol) in anhydrous dichloromethane (40 ml) at 0 
°C. The reaction mixture was then stirred for 2 h at room temperature. The reaction mixture 
was extracted with aqueous NaHCO3 and dichloromethane and then washed with water, brine 
and dried over MgSO4. The solvent was removed under reduced pressure to give the crude 
product which was then purified by flash chromatography (Petrol:EtOAc, 4:1) on silica gel to 
give the pure compound 265 as a colourless syrup (8.2 g, 90%). 
IR γmax (film)/cm
-1: 2954, 2934, 1749, 1371, 1250, 1216, 1069 and 837; 1H NMR (400 MHz in 
CDCl3): δ 0.01 (6H, s, Si(CH3)2), 0.82 (9H, s, SiC(CH3)3), 1.27 (3H, s, CH3 isopropylidene), 1.29 (3H, 
s, CH3 isopropylidene), 1.29 (3H, s, CH3 isopropylidene), 1.42 (3H, s, CH3 isopropylidene), 2.02 
(3H, s, CH3 acetate), 3.57 (1H, dd, J=10.5, 7.3 Hz, CH2, H-1), 3.67 (1H, dd, J=10.5 Hz, CH2, H-1), 
3.85 (1H, dd, J=8.5, 6.8 Hz, H-6), 3.92 (1H, dd, J=8.5, 6.3Hz, H-6), 4.17 (2H, m, H-3, H-5), 4.25 
(1H, dd, J=6.4, 2.4 Hz, H-2), 5.14 (1H, dd, J=5.9, 2.4 Hz, H-4) . 13C NMR (100 MHz, in CDCl3): δ -
5.42 (1C, SiCH3), -5.45 (1C, SiCH3), 18.26 (1C, Cq Si), 21.25 (1C, CH3, acetate), 25.50 (1C, CH3 
isopropylidene), 25.59 (1C, CH3 isopropylidene), 25.86 (3C, 3 x SiC(CH3)3), 26.45 (1C, CH3 
isopropylidene), 26.59 (1C, CH3 isopropylidene), 61.46 (1C, CH2, C-1), 65.90 (1C, CH2, C-6), 
70.20 (1C, CH, C-5), 75.39 (1C, CH, C-4), 75.70 (1C, CH, C-3), 77.24 (1C, CH, C-2), 109.03 (1C, Cq 
isopropylidene), 109.09 (1C, Cq isopropylidene), 169.83 (1C, Cq C=O); m/z [M+H]+: 419.2449; 
[C20H38O7Si+H]
+ requires 419.2460. 
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(R)-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-(4R,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-
4-yl-methyl acetate (266) 
 
265 (4.681 g, 16.26 mmol) was dissolved in THF (50 mL) at 0 °C and TBAF (1 M solution in THF, 
16.26 mL) was added. After stirring for 2 h at room temperature, the mixture was diluted with 
Et2O, washed with water and brine, dried over MgSO4. The solvent was removed under 
reduced pressure and the crude product was purified by column chromatography 
(Petrol:EtOAc, 1:1) on silica gel to give pure compound 266 as a colourless syrup (3.88 g, 78%).  
IR γmax (film)/cm
-1: 3504, 2987, 1741, 1372, 1215, 1158, 1041 and 851; 1H NMR (400 MHz, 
CDCl3): δ 1.35 (3H, s, CH3 isopropylidene), 1.40 (3H, s, CH3 isopropylidene ), 1,41 (3H, s, CH3 
isopropylidene), 1.52 (3H, s, CH3 isopropylidene), 2.10 (3H, s, CH3 acetate), 2.18 (1H, s, OH), 
3.52 (1H, t, J=7.9 Hz, H-1), 4.04 - 3.98 (2H, m, CH2, H-1, H-6), 4.10 (1H, td, J=8.2, 3.8 Hz, H-6), 
4.31 (1H, m, H-3), 4.47 - 4.40 (3H, m, H-2, H-4, H-5): 13C NMR (100 MHz, CDCl3): δ 14.20 (1C, 
CH3 acetate), 20.93 (1C, CH3 isopropylidene), 24.59 (1C, CH3 isopropylidene), 25.24 (1C, CH3 
isopropylidene), 26.82 (1C, CH3 isopropylidene), 63.9 (1C, CH2, C-1), 67.17 (1C, C-6), 70.20 (1C, 
C-5), 75.02 (1C, C-4), 75.23 (1C, C-2), 76.15 (1C, C-3), 108.89 (1C, Cq isopropylidene), 109.5 (1C, 
Cq isopropylidene), 170.75 (1C, Cq C=O); m/z [M+NH4]
+: 322.1855; [C14H24O7+NH4]
+ requires 
322.1860. 
 
 
 
 
 
 159 
 
(R)-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-(4S,5S)-5-formyl-2,2-dimethyl-1,3-dioxolan-4-yl-methyl 
acetate (267)12  
 
DMSO (1.93 mL, 27.13 mmol) was slowly added to a solution of oxalyl chloride (1.3 mL, 14.73 
mmol) in anhydrous dichloromethane (30 ml) at -78 °C and the solution was stirred for 1 h at 
this temperature. A solution of 4-O-acetoxy-2,3:5,6-di-O-isopropylidene-D-mannitol 266 (2.36 
g, 7.8 mmol) in anhydrous dichloromethane (15 ml) was added dropwise to the reaction 
mixture and the solution was stirred for further 1 h. TEA (5.17 mL, 37.2 mmol) was slowly 
added to the reaction mixture at the same temperature and then the solution was allowed to 
warm up to 0 °C and the mixture was stirred for a further 30 min at 0 °C. Then the reaction 
mixture was allowed to warm up to room temperature and was allowed to stir for 30 min at 
this temperature. Water, saturated aqueous solution of NH4Cl and 2 M aqueous HCl were 
added to the reaction mixture which was then extracted with dichloromethane. The organic 
layer was washed further with water and brine and dried over MgSO4. The solvent was 
evaporated under reduced pressure to give pure compound 267 (2.32 g, quantitative) without 
any further purification. 
IR γmax (film)/cm
-1: 2988, 1742, 1374, 1216, 1068 and 852 cm-1; 1H NMR (400 MHz, CDCl3): δ 
1.29 (6H, s, 2 x CH3 isopropylidene), 1.30 (3H, s, CH3 isopropylidene), 1.46 (3H, s, CH3 
isopropylidene), 1.97 (3H, s, CH3 acetate) 3.97 (1H, dd, J=6.4 Hz, 8.8 Hz, CH2, H-6), 4.09 (1H, dd, 
J=6.4, 8.8 Hz, CH2, H-6), 4.18 (2H, m, 2 x H-5, H-3), 4.54 (1H, ddd, J=2.0, 8.0 Hz, H-2), 4.75 (1H, 
m, H-4) 13C NMR (100 MHz, CDCl3): δ 20.63 (1C, CH3 acetate), 24.48 (1C, CH3 isopropylidene), 
24.63 (1C, CH3 isopropylidene), 25.84 (1C, CH3 isopropylidene), 26.66 (1C, CH3 isopropylidene), 
61.8 (1C, CH), 65.62 (1C, CH2, C-6), 70.19 (1C, CH), 75.37 (1C, CH), 78.88 (1C, CH, C-2), 110.06 
(1C, Cq isopropylidene), 110.87 (1C, Cq isopropylidene), 170.38 (1C, C=O ester), 204.49 (1C, 
C=O aldehyde). 
Data is in agreement with the literature reference. 
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(R)-(4S,5R)-5-benzyloxy-methyl-2,2-dimethyl-1,3-dioxolan-4-yl-(R)-2,2-dimethyl-1,3-dioxolan-
4-yl-methanol (293)11 
 
200 (3.315 g, 12.64 mmol) was dissolved in anhydrous DMF and the solution cooled to 0 °C. 
NaH (0.319 g, 13.272 mmol) was added and the mixture was stirred for 10 min at this 
temperature before being allowed to warm up to room temperature. Benzyl bromide (1.80 mL, 
15.2 mmol) was added dropwise, and the mixture was stirred for 5 min, before water was 
added at 0 °C. The mixture was extracted with EtOAc and the organic layer was dried over 
Na2SO4 and concentrated under reduced pressure. The crude mixture was purified by column 
chromatography (Toluene:EtOAc, 9:1) to give pure compound 293 as a colourless syrup (4.02 g, 
90%). 
IR γmax (film)/ cm
-1: 3478, 3089, 3064, 3031, 2988, 2936, 2876, 1877, 1738, 1713, 630, 1587, 
1496, 1454, 1308, 1249, 1042; 1H NMR (500 MHz, CDCl3): δ 1.34 (3H, s, CH3 isopropylidene), 
1.37 (3H, s, CH3 isopropylidene), 1.39 (3H, s, CH3 isopropylidene), 1.51 (3H, s, CH3 
isopropylidene), 2.80 (1H, d, J = 6.8 Hz, 4-OH), 3.50 (1H, d, J = 7.9 Hz, H-4), 3.75 (1H, dd, J = 
10.3, 5.1 Hz, H-1), 3.81 (1H, dd, J = 10.3, 4.9 Hz, H-1), 4.01 – 3.96 (1H, m, H-5), 4.07 – 4.01 (1H, 
m, H-6), 4.15 – 4.07 (1H, m, H-6), 4.37 (1H, dd, J = 7.2, 1.0 Hz, H-3), 4.42 (1H, dt, J = 7.2, 5.0 Hz, 
H-2), 4.59 (2H, s, CH2Ph), 7.32 – 7.28 (1H, m, CH aryl), 7.36 – 7.32 (4H, m, CH aryl); 
13C NMR 
(125 MHz, CDCl3): δ 24.75 (1C, CH3 isopropylidene), 25.31 (1C, CH3 isopropylidene), 26.65 (1C, 
CH3 isopropylidene), 26.86 (1C, CH3 isopropylidene), 67.30 (1C, CH2 C-7), 68.52 (1C, CH carbo), 
70.45 (1C, CH carbo), 73.82 (1C, CH2Ph), 75.56 (1C, CH carbo), 75.81 (1C, CH carbo), 75.94 (1C, 
CH carbo), 108.52 (1C, Cq isopropylidene), 109.32 (1C, Cq isopropylidene), 127.95 (1C, CH aryl), 
128.02 (2C, 2 x CH aryl), 128.51 (2C, 2 x CH aryl), 137.40 (1C, Cq aryl); m/z [M+H]+: 353.1960; 
[C19H28O6+H]
+ requires 353.1959. 
Data is in agreement with the literature reference. 
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(4R,5R)-4-(R)-(allyloxy)-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-methyl-5-benzyloxy-methyl-2,2-
dimethyl-1,3-dioxolane (298) 
 
293 (1 g, 2.714 mmol) was dissolved in anhydrous DMF (20 mL) and NaH (0.103 g, 4.071 mmol) 
was added at 0 °C in small portions. The reaction mixture was stirred for a further 30 min at 
this temperature. Allyl bromide (0.274 mL, 3.17 mmol) was then added over a period of 5 min 
dropwise. After being stirred for 1 h, the reaction was quenched with saturated aqueous NH4Cl. 
The mixture was extracted with diethyl ether. The organic extracts were washed with brine, 
then dried over MgSO4 and evaporated under reduced pressure. The crude mixture was 
purified by column chromatography (Toluene:EtOAc, 9:1) to give pure compound 298 as a 
colourless syrup (1.021 g, 96%). 
 
1H NMR (500 MHz, CDCl3): δ 1.32 (3H, s, CH3 isopropylidene), 1.34 (3H, s, CH3 isopropylidene), 
1.37 (3H, s, CH3 isopropylidene), 1.47 (3H, s, CH3 isopropylidene), 3.70 – 3.61 (3H, m, H-6, H-6, 
H4), 4.07 – 3.93 (3H, m, H-1, H-1, H-3), 4.12 (1H, dd, J = 6.4, 4.4 Hz, H-3), 4.20 – 4.14 (1H, m, H-
2), 4.30 (1H, ddt, J = 13.0, 5.3, 1.5 Hz, CH2Ph), 4.37 (1H, dt, J = 12.0, 5.7 Hz, CH2Ph), 4.53 (1H, d, 
J = 12.0 Hz, CH2-C=C), 4.60 (1H, d, J = 12.1 Hz, CH2-C=C), 5.10 (1H, ddd, J = 10.5, 3.2, 1.5 Hz, 
CH=CH2), 5.29 – 5.24 (1H, m, CH=CH2), 5.92 – 5.79 (1H, m, CH=CH2), 7.37 – 7.30 (5H, m, CH 
aryl); 13C (125 MHz, CDCl3): δ 25.18 (1C, CH3 isopropylidene), 25.68 (1C, CH3 isopropylidene), 
26.29 (1C, CH3 isopropylidene), 26.98 (1C, CH3 isopropylidene), 65.88 (1C, CH2 C-7), 69.07 (1C, 
CH2 C-1), 72.75 (1C, O-CH2), 73.58 (1C, CH2Ph), 76.20 (1C, C-5), 76.98 (1C, C-2), 77.78 (1C, C-4), 
78.10 (1C, C-3), 108.36 (1C, Cq isopropylidene), 108.89 (1C, Cq isopropylidene), 116.10 (1C, CH2 
alkene), 127.77 (1C, CH aryl), 127.94 (2C, 2 x CH aryl), 128.42 (2C, 2 x CH aryl), 134.89 (1C, 
CH=CH2), 137.91 (1C, Cq aryl); m/z [M+NH4]
+: 410.2534; [C22H32O6+NH4]
+ requires 410.2537. 
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(3aS,4R,7aS)-7-bromo-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-6-methoxy-2,2-
dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran (311) 
 
 
A solution of 284 (0.781 g, 3.05 mmol) in anhydrous MeOH (18 mL) was added dropwise to a 
stirred and cooled -50 °C solution of NBS (0.543 g, 3.05 mmol) in anhydrous MeOH. The cooling 
bath was left in place but not recharged and stirring was continued overnight. Most of the 
MeOH was removed under reduced pressure and the residue was diluted with diethyl ether. 
The mixture was washed with a saturated solution of Na2S2O3, water, dried over Na2SO4, and 
evaporated to dryness. The crude product was purified by column chromatography (Petrol: 
EtOAc, 4:1) over silica gel to give pure compound 311 (1.053 g, 94%) as a colourless syrup and a 
single diastereoisomer. 
IR γmax (film)/ cm
-1: 2946, 2940, 2938, 1747, 1434, 1372, 1382, 1230, 1140, 1060, 985, 911; 1H 
NMR (500 MHz, CDCl3): δ 1.40 (3H, s, CH3 isopropylidene), 1.42 (3H, s, CH3 isopropylidene), 
1.46 (3H, s, CH3 isopropylidene), 1.56 (3H, s, CH3 isopropylidene ), 3.56 (3H, s, CH3 methoxy), 
3.75–3.67 (2H, m, CH2, H-7), 4.03-4.06 (2H, m, H-5, H-6), 4.21 (1H, dd, J = 5.3, 2.1 Hz, H-4), 4.35 
(1H, d, J = 8.9 Hz, H-3), 4.45–4.38 (2H, m, H-1, H-2); 13C NMR (100 MHz, CDCl3): δ 25.33 (1C, CH3 
isopropylidene), 26.22 (1C, CH3 isopropylidene), 27.00 (1C, CH3 isopropylidene), 28.17 (1C, CH3 
isopropylidene), 53.06 (1C, C-2), 57.04 (1C, CH3 methoxy), 66.62 (1C, CH2 C-7), 73.54 (1C, C-4), 
73.60 (1C, C-6), 74.06 (1C, C-3), 80.68 (1C, C-5), 102.85 (1C, Cq C-1), 109.55 (1C, Cq 
isopropylidene), 110.67 (1C, Cq isopropylidene); m/z [M+H]+: 367.0757; [C14H23BrO6+H]
+ 
requires 367.0751. 
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2R,3R,4S-5-bromo-2-(R)-1,2-dihydroxyethyl-6-methoxytetrahydro-2H-pyran-3,4-diol (313) 
 
Aqueous 80% TFA (20.12 mL) was added to a solution of 311 (1.01 g, 2.76 mmol) in 
dichloromethane (40 mL). The mixture was stirred for 24 h at room temperature, then 
concentrated and co-evaporated with toluene several times. The reaction mixture was 
concentrated under reduced pressure and the crude product was purified by column 
chromatography (Petrol:EtOAc, 1:1) to give compound 313 (0.72 g, 90%) as a colourless syrup. 
 
 
Used in the next step straight after chromatography. 
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(2R,3S,4S)-5-bromo-2-(R)-1,2-diacetoxyethyl-6-methoxytetrahydro-2H-pyran-3,4-diyl-
diacetate (314) 
 
Acetic anhydride (0.193 ml, 2.05 mmol), DMAP (39 mg, 0.32 mmol) and TEA (0.284 ml, 2.05 
mmol) were added to a solution of 313 (0.132 g, 0.466 mmol) in anhydrous dichloromethane 
(40 ml) at 0 °C. The reaction mixture was then stirred for 2 h at room temperature. The 
reaction mixture was extracted with aqueous NaHCO3 and dichloromethane and then washed 
with water, brine and dried over MgSO4. The solvent was evaporated to dryness to give the 
desired compound and then purified by flash chromatography (Petrol:EtOAc, 2:1) on silica gel 
to give pure compound as a colourless syrup 314 (0.1 g, 77%). 
IR γmax (film)/ cm
-1: 2946, 2940, 2938, 1747, 1434, 1372, 1382, 1230, 1140, 1060, 985, 911; 1H 
NMR (400 MHz, CDCl3): δ 
1H NMR (400 MHz, CDCl3): δ 1.94 (3H, s, CH3 acetate), 1.99 (3H, s, CH3 
acetate), 2.03 (3H, s, CH3 acetate), 2.03 (3H, s, CH3 acetate), 3.52 (3H, s, CH3 methoxy), 3.81 
(1H, dd, J = 9.6, 0.7 Hz, H-4), 3.88 (1H, dd, J = 11.2, 8.6 Hz, H-6), 4.21 (1H, dd, J = 12.3, 3.9 Hz, H-
7), 4.35 (1H, dd, J = 12.3, 2.3 Hz, H-7), 4.42 (1H, d, J = 8.6 Hz, H-6), 5.06 – 4.98 (1H, m, H-5), 5.13 
– 5.06 (1H, m, H-2), 5.25 (1H, d, J = 2.6 Hz, H-1); 13C NMR (100 MHz, CDCl3): δ 20.5 (1C, CH3, 
acetate), 20.5 (1C, CH3 acetate), 20.6 (1C, CH3 acetate), 20.7 (1C, CH3 acetate), 47.9 (1C, C-2), 
57.5 (1C, CH3 methoxy), 62.0 (1C, CH2, C-7), 66.3 (1C, C-4), 67.4 (1C, C-6), 70.6 (1C, C-5), 73.0 
(1C, C-3), 103.8 (1C, C-1), 169.5 (1C, Cq C=O), 169.7 (1C, Cq C=O), 170.2 (1C, Cq C=O), 170.5 (1C, 
Cq C=O); m/z [M+NH4]
+: 472.0818; [C16H23BrO10+NH4]
+ requires 472.0813.  
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(3aS,4R,7aS)-7-bromo-4-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-6-ethoxy-2,2-dimethyltetrahydro-
3aH-[1,3]dioxolo[4,5-c]pyran (312) 
 
A solution of 284 (0.1 g, 0.39 mmol) in anhydrous EtOH (10 mL) was added dropwise to a 
stirred and cooled -50 °C solution of NBS (0.07 g, 0.39 mmol) in anhydrous EtOH. The cooling 
bath was left in place but not recharged and stirring was continued overnight. Most of the 
EtOH was removed under reduced pressure and the residue was diluted with diethyl ether. The 
mixture was washed with a saturated solution of Na2S2O3, water, dried over Na2SO4, and 
evaporated to dryness. The crude product was purified by column chromatography Petrol: 
EtOAc, 4:1) on silica gel to give pure compound 312 as a colourless syrup (0.135 g, 91%) and as 
a single diastereoisomer.  
1H NMR (400 MHz, CDCl3): δ 1.29 (3H, t, J = 7.1 Hz, CH3 ethoxy), 1.40 (3H, s, CH3 isopropylidene), 
1.42 (3H, s, CH3 isopropylidene), 1.46 (3H, s, CH3 isopropylidene), 1.56 (3H, s, CH3 
isopropylidene), 3.68 – 3.61 (1H, m, H-5), 3.72 (2H, ddd, J = 8.3, 5.7, 3.7 Hz, CH2, H-7), 3.94 (1H, 
dq, J = 9.6, 7.1 Hz, H-6), 4.11 (2H, qd, J = 8.9, 5.2 Hz, CH2 ethoxy), 4.20 (1H, dd, J = 5.2, 2.1 Hz, 
H-4), 4.45 – 4.38 (3H, m, H-1, H-2, H-3); 13C NMR (100 MHz, CDCl3): δ 14.96 (1C, CH3 ethoxy), 
25.33 (1C, CH3 isopropylidene), 26.24 (1C, CH3 isopropylidene), 27.03 (1C, CH3 isopropylidene), 
28.17 (1C, CH3 isopropylidene), 53.41 (1C, C-2), 65.68 (1C, CH2, C-7), 66.72 (1C, CH2 ethoxy), 
73.56 (2C, C-6, C-4), 74.03 (1C, C-3), 80.79 (1C, C-5), 101.76 (1C, Cq C-1), 109.55 (1C, Cq 
isopropylidene), 110.63 (1C, Cq isopropylidene); m/z [M+NH4]
+: 398.1181; [C15H25BrO6+NH4]
+ 
requires 398.1173. 
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(4S,5S,6R)-3-bromo-6-(R)-1,2-diacetoxyethyl-tetrahydro-2H-pyran-2,4,5-triyl triacetate (315)  
 
Tetra-acetate 314 (0.111 g, 0.244 mmol) was dissolved in acetic anhydride (0.5 ml) and 2 mL of 
2% H2SO4 in acetic anhydride was added. The reaction mixture was maintained at room 
temperature for 2 h, then diluted with chloroform, and washed successively with an ice-water 
mixture (2 x 200 ml), saturated aqueous NaHCO3, and water. The organic layer was dried over 
MgSO4 and concentrated, and the crude product was purified by column chromatography 
(Petrol:EtOAc, 1:1) on silica gel to give compound as a colourless syrup 315 (0.1 g, 85%).  
[α]25D -81.3 (c 0.00603 in CHCl3); IR γmax (film)/ cm
-1: 2979, 1838, 1751, 1440, 1373, 1227, 1133, 
1070, 1043, 1010; 1H NMR (400 MHz, CDCl3): δ 2.01 (3H, s, CH3 acetate), 2.08 (3H, s, CH3 
acetate), 2.08 (3H, s, CH3 acetate), 2.13 (3H, s, CH3 acetate), 2.21 (3H, s, CH3 acetate), 4.05 – 
4.18 (2H, m, CH2, H-7), 4.30 – 4.37 (2H, m, H-2, H-4), 4.44 (1H, dd, J = 12.3, 2.4 Hz, H-5), 5.11 
(1H, ddd, J = 9.8, 4.2, 2.4 Hz, H-6), 5.40 (1H, dd, J = 11.5, 3.3 Hz, H-3), 5.46 (1H, dd, J = 3.4, 1.4 
Hz, H-1); 13C NMR (100 MHz, CDCl3): δ 20.4 (1C, CH3 acetate), 20.5 (1C, CH3 acetate), 20.5 (1C, 
CH3 acetate), 20.6 (1C, CH3 acetate), 20.7 (1C, CH3 acetate), 44.2 (1C, C-2), 62.0 (1C, CH2, C-7), 
66.7 (1C, C-3), 67.2 (1C, C-6), 68.3 (1C, C-4), 69.5 (1C, C-5), 91.0 (1C, C-1), 168.3 (1C, Cq C=O, 
acetate), 169.6 (1C, Cq, C=O acetate), 169.7 (1C, Cq C=O acetate), 170.1 (1C, Cq C=O acetate), 
170.2 (1C, Cq C=O acetate); m/z [M+NH4]
+ : 500.0759; [C17H23BrO11+NH4]
+ requires 500.0762. 
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(R)-1-(2R,3R,4R)-3,4-diacetoxy-3,4-dihydro-2H-pyran-2-yl-ethane-1,2-diyl-diacetate (299) 
 
Zinc dust (1.78 g, 27.28 mmol) was suspended into a stirred solution of AcONa (2.1 g, 25.55 
mmol) and AcOH (6 mL) in water (1.5 mL), and saturated aqueous CuSO4 (1.2 mL) was then 
added. The blue colour disappeared. A solution of 315 (0.269 g, 0.56 mmol) in Ac2O (2 mL) was 
then added at a fast dropwise rate, and stirring was continued for 3 h. The mixture was diluted 
with dichloromethane and filtered through a pad of celite. The combined organic extracts were 
washed with saturated aqueous NaHCO3, brine and dried over MgSO4 and the solvent was 
removed under reduced pressure. The crude product was purified by column chromatography 
(Petrol:EtOAc, 1:3) over silica gel to give a pure compound 299 (0.162 g, 82%) as a colourless 
oil. 
[α]25D 10.7 (c 0.0105 in CHCl3); IR γmax (film)/ cm
-1: 1749, 1654, 1436, 1372, 1226, 1151, 1128, 
1063, 1040, 1013; 1H NMR (400 MHz, CDCl3): δ 2.03 (3H, s, CH3 acetate), 2.06 (3H, s, CH3 
acetate), 2.10 (3H, s, CH3 acetate), 2.12 (3H, s, CH3 acetate), 4.17 (1H, dd, J = 12.3, 4.5 Hz, H-7), 
4.25 (1H, d, J = 9.7 Hz, H-5), 4.55 (1H, dd, J = 12.3, 2.3 Hz, H-7), 4.71 (1H, dt, J = 6.3, 1.9 Hz, H-6), 
5.19 (1H, ddd, J = 9.7, 4.5, 2.4 Hz, H-4), 5.47 (1H, dd, J = 3.3, 1.3 Hz, H-3), 5.63 (1H, ddd, J = 3.9, 
3.0, 2.0 Hz, H-2), 6.47 (1H, dd, J = 6.3, 2.1 Hz, H-1); 13C NMR (100 MHz, CDCl3): δ 20.61 (1C, CH3 
acetate), 20.69 (1C, CH3 acetate), 20.75 (1C, CH3 acetate), 20.78 (1C, CH3 Acetate), 61.53 (1C, 
CH2, C-7), 62.14 (1C, C-3), 64.25 (1C, C-6), 67.48 (1C, C-4), 72.27 (1C, C-5), 99.34 (1C, C-2), 
144.97 (1C, C-1), 169.68 (1C, Cq C=O acetate), 170.32 (1C, Cq C=O acetate), 170.43 (1C, Cq C=O 
acetate), 170.60 (1C, Cq C=O acetate); m/z [M+NH4]
+: 362.1450; [C15H20O9+NH4]
+ requires 
362.1446. 
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2R,3R,4R-2-R-1,2-dihydroxyethyl-3,4-dihydro-2H-pyran-3,4-diol (300) 
 
A solution of 299 (1 g, 2.91 mmol) in anhydrous methanol (12 mL) was treated with of sodium 
methoxide (2 M, 0.2 mL) in 3 mL of anhydrous methanol. The combined solution was stirred at 
room temperature overnight and then concentrated to dryness. The crude product was 
purified by column chromatography (Petrol: EtOAc, 1:2) to give pure compound 300 (0.487 g, 
95%). 
 
Used straight in the next step after purification. 
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(R)-5-(2R,3S,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-yl-
2,2,3,3,8,8,9,9-octamethyl-4,7-dioxa-3,8-disiladecane (301) 
 
Compound 300 (0.901 g, 2.62 mmol) was taken up in 11 mL of anhydrous DMF and treated 
with imidazole (1.71 g, 25.14 mmol), followed by tert-butyldimethylchlorosilane (1.9 g, 12.6 
mmol). The resulting solution was stirred at room temperature for 16 h, diluted with 200 mL of 
diethyl ether, washed with water (1 x 100 mL) and a copper (II) sulfate solution (2 x 100 mL). 
The aqueous layers were back extracted with diethyl ether, and then the combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The crude product 
was purified by column chromatography on silica gel (Petrol:Ether, 98:2) to furnish compound 
301 (0.92 g, 60%) as a clear, homogenous, colourless oil.  
IR γmax (film)/ cm
-1: 2943, 2892, 2887, 1651, 1463, 1452, 1384, 1241, 1148, 1112, 1099, 1001; 
[α]25D -16 (c 0.0115 in CHCl3); 
1H NMR (500 MHz, CDCl3): δ -0.07 (3H, s, SiCH3), -0.07 (3H, s, 
SiCH3), -0.00 (6H, s, 2 x SiCH3), 0.01 (6H, s, 2 x SiCH3), 0.02 (6H, s, 2 x SiCH3), 0.78 (12H, s, 4 x 
SiC(CH3)), 0.78 (12H, s, 4 x SiC(CH3)), 0.80 (12H, s, 4x SiC(CH3)), 3.59 (2H, dd, J = 10.7, 4.3 Hz, 
CH2 H-7), 3.67 (1H, dd, J = 10.6, 2.6 Hz, H-5), 3.91 – 3.87 (1H, m, H-6), 3.94 – 3.92 (1H, m, H-4), 
4.39 – 4.35 (2H, m, H-2, H-3), 6.20 (1H, dd, J = 6.1, 1.3 Hz, H-1); 13C (125 MHz, CDCl3): δ -5.47, -
5.35, -5.04, -4.85, -4.70, -4.29 (8C, 8 x SiCH3), 18.20, 18.21, 18.48 (4C, 4 x Cq, SiC), 25.82, 25.90, 
26.00 (12C, 12 x SiC(CH3)3), 63.54 (1C, CH carbo), 64.59 (1C, CH2, C-7), 65.72 (1C, CH carbo), 71.29 
(1C, CH carbo), 75.13 (1C, CH carbo), 102.70, (1C, C-1), 144.03 (1C,  C-2); m/z [M+NH4]
+: 650.4460; 
[C31H68O5Si4+NH4]
+ requires 650.4482. 
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(R)-5-(1S,3R,4S,5R,6R)-4,5-bis((tert-butyldimethylsilyl)oxy)-2,7 dioxabicyclo[4.1.0]heptan-3-
yl-2,2,3,3,8,8,9,9-octamethyl-4,7-dioxa-3,8-disiladecane (303) 
 
The glycal 301 (0.083 g, 0.131 mmol) was dissolved in 5 mL of dichloromethane, and the 
resulting solution was cooled to 0 °C. A solution of dimethyldioxirane in acetone (5.3 mL, 0.16 
mmol, ca. 0.03 M) was added dropwise. The resulting mixture was stirred at 0 °C for 1 h or until 
TLC indicated complete consumption of the starting material. The solution was evaporated to 
dryness and the residue was dried under reduced pressure to afford the 1,2-anhydro sugar 303 
in quantitative yield as a white solid (0.084 g). 
[α]25D -24.0 (c 0.001 in CHCl3); IR γmax (film)/ cm
-1: 2952, 2928, 2856, 2885, 1472, 1462, 1438, 
1389, 1360, 1329, 1249, 1148, 1112, 1096, 1062, 1027, 1005; 1H NMR (500 MHz, CDCl3): δ -0.00 
(4H, s), 0.00 (4H, s), 0.05 (4H, s), 0.06 (4H, s), 0.11 (4H, s), 0.12 (4H, s) (24H, 4 x Si(CH3)2), 0.82 
(12H, s, 4 x SiC(CH3)), 0.83 (12H, s, 4 x SiC(CH3)), 0.89 (12H,s, 4x SiC(CH3)), 2.79 (1H, t, J = 2.1 Hz, 
H-2), 3.47 (1H, d, J = 7.4 Hz, H-6), 3.60 (1H, dd, J = 10.6, 4.9 Hz, H-7), 3.70 (1H, dd, J = 10.6, 3.8 
Hz, H-7), 3.80 – 3.78 (1H, m, H-3), 3.89 (1H, d, J = 4.0 Hz, H-4), 3.94 – 3.90 (1H, m, H-5), 4.90 
(1H, d, J = 2.2 Hz, H-1); 13C NMR (125 MHz, CDCl3): δ -5.43, -5.41, -5.05, -4.89, -4.78, -4.38 (8C x 
SiCH3), 18.16, 18.24, 18.43 (4C x Cq, SiC), 25.79, 25.85, 25.88, 25.97 (12C x SiC(CH3)3), 52.65 (1C, 
C-2), 62.32 (1C, C-5), 64.49 (1C, CH2, C-7), 68.44 (1C, C-3), 68.85 (1C, C-4), 72.30 (1C, C-3), 77.40 
(1C, C-1); m/z [M-H]-: 647.4004; [C31H68O6Si4-H]
- requires 647.4009. 
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(R)-5-2R,3S,4R-3,4-bis-triisopropylsilyl-oxy-3,4-dihydro-2H-pyran-2-yl-3,3,8,8-tetraisopropyl-
2,9-dimethyl-4,7-dioxa-3,8-disiladecane (302) 
 
 
Compound 300 (0.6 g, 3.41 mmol) was dissolved in anhydrous DMF (17 mL) and treated with 
imidazole (1.86 g, 27.3 mmol), followed by Triisopropylsilyl chloride (3.36 mL, 15.69 mmol). The 
resulting solution was stirred at 60 °C for 16 h, then diluted with 200 mL of diethyl ether, 
washed with water (1 x 100 mL) and a copper (II) sulfate solution (2 x 100mL). The aqueous 
layers were back extracted with diethyl ether, and then the combined organic layers were 
dried over MgSO4 and concentrated under reduced pressure. The crude product was purified 
by column chromatography on silica gel (Petrol : Ether, 98:2) to furnish compound 302 (1.44 g, 
51%) as a clear, homogenous, colourless oil.  
 
IR γmax (film)/cm-1: 2944, 2892, 2867, 2908, 1658, 1464, 1384, 1367, 1243, 1102, 1067, 1014, 
997, 883; 1H NMR (500 MHz, CDCl3): δ 0.98-1.02 (84H, m, 4 x Si(CH(CH3)2)3), 3.45 (1H, dd, J = 
8.9, 2.2 Hz, H-6), 3.86 (1H, dd, J = 9.8, 3.4 Hz, H-7), 3.91 (1H, dd, J = 9.8, 3.8 Hz, H-7), 3.96 (1H, 
ddd, J = 8.3, 5.6, 3.8 Hz, H-4), 4.31 – 4.16 (1H, m, H-3), 4.98 – 4.80 (1H, m, H-5), 5.80 – 5.65 (1H, 
m, H-2), 6.17 – 6.00 (1H, m, H-1); 13C NMR (125 MHz, CDCl3): δ 11.85, 12.30, 12.92 (12C, 4 x 
Si(CH)3), 17.70, 17.97, 17.98, 18.12 (24C, 4 x SiCH(CH3)2), 63.81 (1C, C-4), 64.71 (1C, CH2, C-7), 
65.87 (1C, C-6), 71.78 (1C, C-3), 75.08 (1C, C-5), 103.01 (1C, C-2), 143.93 (1C, C-1); m/z 
[M+NH4]
+: 818.6354; [C43H92O5Si4+NH4]
+ requires 818.6360. 
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(5R)-5-(3R,4S,5R)-4,5-bis-triisopropylsilyl-oxy-2,7-dioxabicyclo[4.1.0]heptan-3-yl-3,3,8,8-
tetraisopropyl-2,9-dimethyl-4,7-dioxa-3,8-disiladecane (304) 
 
The glycal 302 (0.1 g, 0.125 mmol) was dissolved in 5 mL of dichloromethane, and the resulting 
solution was cooled to 0 °C. A solution of dimethyldioxirane in acetone (10.6 mL, 0.3 mmol, ca. 
0.03 M) was added dropwise. The resulting mixture was stirred at 0 °C for 1 h or until TLC 
indicated complete consumption of the starting material. The solution was evaporated to 
dryness and the residue was dried under reduced pressure to afford the 1,2-anhydro sugar 304 
(0.101 g) as a colourless oil in quantitative yield. 
[α]25D -0.6 (c 0.077 in CHCl3); 
1H NMR (500 MHz, CDCl3): δ 1.05 - 0.98.(84H, m, 4X Si(CH(CH3)2)3), 
2.86 (1H, d, J = 2.4 Hz), 3.09 (1H, s, H-4), 3.59 (1H, d, J = 6.4 Hz, H-6), 3.77 (1H, dd, J = 10.5, 5.1 
Hz, H-7), 3.83 (1H, dd, J = 10.5, 4.2 Hz, H-7), 3.94 (1H, s, H-5), 4.10 (1H, dd, J = 10.9, 4.8 Hz, H-3), 
4.91 (1H, d, J = 2.4 Hz, H-1); 13C NMR (125 MHz, CDCl3): δ 12.01, 12.12, 12.77 (12C, 4X Si(CH)3), 
17.93, 17.97, 17.98, 18.12 (24C, 4X SiCH(CH3)2), 53.04 (1C, C-2), 62.84 (1C, C-4), 64.55 (7C, CH2), 
68.68 (1C, C-6), 69.36 (1C, C-5), 73.09 (1C, C-3), 77.64 (1C, C-1); m/z [M+H]+: 817.6044; 
[C43H92O6Si4+H]
+ requires 817.6044. 
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1-2H1-(R)-5-(2R,3S,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-yl-
2,2,3,3,8,8,9,9-octamethyl-4,7-dioxa-3,8-disiladecane (319) 
 
 
Glycal 301 (0.1 g, 0.125 mmol) was dissolved in anhydrous THF at -78 °C and t-BuLi (0.4 mL, 
0.75 mmol) was added dropwise. The reaction was allowed to stir at -78 °C for 30 min, before 
allowing the solution to warm up to 0 °C where it was stirred for a further 30 min. After which 
the solution was cooled to -78 °C where an excess of D2O was added (5 equiv). The reaction 
mixture was quenched with a saturated solution of NH4Cl, and then the solution was filtered 
through a pad of Na2SO4. The solution was evaporated to dryness and the residue was dried 
under reduced pressure to yield compound 319 (0.078 g, quantitative) without further 
purification. 
1H NMR (500 MHz, CDCl3): δ -0.07 (s, 6H), -0.07 (s, 6H), -0.00 (s, 6H), 0.00 (s, 6H), 0.78 (s, 12H), 
0.78 (s, 12H), 0.80 (s, 12H), 3.63 – 3.57 (m, 2H), 3.68 – 3.65 (m, 1H), 3.90 (dd, J = 6.2, 2.9 Hz, 
2H), 4.41 – 4.34 (m, 2H).  
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1-2H1-(R)-5-2R,3S,4R-3,4-bis-triisopropylsilyl-oxy-3,4-dihydro-2H-pyran-2-yl-3,3,8,8-
tetraisopropyl-2,9-dimethyl-4,7-dioxa-3,8-disiladecane (320) 
 
 
Glycal 302 (0.1 g, 0.125 mmol) was dissolved in anhydrous THF at -78 °C and t-BuLi in n-hexane 
(0.4 mL, 0.75 mmol, 1.9 M) was added dropwise. The reaction was allowed to stir at -78 °C for 
30 min, before allowing the solution to warm up to 0 °C where it was stirred for a further 30 
min. After which the solution was cooled to -78 °C where an excess of D2O was added. The 
reaction mixture was quenched with a saturated solution of NH4Cl, and then the solution was 
filtered through a pad of Na2SO4. The solution was evaporated to dryness and the residue was 
dried under reduced pressure to yield compound 320 (0.1 g, quantitative) without further 
purification.  
1H NMR (500 MHz, CDCl3): δ 1.02 - 0.98 (84H, m, 4X Si(CH(CH3)2)3). 3.45 (dd, J = 8.9, 2.2 Hz, 1H), 
3.86 (dd, J = 9.8, 3.4 Hz, 1H), 3.91 (dd, J = 9.8, 3.8 Hz, 1H), 3.96 (ddd, J = 8.3, 5.6, 3.8 Hz, 1H), 
4.31 – 4.16 (m, 1H), 4.88 – 4.80 (m, 1H), 5.78 – 5.67 (m, 1H). 
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1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione (324)10 
 
5,5-dimethylhydantoin 323 (15 g, 117 mmol) was dissolved in a 5% solution of NaOH at room 
temperature. Neat bromine (12 mL, 234 mmol) was added to the solution dropwise and left to 
stir for 1 h. After formation of a colourless precipitate, the solution was filtered and the solid 
was washed with an ice-water mixture until the filtrate ran clear. The solid was then dried in a 
vacuum oven at 50 °C for 2 h to give the pure compound 324 as a pale yellow solid (29.8 g, 
89%). 
mp 197-198 °C; IR γmax (film)/ cm
-1: 1777, 1716, 1456, 1387, 1355, 1209, 1072, 854, 734; 1H 
NMR δ (CDCl3): 1.38 (s, 6H, 2 x CH3); 
13C NMR (75 MHz, CDCl3): δ 23.8 (2 x CH3), 68.9 (Cq C-5), 
quaternary carbonyls not observed. 
 
Data is in agreement with the literature reference. 
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2-(1R)-(4R,5S)-5-(R)-2,2-dimethyl-1,3-dioxolan-4yl-hydroxy-methyl-2,2-dimethyl-1,3-
dioxolan-4-yl-hydroxy-methyl-1,3-dithian-2-yl-methyl acetate (227) 
 
Acetic anhydride (0.24 mL, 2.53 mmol) followed by TEA (0.35 mL, 2.53 mmol) was added to a 
solution of 226 (0.925 g, 2.25 mmol) in anhydrous dichloromethane at 0 °C. The mixture was 
warmed to room temperature and left to stir overnight. A saturated solution of NaHCO3 was 
added and the mixture was extracted with dichloromethane. The combined organic layers 
were washed further with water, brine, dried over Na2SO4and the solvent removed under 
reduced pressure. The crude product was purified by column chromatography (Petrol: EtOAc, 
5:1) on silica gel to furnish the pure compound 227 as a colourless oil (0.930 g, 91%). 
[α]25D -6.1 (c 0.0105 in CHCl3); IR γmax (film)/ cm
-1: 3456, 2985, 2941, 1742 1379, 1218, 1144, 
1066, 913, 881; 1H NMR (500 MHz, CDCl3): δ 1.35 (3H, s, CH3 isopropylidene), 1.41 (3H, s, CH3 
isopropylidene), 1.42 (3H, s, CH3 isopropylidene), 1.53 (3H, s, CH3 isopropylidene), 2.11 (3H, s, 
CH3 acetate), 2.80 – 2.62 (2H, m, SCH2), 3.03 – 2.86 (2H, m, SCH2), 3.60 (3H, t, J = 12.6 Hz, 4-H, 
SCH2), 4.06 – 3.94 (2H, m, H-7), 4.11 (3H, qd, J = 6.8, 4.0 Hz, CH2OAc, H-3), 4.48 – 4.38 (3H, m, 
H-5, 2-OH, H-6), 4.70 (1H, t, J = 7.1 Hz, H-2), 4.78 (1H, dd, J = 11.8, 7.7 Hz, 5-OH); 13C NMR (125 
MHz, CDCl3): δ 20.98 (1C, CH3 acetate), 24.32 (1C, CH2 dithi), 25.08 (1C, CH3 isopropylidene), 
25.26 (1C, CH3 isopropylidene), 25.74 (1C, CH3 isopropylidene), 25.78 (1C, CH3 isopropylidene), 
26.05 (1C, CH2 dithi), 26.89 (1C, CH2 dithi), 56.59 (1C, Cq dithi), 63.75 (1C, CH2, C-6), 67.32 (1C, 
C-4), 70.58 (1C, C-1), 72.14 (1C, CH2OAc), 73.56 (1C, C-5), 75.77 (1C, C-3), 76.93 (1C, C-2), 
108.97 (1C, Cq isopropylidene), 109.25 (1C, Cq isopropylidene), 170.19 (1C, Cq, C=O). 
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(3aR,5R,5aS,8aS,8bR)-5-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-2,2,7,7-tetramethyltetrahydro-
3aH-bis[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl acetate (238) 
 
227 (1.302 g, 2.9 mmol) was dissolved in reagent grade acetone and DBDMH (2.33 g, 8.15 
mmol) in acetone was added at 0 °C. The mixture was stirred at 0 °C for a further 30 min. A 
saturated solution of Na2S2O3 and NaHCO3 was added and the mixture was extracted with 
EtOAc. The combined organic extracts were washed further with water, brine, dried over 
Na2SO4 and concentrated under reduced pressure. The crude product was purified by column 
chromatography (Petrol: EtOAc, 4:1) on silica gel to furnish the pure compound 238 as a 
colourless oil (0.78 g, 67%).  
[α]25D -8.7 (c 0.0117 in CHCl3); IR γmax (film)/ cm
-1: 2989, 2937, 1752, 1457 1381, 1259, 1224, 
1167, 1158, 1119, 1072, 984, 899, 847; 1H NMR (500 MHz, CDCl3): δ 1.31 (3H, s, CH3 
isopropylidene), 1.32 (3H, s, CH3 isopropylidene), 1.35 (3H, s, CH3 isopropylidene), 1.37 (3H, s, 
CH3 isopropylidene), 1.40 (3H, s, CH3 isopropylidene), 1.48 (3H, s, CH3 isopropylidene), 2.04 (3H, 
s, CH3 Acetate), 3.67 (1H, dd, J = 8.8, 1.8 Hz, H-7), 3.90 (1H, d, J = 11.7 Hz, H-2), 3.94 (1H, dd, J = 
8.8, 3.8 Hz, H-7), 4.00 (1H, dd, J = 8.8, 6.0 Hz, H-3), 4.22 – 4.16 (1H, m, H-4), 4.30 (1H, d, J = 2.7 
Hz, H-6), 4.34 (1H, dd, J = 7.9, 1.8 Hz, CH2OAc), 4.39 (1H, d, J = 11.7 Hz, H-5), 4.62 (1H, dd, J = 
7.9, 2.7 Hz, CH2OAc); 
13C NMR (125 MHz, CDCl3): δ 20.77 (1C, CH3 Acetate), 24.18 (1C, CH3 
isopropylidene), 25.14 (1C, CH3 isopropylidene), 25.21 (1C, CH3 isopropylidene), 25.71 (1C, CH3 
isopropylidene), 26.48 (1C, CH3 isopropylidene), 27.11 (1C, CH3 isopropylidene), 64.53 (1C, 
CH2OAc), 66.99 (1C, CH2, C-7), 69.40 (1C, C-3), 70.55 (1C, C-4), 70.64 (1C, C-5), 70.73 (1C, C-2), 
73.23 (1C, C-6), 102.12 (1C, Cq C-1), 108.90 (1C, Cq isopropylidene), 109.34 (1C, Cq 
isopropylidene), 109.43 (1C, Cq isopropylidene), 169.87 (1C, Cq C=O); m/z [M+H]+: 403.1970; 
[C19H30O9+H]
+ requires 403.1963. 
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(1R)-2-tert-butyldimethylsilyl-oxy-methyl-1,3-dithian-2-yl-(4R,5S)-5-(R)-2,2-dimethyl-1,3-
dioxolan-4-yl-hydroxy-methyl-2,2-dimethyl-1,3-dioxolan-4-yl-methanol (237) 
 
Imidazole (0.10 g, 1.47 mmol) and TBSCl (0.09 g, 0.6 mmol) were added to a solution of 226 
(0.2 g, 0.49 mmol) in anhydrous DMF (5 mL). The resulting solution was stirred at room 
temperature for 16 h, and then diluted with (20 mL) of diethyl ether, washed with water (1 x 
100 mL) and a copper (II) sulfate solution (2 x 100 mL). The aqueous layers were back extracted 
with diethyl ether, and then the combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography on silica gel (Petrol:EtOAc, 4:1) to furnish pure compound 237 (0.195 g, 76%) 
as a clear, colourless oil.  
Refer to provisional structure assignment: 1H NMR (500 MHz, CDCl3): δ 0.09 (3H, s, SiCH3), 0.10 
(3H, s, SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.34 (3H, s, CH3 isopropylidene), 1.38 (3H, s, CH3 
isopropylidene), 1.38 (3H, s, CH3 isopropylidene), 1.52 (3H, s, CH3 isopropylidene), 2.00 – 1.93 
(2H, m, SCH2), 2.83 – 2.72 (4H, m, 2 x SCH2), 3.52 (1H, d, J = 8.0 Hz, H-5), 3.94 (1H, dd, J = 10.2, 
1.1 Hz, H-3), 4.02 – 3.98 (1H, m, H-7), 4.16 – 4.09 (3H, m, H-2, H-4, H-7), 4.22 (1H, d, J = 10.2 Hz, 
H-1), 4.34 (1H, d, J = 7.4 Hz, CH2-OTBS), 4.69 (1H, d, J = 7.4 Hz, CH2-OTBS); 
13C NMR (125 MHz, 
CDCl3): δ -5.72 (1C, SiCH3), -5.65 (1C, SiCH3), 18.19 (1C, Cq, SiC), 24.64 (1C, CH2 dithi), 25.15 (1C, 
CH2 dithi), 25.34 (1C, CH3 isopropylidene), 25.65 (1C, CH3 isopropylidene), 25.70 (3C, SiC(CH3)3), 
25.95 (1C, CH2 dithi), 26.22 (1C, CH3 isopropylidene), 26.94 (1C, CH3 isopropylidene), 56.45 (1C, 
Cq, dithi), 67.32 (1C, CH2OSi), 67.80 (1C, CH2, C-6), 71.42 (1C, C-4), 73.07 (1C, C-2), 73.93 (1C, C-
1), 75.32 (1C, C-3), 77.38 (1C, C-5), 108.93 (1C, Cq isopropylidene), 109.16 (1C, Cq 
isopropylidene); m/z [M-H]-: 523.2224; [C23H44O7S2Si-H]
- requires 523.2225. 
 179 
 
Tert-butyl-(3aR,5R,5aS,8aS,8bR)-5-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-2,2,7,7-
tetramethyltetrahydro-3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methoxy-
dimethylsilane (239) 
 
237 (0.174 g, 0.332 mmol) was dissolved in acetone reagent grade and a solution of DBDMH 
(0.27 g, 0.94 mmol) in acetone was added at 0 °C. The mixture was stirred at 0 °C for a further 
30 min. A saturated solution of Na2S2O3 and NaHCO3 was added and the mixture was extracted 
with EtOAc. The combined organic extracts were washed further with water, brine, dried over 
Na2SO4 and concentrated under reduced pressure. The crude product was purified by column 
chromatography (Petrol: EtOAc, 4:1) on silica gel to furnish compound 239 as a colourless 
syrup (0.11 g, 70%). 
Refer to provisional structure assignment: 1H NMR (500 MHz, CDCl3): δ 0.07 (3H, s, SiCH3), 0.08 
(3H, s, SiCH3), 0.91 (9H, s, SiC(CH3)3), 1.36 (6H, s, 2 x CH3 isopropylidene), 1.41 (3H, s, CH3 
isopropylidene), 1.42 (3H, s, CH3 isopropylidene), 1.53 (3H, s, CH3 isopropylidene), 3.62 (1H, d, J 
= 10.5 Hz, H-7), 3.74 – 3.70 (2H, m, H-7, H-4), 3.99 (1H, dd, J = 8.8, 3.8 Hz, CH2OSi), 4.05 (1H, dd, 
J = 8.7, 6.0 Hz, CH2OSi), 4.24 – 4.18 (1H, m, H-3), 4.39 (1H, dd, J = 7.9, 1.8 Hz, H-6), 4.43 (1H, d, J 
= 2.6 Hz, H-5), 4.65 (1H, dd, J = 7.9, 2.6 Hz, H-2); 13C NMR (125 MHz, CDCl3): δ -5.63 (1C, SiCH3), 
-5.34 (1C, SiCH3), 18.48 (1C, Cq SiC), 24.17 (1C, CH3 isopropylidene), 25.31 (1C, CH3 
isopropylidene), 25.72 (1C, CH3 isopropylidene), 25.80 (1C, CH3 isopropylidene), 25.96 (3C, 
SiC(CH3)3), 26.72 (1C, CH3 isopropylidene), 27.20 (1C, CH3 isopropylidene), 64.28 (1C, CH2 7-C), 
67.25 (1C, CH2OSi), 69.31 (1C, C-3), 69.52 (1C, C-4), 70.90 (1C, C-5) , 70.99 (1C, C-2), 73.40 (1C, 
C-6), 103.90 (1C, Cq C-1), 108.65 (1C, Cq isopropylidene), 109.25 (1C, Cq isopropylidene), 
109.47 (1C Cq isopropylidene); m/z [M+NH4]
+: 492.2978; [C23H42O8Si+NH4]
+ requires 492.2987. 
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(3aR,5R,5aS,8aS,8bR)-5-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-2,2,7,7-tetramethyltetrahydro-
3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methanol (240) 
 
238 (0.75 g, 1.86 mmol) was dissolved in 10 mL of anhydrous methanol and several drops of 
methanolic 2 M sodium methoxide solution were added at room temperature. The mixture 
was stirred overnight at room temperature after which the mixture was concentrated. The 
crude mixture was purified by column chromatography (Petrol:EtOAc, 4:1) on silica gel to 
furnish pure compound 240 (0.64 g, 95%). 
[α]25D -25.6 (c 0.0078 in CHCl3); IR γmax (film)/ cm
-1: 3501, 2989, 2941, 2857, 1372, 1252, 1211, 
1072; 1H NMR (500 MHz, CDCl3): δ 1.36 (3H, s, CH3 isopropylidene), 1.37 (3H, s, CH3 
isopropylidene), 1.38 (3H, s, CH3 isopropylidene), 1.42 (3H, s, CH3 isopropylidene), 1.44 (3H, s, 
CH3 isopropylidene), 1.53 (3H, s, CH3 isopropylidene), 2.13 (1H, s, OH), 3.69 –3.59 (2H, m, H-4, 
H-3), 3.72 (1H, dd, J = 8.9, 1.9 Hz, H-5), 3.98 (1H, dd, J = 8.8, 3.7 Hz, H-7), 4.06 (1H, dd, J = 8.8, 
3.7 Hz, H-7), 4.27-4.23 (1H, m, H-6), 4.36 (1H, d, J = 2.7 Hz, H-2), 4.39 (1H, dd, J = 7.9, 1.9 Hz, 
CH2OH), 4.66 (1H, dd, J = 7.9, 2.7 Hz, CH2OH); 
13C NMR (125 MHz, CDCl3): δ 24.18 (1C, CH3 
isopropylidene), 25.28 (1C, CH3 isopropylidene), 25.39 (1C, CH3 isopropylidene), 25.67 (1C, CH3 
isopropylidene), 26.52 (1C, CH3 isopropylidene), 27.22 (1C, CH3 isopropylidene), 65.24 (1C, CH2-
OH), 67.15 (1C, CH2 C-7), 69.56 (1C, C-3), 70.62 (1C, C-4), 70.72 (1C, C-5), 71.35 (1C, C-2), 73.30 
(1C, C-6), 103.72 (1C, Cq C-1), 108.88 (1C, Cq isopropylidene), 109.51 (1C, Cq isopropylidene), 
109.53 (1C, Cq isopropylidene); m/z [M+NH4]
+: 378.2122; [C17H28O8+NH4]
+ requires 378.2122. 
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(3aR,5R,5aS,8aS,8bR)-5-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-2,2,7,7-tetramethyltetrahydro-
3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl methanesulfonate (325) 
 
Alcohol 240 (0.07 g, 0.194 mmol) was dissolved in pyridine (5 mL), methanesulfonylchloride 
(0.025 mL, 0.305 mmol) was added and after 1 h dichloromethane was added. The organic 
layer was washed subsequently with a 1 M HCl (100 mL), saturated aqueous NaHCO3 (50 mL), 
water (50 mL) and brine (50 mL) and dried over Na2SO4. The solvent was concentrated under 
reduced pressure and the crude product was purified by column chromatography 
(Petrol:EtOAc, 1:2) on silica gel to furnish the pure compound 325 as a colourless liquid (0.069 
g, 82%).  
IR γmax (film)/ cm
-1: 3444 2989, 2938, 1634, 1457, 1371, 1256, 1209, 1177, 1117, 1072, 1047; 1H 
NMR (500 MHz, CDCl3): δ 1.30 (3H, s, CH3 isopropylidene), 1.31 (3H, s, CH3 isopropylidene), 
1.34 (3H, s, CH3 isopropylidene), 1.35 (3H, s, CH3 isopropylidene), 1.38 (3H, s, CH3 
isopropylidene), 1.47 (3H, s, CH3 isopropylidene), 2.98 (3H, s, CH3 mesylate), 3.67 (1H, dd, J = 
8.7, 1.8 Hz, CH2-OSO2CH3), 3.91 (1H, dd, J = 8.8, 3.7 Hz, CH2-OSO2CH3), 3.98 (1H, dd, J = 8.8, 6.0 
Hz, H-7), 4.12–4.18 (2H, m, H-4, H-7), 4.22 (1H, d, J = 10.8 Hz, H-3), 4.27 (1H, d, J = 2.7 Hz, H-6), 
4.33 (1H, dd, J = 7.9, 1.8 Hz, H-5), 4.61 (1H, dd, J = 7.9, 2.7 Hz, H-2); 13C NMR (125 MHz, CDCl3): 
δ 24.2 (1C, CH3 isopropylidene), 25.2 (1C, CH3 isopropylidene), 25.3 (1C, CH3 isopropylidene), 
25.8 (1C, CH3 isopropylidene), 26.6 (1C, CH3 isopropylidene), 27.2 (1C, CH3 isopropylidene), 37.6 
(1C, CH3 mesylate), 67.0 (1C, CH2, C-7), 69.2 (1C, C-4), 69.7 (1C, CH2-OSO2CH3), 70.5 (2C, C-3, C-
5), 70.6 (1C, C-2), 73.2 (1C, C-6), 101.3 (1C, Cq C-1), 109.6 (1C, Cq isopropylidene), 109.6 (1C, Cq 
isopropylidene), 109.7 (1C, Cq isopropylidene); m/z [M+NH4]
+: 456.1894; [C18H30O10S+NH4]
+ 
requires 456.1898. 
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(3aS,5R,5aS,8aS,8bR)-5-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-3a-iodomethyl-2,2,7,7 
tetramethyltetrahydro-3aH-bis([1,3]dioxolo[4,5-b:4',5'-d]pyran (326) 
 
Alcohol 240 (0.11 g 0.305 mmol) was dissolved in anhydrous toluene (20 mL) at 60 °C under 
vigorous stirring and triphenylphosphine (0.21 g, 0.8 mmol) and Imidazole (0.08 g, 1.10 mmol) 
were added. After dissolution, Iodine (0.203 g, 0.8 mmol) was added and the heating was 
continued for 4 h. The solution was cooled and diluted with EtOAc (200 mL). The organic layer 
was washed with saturated solution of Na2SO3 (10 mL) then water (2 x 20 mL), 1 M HCl (20 mL), 
water and finally saturated NaHCO3 (20 mL) and water (20 mL). After drying over magnesium 
sulfate, the solvent was removed under reduced pressure and the residue purified by column 
chromatography (Petrol:EtOAc 4:1) on silica gel to furnish pure compound 326 (0.1 g, 70%). 
 
Refer to provisional structure assignment: 1H NMR (500 MHz, CDCl3): δ 1.36 (s, 3H, CH3 
isopropylidene), 1.37 (s, 3H, CH3 isopropylidene), 1.42 (s, 3H, CH3 isopropylidene), 1.43 (s, 3H, 
CH3 isopropylidene), 1.44 (s, 3H, CH3 isopropylidene), 1.53 (s, 3H, CH3 isopropylidene), 3.32 (d, J 
= 10.7 Hz, 1H, CH2-I), 3.51 (d, J = 10.7 Hz, 1H, CH2-I), 3.73 (dd, J = 8.7, 1.9 Hz, 1H, H-7), 4.03 (dd, 
J = 8.8, 3.9 Hz, 1H, H-7), 4.09 (dd, J = 8.8, 6.0 Hz, 1H, H-4), 4.27 (ddd, J = 8.7, 6.0, 3.9 Hz, 1H, H-
3), 4.33 (d, J = 2.8 Hz, 1H, H-6), 4.37 (dd, J = 7.9, 1.9 Hz, 1H, H-5), 4.64 (dd, J = 7.8, 2.8 Hz, 1H, H-
2); 13C NMR (125 MHz, CDCl3): δ 10.3 (1C, CH2I), 24.4 (1C, CH3 isopropylidene), 25.4 (1C, CH3 
isopropylidene), 25.5 (1C, CH3 isopropylidene), 25.9 (1C, CH3 isopropylidene), 26.7 (1C, CH3 
isopropylidene), 27.2 (1C, CH3 isopropylidene), 67.1 (1C, CH2 C-7), 70.1 (1C, CH carbo), 70.7 (1C, 
CH carbo), 71.3 (1C, CH carbo), 72.0 (1C, CH carbo), 73.3 (1C, CH carbo), 100.8 (1C, Cq C-1), 
108.8 (1C, Cq isopropylidene), 109.5 (1C, Cq isopropylidene), 109.7 (1C, Cq isopropylidene); m/z 
[M+NH4]
+: 488.1128; [C17H27IO7+NH4]
+ requires 488.1140. 
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(3aR,5R,5aS,8aS,8bR)-5-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-2,2,7,7-tetramethyltetrahydro-
3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-trifluoromethanesulfonate (241) 
 
Alcohol 240 (0.1 g, 0.2774 mmol) and pyridine (0.023 mL, 0.2774 mmol) were dissolved in 
anhydrous dichloromethane. The solution was then added to a solution of 
Trifluoromethanesulfonic anhydride (0.05 mL, 0.2774 mmol) in anhydrous dichloromethane at 
0 °C, dropwise over a 15 min period. The reaction mixture was stirred for a further 30 min 
period at 0 °C, reaction was then allowed to warm up to room temperature for a further 30 
min. The reaction mixture was then transferred to a separating funnel and washed quickly with 
an ice-water mixture (2 x 20 mL). The combined organic layers was dried over Na2SO4 and 
evaporated to dryness. The crude product was purified by column chromatography 
(Petrol:EtOAc, 1:2) on silica gel to furnish the pure compound 241 as a colourless oil (0.131 g, 
96%).  
 
 [α]25D -6.0 (c 0.0168 in CHCl3); IR γmax (film)/ cm
-1: 2991, 2939, 2253, 1456, 1419, 1382, 1346, 
1320, 1249, 1211, 1168, 1117, 1046; 1H NMR (500 MHz, CDCl3): δ 1.35 (3H, s, CH3 
isopropylidene), 1.36 (3H, s, CH3 isopropylidene), 1.38 (3H, s, CH3 isopropylidene), 1.41 (3H, s, 
CH3 isopropylidene), 1.43 (3H, s, CH3 isopropylidene), 1.54 (3H, s, CH3 isopropylidene), 3.73 (1H, 
dd, J = 8.8, 1.9 Hz, CH2-CF3SO3), 3.97 (1H, dd, J = 8.9, 3.6 Hz, CH2-CF3SO3), 4.04 (1H, dd, J = 8.9, 
6.0 Hz, H-7), 4.21 (1H, ddd, J = 8.8, 6.0, 3.6 Hz, H-7), 4.31 (1H, d, J = 2.8 Hz, H-4), 4.36 (1H, d, J = 
10.5 Hz, H-3), 4.39 (1H, dd, J = 7.9, 1.9 Hz, H-6), 4.51 (1H, d, J = 10.5 Hz, H-5), 4.68 (1H, dd, J = 
7.9, 2.8 Hz, H-2); 13C NMR (125 MHz, CDCl3): δ 24.1 (1C, CH3 isopropylidene), 25.1 (1C, CH3 
isopropylidene), 25.2 (1C, CH3 isopropylidene), 25.6 (1C, CH3 isopropylidene), 26.6 (1C, CH3 
isopropylidene), 27.2 (1C, CH3 isopropylidene), 67.0 (CH2, CH2-CF3SO3), 69.9 (1C, C-7), 70.3 (1C, 
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C-3), 70.4 (1C, C-4), 70.4 (1C, C-5), 73.1 (1C, C-2), 73.9 (1C, CH2, C-6), 100.5 (1C, C-1), 109.6 (1C, 
Cq isopropylidene), 109.7 (1C, Cq isopropylidene), 109.7 (1C, Cq isopropylidene), 110.2 (1C, Cq 
CF3); m/z [M+H]
+: 493.1343 ; [C18H27F3O10S+H]
+ requires 493.1350. 
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S-(3aS,5R,5aS,8aS,8bR)-5-(R)-2,2-dimethyl-1,3-dioxolan-4-yl-2,2,7,7-tetramethyltetrahydro-
3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-ethanethioate (242) 
 
A mixture of the triflate 241 (0.097 g, 0.203 mmol) and potassium thioacetate (0.0463 g, 0.405 
mmol) in anhydrous DMF (5 mL) was heated at 80 °C for 1 h (colour change from yellow to 
brown observed) or until TLC (Petrol:EtOAc 4:1) showed complete consumption of the starting 
material. The DMF was evaporated under reduced pressure. After diethyl ether was added to 
the reaction mixture and the mixture was washed with water, brine and the combined organic 
layers were then dried over Na2SO4. The solvents were removed under reduced pressure and 
the crude product was purified by column chromatography (Petrol:EtOAc, 4:1) on silica gel to 
furnish pure compound as a colourless liquid 242 (0.079 g, 93%). 
 [α]25D -24.4 (c 0.0087 in CHCl3); IR γmax (film)/ cm
-1: 2994, 2937, 1697, 1371, 1210, 1100, 1070 
996, 911; 1H NMR (500 MHz, CDCl3): δ 1.29 (6H, s, 2 x CH3 isopropylidene), 1.33 (3H, s, CH3 
isopropylidene), 1.34 (3H, s, CH3 isopropylidene), 1.42 (3H, s, CH3 isopropylidene), 1.43 (3H, s, 
CH3 isopropylidene), 2.28 (3H, s, CH3 thioacetate), 3.26 (1H, d, J = 13.8 Hz, CH2SAC), 3.32 (1H, d, 
J = 13.8 Hz, CH2SAC), 3.61 (1H, dd, J = 8.5, 1.8 Hz, H-7), 3.91 (1H, dd, J = 8.8, 4.0 Hz, H-7), 3.99 
(1H, dd, J = 8.8, 6.1 Hz, H-3), 4.14 (1H, d, J = 2.6 Hz, H-4), 4.17 (1H, ddd, J = 8.5, 6.1, 4.1 Hz, H-6), 
4.29 (1H, dd, J = 7.9, 1.8 Hz, H-5), 4.55 (1H, dd, J = 7.9, 2.6 Hz, H-2); 13C NMR (125 MHz, CDCl3): 
δ 24.30 (1C, CH3 isopropylidene), 25.14 (1C, CH3 isopropylidene), 25.36 (1C, CH3 
isopropylidene), 25.72 (1C, CH3 isopropylidene), 26.48 (1C, CH3 isopropylidene), 27.14 (1C, CH3 
isopropylidene), 30.39 (1C, CH3 thioacetate), 37.17 (1C, CH2, CH2SAc), 67.00 (1C, CH2, C-7), 
69.70 (1C, C-3), 70.47 (1C, C-4), 71.03 (1C, C-5), 73.07 (1C, C-2), 73.39 (1C, C-6), 102.96 (1C, Cq 
C-1), 108.73 (1C, Cq isopropylidene), 109.37 (1C, Cq isopropylidene), 109.56 (1C, Cq 
isopropylidene), 194.61 (1C, Cq C=O); m/z [M+H]+: 419.1731; [C19H30O8S+H]
+ requires 419.1734. 
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S-(3aS,5R,5aS,8aS,8bR)-5-(R)-1,2-dihydroxyethyl-2,2,7,7 tetramethyltetrahydro-3aH-bis-
[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-ethanethioate (243) 
 
The triacetonide (0.130 g, 0.311 mmol) 242 was dissolved in 80% aqueous acetic acid (2.2 mL) 
and the mixture was stirred at 50 °C for 3 h or until TLC (EtOAc, KMNO4 stain) showed 
complete consumption of the starting material and a single product was observed. The solvent 
was removed under reduced pressure and the crude product was purified by column 
chromatography (EtOAc, 100%) to furnish the pure compound as a white solid 243 (0.105 g, 
89%).  
IR γmax (film)/ cm
-1: 3442, 2994, 2935, 1697, 1374, 1256, 1210, 1166, 1070, 997, 887, 627; 1H 
NMR (500 MHz, CDCl3): δ 1.35 (3H, s, CH3 isopropylidene), 1.38 (3H, s, CH3 isopropylidene), 
1.48 (3H, s, CH3 isopropylidene), 1.49 (3H, s, CH3 isopropylidene), 2.34 (3H, s, CH3  thioacetate), 
3.32 (1H, d, J = 13.7 Hz, CH2SAC), 3.37 (1H, d, J = 13.7 Hz, CH2SAC), 3.72 – 3.81 (3H, m, H-6, H-7, 
H-7), 3.85 – 3.89 (1H, m, H-5), 4.20 (1H, d, J = 2.6 Hz, H-4), 4.42 (1H, dd, J = 7.9, 1.9 Hz, H-3), 
4.63 (1H, dd, J = 7.9, 2.6 Hz, H-2); 
13C NMR (125 MHz, CDCl3): δ 24.4 (1C, CH3 isopropylidene), 
25.0 (1C, CH3 isopropylidene)., 25.8 (1C, CH3 isopropylidene), 26.3 (1C, CH3 isopropylidene), 
30.4 (1C, CH3 thioacetate), 37.4 (1C, CH2, CH2SAc), 64.1 (1C, CH2, C-7), 69.0 (1C, C-3), 69.9 (1C, 
C-4), 70.6 (1C, C-6), 71.2 (1C, C-5), 73.0 (1C, C-2), 102.9 (1C, Cq C-1), 108.9 (1C, Cq 
isopropylidene), 109.6 (1C, Cq isopropylidene), 194.6 (1C, Cq C=O); m/z [M+H]+: 379.1419; 
[C16H26O8S+H]
+ requires 379.1421. 
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S-(3aS,5R,5aS,8aS,8bR)-5-(R)-2-((tert-butyldimethylsilyl)oxy)-1-hydroxyethyl-2,2,7,7-
tetramethyltetrahydro-3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-ethanethioate 
(244) 
 
Imidazole (0.043 g, 0.633 mmol) and TBSCl (0.04 g, 0.253 mmol) were added to a solution of 
243 (0.08 g, 0.211 mmol) in anhydrous DMF (5 mL).  The resulting solution was stirred at room 
temperature for 16 h, and then diluted with (20 mL) of diethyl ether, washed with water (1 x 
100 mL) and a copper (II) sulfate solution (2 x 100 mL). The aqueous layers were back extracted 
with diethyl ether, and then the combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography on silica gel (Petrol:EtOAc, 4:1) to furnish pure compound 244 (0.075 g, 72%) 
as a clear, colourless oil.  
IR γmax (film)/ cm
-1: 3529, 2966, 2934, 2933, 2957, 1697, 1462, 1382, 1253, 1210, 1072; 1H NMR 
(500 MHz, CDCl3): δ -0.00 (3H, s, SiCH3), 0.01 (3H, s, SiCH3), 0.82 (9H, s, SiC(CH3)3), 1.29 (3H, s, 
CH3 isopropylidene), 1.31 (3H, s, CH3 isopropylidene), 1.40 (3H, s, CH3 isopropylidene), 1.42 (3H, 
s, CH3 isopropylidene), 2.27 (3H, s, CH3 thioacetate), 2.59 (1H, s, OH), 3.27 (1H, d, J = 4.0 Hz, 
CH2SAC), 3.30 (1H, d, J = 13.7 Hz, CH2SAC), 3.59 – 3.54 (1H, m, H-6), 3.63 (1H, dd, J = 8.5, 1.8 Hz, 
H-4), 3.78 – 3.73 (2H, m, H-7, H-7), 4.10 (1H, dd, J = 9.3, 2.5 Hz, H-3), 4.38 (1H, dd, J = 7.9, 1.9 
Hz, H-3), 4.54 (1H, dd, J = 7.9, 2.5 Hz, H-2); 13C NMR (125 MHz, CDCl3): δ -5.4 (1C, SiCH3), -5.3 
(1C, SiCH3), 18.3 (1C, Cq, SiC), 24.3 (1C, CH3 isopropylidene), 25.0 (1C, CH3 isopropylidene), 25.8 
(1C, CH3 isopropylidene), 26.0 (3C, SiC(CH3)3), 26.6 (1C, CH3 isopropylidene), 30.3 (1C, CH3 SAc), 
37.5 (1C, CH2OSAc), 64.0 (1C, CH2 C-7), 68.3 (1C, C-3), 69.5 (1C, C-4), 70.6 (1C, C-6), 71.1 (1C, C-
5), 73.0 (1C, C-2), 102.8 (1C, Cq C-1), 108.6 (1C, Cq isopropylidene), 109.4 (1C, Cq 
isopropylidene), 194.8 (1C, Cq C=O); m/z [M+H]+: 493.2280; [C22H40O8SSi+H]
+ requires 
493.2286. 
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S-(3aS,5S,5aR,8aS,8bR)-5-2-tert-butyldimethylsilyloxyacetyl-2,2,7,7-tetramethyltetrahydro-
3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-ethanethioate (247) 
 
DMSO (0.02 mL, 0.28 mmol) was slowly added to a solution of oxalyl chloride (0.011 mL, 0.122 
mmol) in anhydrous dichloromethane at -78 °C and the solution was stirred for a further 30 
min at this temperature. A solution of 244 (0.04 g, 0.081mmol) in anhydrous dichloromethane 
was added dropwise to the reaction mixture and the solution was stirred for 1 h. TEA (0.05 mL, 
0.39 mmol) was slowly added to the reaction mixture at the same temperature and the 
solution was then warmed up to 0 °C and stirred at this temperature for a further 30 min. After 
the mixture was allowed to warm up to room temperature, water, a saturated solution of 
NH4Cl and a 2 M HCl were added the mixture was extracted with dichloromethane. The 
combined organic layers were further washed with water, brine and dried over MgSO4. The 
solvent was removed under reduced pressure and the product 247 as a colourless syrup (0.039 
g, quantitative). 
IR γmax (film)/ cm
-1: 2989, 2931, 2856, 2856, 1742, 1699, 1462, 1384, 1324, 1256, 1210, 1128, 
1071; 1H (500 MHz, CDCl3): δ -0.00 (3H, s, SiCH3), 0.01 (3H, s, SiCH3), 0.82 (9H, s, SiC(CH3)3), 1.29 
(3H, s, CH3 isopropylidene), 1.31 (3H, s, CH3 isopropylidene), 1.40 (3H, s, CH3 isopropylidene), 
1.42 (3H, s, CH3 isopropylidene), 2.27 (3H, s, CH3 thioacetate), 3.32 – 3.24 (2H, m, CH2SAc), 3.59 
– 3.55 (1H, m, H-3), 3.63 (1H, dd, J = 8.5, 1.9 Hz, H-4), 3.76 (1H, d, J = 1.9 Hz, H-2), 4.11 (1H, d, J 
= 2.5 Hz, H-5), 4.38 (1H, dd, J = 7.9, 1.9 Hz, H-7), 4.55 – 4.52 (1H, m, H-7); 13C NMR (125 MHz, 
CDCl3): δ -5.48 (1C, SiCH3), -5.26 (1C, SiCH3), 18.52 (1C, Cq, SiC) 24.86 (1C, CH3 isopropylidene), 
25.59 (1C, CH3 isopropylidene), 25.89 (3C, SiC(CH3)3), 25.95 (1C, CH3 isopropylidene), 26.35 (1C, 
CH3 isopropylidene), 30.40 (1C, CH3, SAc), 37.45 (1C, CH2OSAc), 64.01 (1C, CH2 C-7), 70.94 (1C, 
C-4), 71.91 (1C, C-3), 73.01 (1C, C-5), 74.65 (1C, C-2), 102.80 (1C, Cq C-1), 109.05 (1C, Cq 
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isopropylidene), 109.81 (1C, Cq isopropylidene), 194.23 (1C, Cq C=O, SAc), 205.65 (1C Cq, C=O); 
m/z [M+NH4]
+: 508.2383; [C22H38O8SSi+NH4]
+ requires 508.2395. 
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S-(3aS,5R,5aS,8aS,8bR)-5-(R)-2-tert-butyldiphenylsilyl-oxy-1-hydroxyethyl-2,2,7,7-
tetramethyltetrahydro-3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-ethanethioate 
(245) 
 
TBDPSCl (0.25 mL, 0.941 mmol) and Imidazole (0.13 g, 1.882 mmol) were added to a solution of 
243 (0.356 g, 0.941 mmol) in anhydrous DMF (25 mL). The reaction was heated at 50 °C and 
left to stir for 48 h. After 48 h water (100 mL) was added, and the mixture was extracted with 
diethyl ether three times. The combined organic layer was washed successively with water, 
brine and dried over Na2SO4. The solvent was removed under reduced pressure and the crude 
product was purified by column chromatography (Petrol:EtOAc, 4:1) to yield the pure 
compound 245 (0.43 g, 74%) as a colourless oil.  
IR γmax (film)/ cm
-1: 3551, 3072, 3049, 2989, 2934, 2895, 2858, 1695, 1472, 1462, 1428, 1382, 
1373, 1256, 1210, 1186, 1132, 1105, 1073, 906; 1H NMR (500 MHz, CDCl3): δ 1.06 (9H, s, 
Si(CH3)3), 1.35 (3H, s, CH3 isopropylidene), 1.38 (3H, s, CH3 isopropylidene), 1.41 (3H, s, CH3 
isopropylidene), 1.47 (3H, s, CH3 isopropylidene), 1.96 (1H, s, OH), 2.30 (3H, s, CH3 thioacetate), 
3.26 (2H, s, CH2SAC), 3.80 – 3.72 (3H, m, H-4, H-2, H-3), 3.85 (1H, ddd, J = 8.7, 5.1, 3.9 Hz, H-6), 
4.12 (1H, d, J = 2.5 Hz, H-5), 4.38 (1H, dd, J = 7.9, 1.9 Hz, H-7), 4.54 (1H, dd, J = 7.9, 2.5 Hz, H-7), 
7.37 – 7.29 (6H, m, CH aryl), 7.70 (4H, m, CH aryl); 13C NMR (125 MHz, CDCl3): δ 19.35 (1C, Cq, 
SiC), 24.43 (1C, CH3 isopropylidene), 25.09 (1C, CH3 isopropylidene), 25.87 (1C, CH3 
isopropylidene), 26.63 (1C, CH3 isopropylidene), 27.02 (3C, SiC(CH3)3), 30.45 (1C, CH3  
thioacetate), 37.66 (1C, CH2SAc), 64.66 (1C, CH2, C-7), 68.20 (1C, C-3), 69.91 (1C, C-4), 70.79 
(1C, C-6), 71.28 (1C, C-5), 73.09 (1C, C-2), 102.95 (1C, Cq, C-1), 108.63 (1C, Cq, isopropylidene), 
109.42 (1C, Cq, isopropylidene), 127.84 (2C, 2CH aryl), 127.90 (2C, 2CH aryl), 129.78 (1C, CH 
aryl), 129.91 (1C, CH aryl), 133.02 (1C, CH aryl), 133.20 (1C, CH aryl), 135.77 (2C, 2CH aryl), 
135.79 (2C, 2CH aryl), 194.93 (1C, Cq C=O thioacetate); m/z [M+NH4]
+: 634.2857; 
[C32H44O8SSi+NH4]
+ requires 634.2864.  
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S-(3aS,5S,5aR,8aS,8bR)-5-2-tert-butyldiphenylsilyl-oxy-acetyl-2,2,7,7-tetramethyltetrahydro-
3aH-bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl) ethanethioate (248) 
 
DMSO (0.114 mL, 1.6 mmol) was slowly added to a solution of oxalyl chloride (0.061 mL, 0.713 
mmol) in anhydrous dichloromethane at -78 °C and the solution was stirred for a further 30 
min at this temperature. A solution of 245 (0.293 g, 0.48 mmol) in anhydrous dichloromethane 
was added dropwise to the reaction mixture and the solution was stirred for 1 h. TEA (0.318 
mL, 2.28 mmol) was slowly added to the reaction mixture at the same temperature and the 
solution was then warmed up to 0 °C and stirred at this temperature for a further 30 min. After 
the mixture was allowed to warm up to room temperature, water, a saturated solution of 
NH4Cl and a 2 M HCl were added the mixture was extracted with dichloromethane. The 
combined organic layers were further washed with water, brine and dried over MgSO4. The 
solvent was removed under reduced pressure and the product 248 as a colourless syrup. (0.294 
g, quantitative) 
IR γmax (film)/ cm
-1: 3072, 3050, 2990, 2934, 2896, 2858, 1962, 1892, 1742, 1704, 1695, 1589, 
1473, 1462, 1428, 1384, 1373, 1324, 1307, 1256, 1210, 1163, 1113; 1H NMR (500 MHz, CDCl3): 
δ 1.02 (9H, s, Si(CH3)3), 1.18 (3H, s, CH3 isopropylidene), 1.18 (3H, s, CH3 isopropylidene), 1.30 
(3H, s, CH3 isopropylidene), 1.37 (3H, s, CH3 isopropylidene), 2.15 (3H, s, CH3 thioacetate), 3.16 
(1H, d, J = 13.8 Hz, CH2SAc), 3.33 (1H, d, J = 13.8 Hz, CH2SAc), 4.11 (1H, d, J = 2.2 Hz, H-3), 4.29 
(1H, d, J = 1.8 Hz, H-4), 4.42 (1H, m, H-7), 4.54 – 4.49 (2H, m, H-2, H-5), 4.60 (1H, m, H-7), 7.37 – 
7.27 (6H, m, CH aryl), 7.63 – 7.58 (4H, m, CH aryl); 13C NMR (125 MHz, CDCl3): δ 19.36 (1C, Cq, 
SiC), 24.07 (1C, CH3 isopropylidene), 24.85 (1C, CH3 isopropylidene), 25.36 (1C, CH3 
isopropylidene), 26.33 (1C, CH3 isopropylidene), 26.77 (3C, SiC(CH3)3), 30.22 (1C, CH3  
thioacetate), 37.31 (1C, CH2SAc), 69.03 (1C, CH2, C-7), 70.92 (1C, C-4), 71.86 (1C, C-3), 72.93 
(1C, C-5), 74.66 (1C, C-2), 102.76 (1C, Cq, C-1), 109.00 (1C, Cq, isopropylidene), 109.83 (1C, Cq, 
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isopropylidene), 127.70 (2C, 2CH aryl), 127.75 (2C, 2CH aryl), 129.68 (1C, CH aryl), 129.72 (1C, 
CH aryl), 133.02 (1C, CH aryl), 133.26 (1C, CH aryl), 135.57 (2C, 2CH aryl), 135.64 (2C, 2CH aryl), 
194.18 (1C, Cq C=O, SAc), 204.68 (1C, Cq C=O); m/z [M+NH4]+: 632.2702; [C32H42O8SSi+NH4]
+ 
requires 632.2708. 
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S-(3aS,5R,5aS,8aS,8bR)-5-(R)-1-hydroxy-2-trityloxy-ethyl-2,2,7,7-tetramethyltetrahydro-3aH-
bis-[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-ethanethioate (246) 
 
Diol 243 (0.733 g, 1.94 mmol) and TEA (0.54 mL, 3.88 mmol) were dissolved in anhydrous 
dichloromethane. Trityl chloride (0.6 g, 2.134 mmol) was added dropwise in a dichloromethane 
solution at 0 °C. The reaction mixture was allowed to warm up to room temperature and 
stirred a further 8 h or until TLC showed complete consumption of the starting material. Water 
was added to the reaction mixture and the mixture was extracted with dichloromethane (50 
mL x 2). The combined organic layers were dried over MgSO4 and the solvent was removed 
under reduced pressure. The crude product was purified by column chromatography 
(Petrol:EtOAc, 4:1) on silica gel to give the pure compound 246 as a white solid (1.066 g, 89%). 
Prior to chromatography a few drops of TEA 2% of eluent was added to neutralise the silica gel.  
IR γmax (film)/ cm
-1: 3434, 3059, 2988, 2945, 1693, 1494, 1451, 1382, 1321, 1309, 1258, 1172, 
1140, 995, 908; 1H NMR (500 MHz, CDCl3): δ 1.32 (3H, s, CH3 isopropylidene), 1.38 (3H, s, CH3 
isopropylidene), 1.40 (3H, s, CH3 isopropylidene), 1.45 (3H, s, CH3 isopropylidene), 2.33 (3H, s, 
CH3 thioacetate), 2.66 (1H, s, OH), 3.29 (1H, d, J = 6.8 Hz, CH2SAc), 3.33 (2H, d, J = 3.0 Hz, H-2, 
H-4), 3.43 (1H, d, J = 6.8 Hz, CH2SAc), 3.93 (2H, s, H-7, H-7), 4.19 (1H, d, J = 2.3 Hz, H-5), 4.37 
(1H, d, J = 7.9 Hz, H-3), 4.59 (1H, dd, J = 7.9, 2.3 Hz, H-6), 7.29-7.23 (10H, m, CH aryl), 7.45 (5H, 
m, CH aryl); 13C NMR (125 MHz, CDCl3): δ 24.3 (1C, CH3 isopropylidene), 25.0 (1C, CH3 
isopropylidene), 25.8 (1C, CH3 isopropylidene), 26.4 (1C, CH3 isopropylidene), 30.4 (1C, CH3  
thioacetate), 37.5 (1C, CH2SAc), 63.7 (1C, CH2, C-7), 68.0 (1C, C-6), 69.5 (1C, C-3), 70.8 (1C, C-4), 
71.2 (1C, C-2), 72.9 (1C, C-5), 86.7 (1C, Cq aryl), 103.0 (1C, Cq C-1), 108.6 (1C, Cq 
isopropylidene), 109.3 (1C, Cq isopropylidene), 127.0 (3C, 3CH, aryl), 127.9 (6C, 6CH, aryl), 
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128.8 (6C, 6CH, aryl), 143.9 (3C, 3Cq, aryl), 195.0 (1C, Cq, C=O, SAc); m/z [M+Na]+: 643.2327; 
[C35H40O8S+Na]
+ requires 643.2336. 
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S-(3aS,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-5-2-trityloxy-acetyl-tetrahydro-3aH-bis-
[1,3]dioxolo-[4,5-b:4',5'-d]pyran-3a-yl-methyl-ethanethioate (249) 
 
DMSO (0.077 mL, 1.08 mmol) was slowly added to a solution of Oxalyl chloride (0.0412 mL, 
0.48 mmol) in anhydrous dichloromethane at -78 °C and the solution was stirred for a further 
30 min at this temperature. A solution of 246 (0.2 g, 0.322 mmol) in anhydrous 
dichloromethane was added dropwise to the reaction mixture and the solution was stirred for 
1 h. TEA (0.216 mL, 1.55 mmol) was slowly added to the reaction mixture at the same 
temperature and the solution was then warmed up to 0 °C and stirred at this temperature for a 
further 30 min. After the mixture was allowed to warm up to room temperature, water, a 
saturated solution of NH4Cl and a 2 M HCl were added the mixture was extracted with 
dichloromethane. The combined organic layers were further washed with water, brine and 
dried over MgSO4. The solvent was removed under reduced pressure and the product was 
purified by column chromatography (Petrol:EtOAc, 4:1) on silica gel to give pure compound 
249 (0.102 g, 51%) Prior to column chromatography 2% TEA was added to the eluent to 
neutralise the silica gel.  
IR γmax (film)/ cm
-1: 3087, 3059, 3024, 2989, 2936, 2945, 1738, 1697, 1491, 1449, 1442, 1384, 
1373 1323, 1162, 1099, 1070, 1033, 954, 906; 1H NMR (500 MHz, CDCl3): δ 1.12 (3H, s, CH3 
isopropylidene), 1.19 (3H, s, CH3 isopropylidene), 1.32 (3H, s, CH3 isopropylidene), 1.41 (3H, s, 
CH3 isopropylidene), 2.26 (3H, s, CH3 thioacetate), 4.02 – 4.11 (3H, m, CH2SAC, H-3), 4.12 – 4.15 
(1H, m, H-4), 4.26 – 4.29 (1H, m, H-7), 4.48 – 4.52 (1H, m, H-7), 4.52 – 4.56 (2H, m, H-2, H-5), 
7.16 – 7.29 (10H, m, CH aryl), 7.40 – 7.45 (5H, m, CH aryl); 13C NMR (125 MHz, CDCl3): δ 24.1 
(1C, CH3 isopropylidene), 24.8 (1C, CH3 isopropylidene), 25.4 (1C, CH3 isopropylidene), 26.3(1C, 
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CH3 isopropylidene), 30.3 (1C, CH3  thioacetate), 37.4 (1C, CH2OSAc), 69.2 (1C, CH2 C-7), 70.9 
(1C, C-4), 72.0 (1C, C-3), 72.9 (1C, C-5), 74.6 (1C, C-2), 86.9 (1C, Cq aryl), 102.7 (1C, Cq, C-1), 
109.1 (1C, Cq isopropylidene), 109.8 (1C, Cq isopropylidene)127.1 (3C, 3CH aryl), 128.0 (6C, 
6CH aryl), 128.7 (6C, 6CH aryl), 143.5 (3C, 3Cq aryl), 194.3 (1C, C=O ketone), 203.4 (1C, C=O, 
thioacetate); m/z [M+NH4]
+: 636.2624; [C35H38O8S+NH4]
+ requires 636.2626. 
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